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1A.1 Which patients miss booked appointments with their general practice and why? A 
systematic review 
Jo Parsons and Carol Bryce, University of Warwick 
Dr Joanne Parsons, Dr Carol Bryce, Adam Steege, Joanna Gao and Dr Helen Atherton. 
Problem  
Missed GP appointments have substantial time and cost implications for the NHS, with an estimated 
15 million appointments being missed annually. The high volume of missed appointments potentially 
exacerbates health inequalities of some patient groups, reduces access to general practice 
appointments, and decreases finite GP capacity. The aim of this review is to examine which patient 
groups are more likely to miss appointments, and to explore the reasons that patients miss 
appointments. 
Approach 
Medline, Premedline, Embase, PsychInfo, Web of Science, Scopus, Cochrane reviews and 
CENTRAL were searched. Terms relating to General Practice and missed appointments were 
included in the searches. We included all studies published since 2003 which considered missed 
appointments using any study design. Titles, abstracts and full texts of results were screened, and 
relevant data was extracted from included studies. Quality assessment was conducted on included 
studies, using the Mixed Methods Appraisal Tool. A narrative synthesis will be conducted on included 
studies. 
Findings  
Preliminary results indicate that 40 studies fit eligibility criteria to be included in the review, which is 
ongoing. The review aims to identify patients who miss booked appointments in general practice. 
Using demographic information about patients who miss appointments we will discuss who books the 
missed appointments, who the appointments were booked with and reasons why patients missed 
these appointments. This data will be used to further understand which patients miss booked 
appointments and why. 
Consequences  
Understanding missed appointments and the reasons patients miss appointments will help identify 
patient groups that are more likely to miss appointments and use this information to target initiatives 
to reduce missed appointments, and shape services to suit these groups. Reducing the number of 
missed appointments will help to reduce the cost and burden on general practices and the work will 
help identify any patterns of health inequity within the NHS. This will further help to identify and make 
plans to rectify unmet need. 
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1A.2 Is continuity of primary care declining in England? A longitudinal study at practice-level 
with repeated measures for the years 2012 to 2017 
Peter Tammes, University of Bristol 
Richard W Morris, Chris Salisbury 
Problem  
Continuity of care, usually defined as seeing the same GP, is central to primary care and is 
associated with improved patient outcomes. We aimed (i) to confirm reports of decline in continuity of 
care, ii) to identify patient characteristics and experiences associated with any decline, iii) to identify 
consequences of any decline for patients. 
Approach 
Longitudinal study applying multilevel modelling whereby time and practices were level-1 and level-2 
units, respectively. Aggregated data at practice-level came from repeated questions in GP-Patient 
Surveys between 2012-2017. We analysed (i) trends in percentages of patients reporting A) having a 
preferred GP, and B) seeing their preferred GP always/often. We also estimated regression 
coefficients for relationships between percentages of patients (iiA) having and (iiB) seeing their 
preferred GP always/often and percentages of patients in a practice with long-term conditions (LTCs) 
and difficulties in appointment-making, and (iii) between the percentage of patients confident in 
health-management and percentage of patients seeing their preferred GP always/often. We focused 
on relationships within practices over time, since these reflect effects of changes in the indicators on 
changes in outcome. Models were adjusted for age, gender, ethnicity, religion, full-time work/study, 
and response rates. Practice-years were excluded if response rate was less than 20% or had missing 
information, resulting in over 42,000 observations (practice-years) in the three regression modelsF. 
Findings  
Overall, 56.7% (95%CI 56.4, 57.0) of patients had a preferred GP in 2012, this declined gradually by 
9.4%-points (95%CI -9.6, -9.2) by 2017. Of these patients, 66.4% (95%CI 66.0, 66.8) always/often 
saw their preferred GP when consulting in 2012. This gradually declined by 9.7%-points (95%CI -
10.0, -9.4) by 2017. When practices showed an increase over time of 10% of their patients having 
difficulties in appointment-making then the percentage having a preferred GP decreased by 0.7%-
points (95%CI -0.8, -0.6) and the percentage always/often seeing their preferred GP decreased by 
4.6%-points (95%CI -4.7, -4.4). An increase over time of 10% of patients having LTCs was associated 
with an increasing percentage having a preferred GP by 1.7%-points (95%CI 1.6, 1.8) and increasing 
percentage seeing always/often their preferred GP by 0.5%-points (95%CI 0.3, 0.6). When practices 
showed a decrease over time of 10% of their patients seeing their preferred GP always/often then the 
percentage of patients confident in health-management decreased by 0.2% (95%CI -0.2, -0.1). 
Consequences  
Patients reported a steady decline over time in continuity of care. Access difficulties led to worse 
continuity of care while an increase in patients with LTCs resulted only in a slight increase in 
continuity of care. Declining continuity of care was associated with a slight decline in patient health-
management. Continuation of declining continuity of care could result in poorer patients’ outcomes 
and should alarm clinicians and policymakers. 
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1A.3 A Quantitative Service Evaluation of a Telephone Outreach Initiative to Enhance the 
Uptake of NHS Health Checks 
Nikki Coghill, University of Bath 
Problem  
The NHS Health Check programme aims to identify cardiovascular (CV) risk in those aged 40-74, with 
the goal of reducing cardiovascular events and health inequalities.CV incident is higher in lower 
socioeconomic and ethnic minority groups. Invitations for a Checks are usually made via letter. 
However, research has indicated that telephone and verbal invitations increase likelihood of 
attendance. To address this and encourage the above groups to better engage with NHS Health 
Checks we adopted a novel approach compared to the usual invite. Our aim was to determine the 
efficacy of a targeted telephone outreach service for inviting patient from ‘hard to reach groups for an 
NHS health Check, in general practices located in the most deprived areas of Bristol.  
Approach 
Using a quasi-experimental approach, 12 general-practices self-selected to use the telephone 
outreach initiative (intervention). Specially trained, community-link workers contacted patients, and 
conducted aspects of the Check by phone. Following this, patient’s were invited to complete 
remaining aspects of their Check at their general-practice. Five practices acted as a control, using a 
letter, opportunistic or telephone call invitations; with no aspect of the Check being conducted during 
the telephone call. Primary outcome: Compare the rate of uptake of an NHS Health Check in the 
target population, in GP practices using the telephone outreach initiative, with the rate of uptake in 
control Secondary outcomes: Investigate the relationship between attendance and patient 
demographics (age, gender, IMD and ethnicity) in the target population. Descriptive statistics 
characterised populations and binary logistical regression tested associations between attendance for 
a health check and population characteristics.  
Findings  
Uptake was 24% and 35% in intervention versus control practices. Missing data precluded inclusion 
of ethnicity in regression models. Intervention practices were more successful at attracting ethnic 
minority patients to complete their Check (25.6%) compared to control practices (7.2%). In 
intervention practices after controlling for age, gender, IMD quintile and telephone-call outcome, age 
wasn’t a significant predictor of attendance; compared to women, men were significantly less likely to 
complete their Check (OR 0.75 95% CI 0.58 to 0.98); IMD was a significant predicator of attendance 
with those in the fifth IMD quintile being less likely to attend compared to those in the first IMD quintile 
(OR 0.64 95% CI 0.50 to 0.82).  
Consequences  
Despite this initiative being offered by the most deprived practices in Bristol, it attracted the least 
deprived patients. However, intervention practises were more successful at attracting patients from 
ethnic minorities. We only evaluated the first nine months of the initiative. Previous novel initiatives 
encouraging uptake of Health Checks, in Bristol, have shown a lagged adoption. Feedback on 
improvements, based on recommendations from this evaluation, may result in enhanced uptake from 
the intervention as it further embeds within practices. 
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1A.4 Inequalities in place of death associated with deprivation in England 
Sam Hodgson, University of Southampton 
Layla Guscoth, Jack Hodgson 
Problem  
Inequality is rising in the United Kingdom in multiple domains. Achieving equity in access to preferred 
place of death has been on the public and political agenda for decades. A majority of patients would 
prefer to die in their own home or a hospice, and few would choose to die in hospital. Historic data 
demonstrate an association between deprivation rates and inequalities in place of death. We analyse 
associations and trends in deprivation and location of death in England between 2015 and 2019.  
Approach 
We performed cross-sectional analyses of association between place of death and deprivation in 
England between 2015 and 2019. Data on Index of Multiple Deprivation (IMD) and place of death was 
obtained from publicly available Office of National Statistics datasets. Recorded death locations were: 
usual residence; in a hospital; in a care home; in a hospice. Associations between levels of 
deprivation and proportions of deaths in each location were assessed with correlation coefficients 
calculated using Kendall’s method, and compared over time.  
Findings  
The proportion of patients dying in hospital was higher in more deprived areas in both 2015 
(correlation coefficient = 0.30, p < 0.001) and 2019 (correlation coefficient = 0.23, p < 0.001). The 
proportion of patients dying at their usual residence was lower in more deprived areas in both 2015 
(correlation coefficient -0.29, p < 0.001) and 2019 (correlation coefficient = -0.24, P < 0.001). There 
was no correlation between the proportion of patients dying in hospice and IMD in either 2015 
(correlation coefficient = -0.04, p = 0.40) or 2019 (correlation coefficient = -0.03, p = 0.51). There was 
no significant difference between 2015 and 2019 correlation coefficients for any of the analysed 
places of death.  
Consequences  
Inequalities in place of death associated with deprivation levels persisted from 2015 to 2019 in 
England. Despite few people wanting to die in hospital, there is a clear socioeconomic disparity in 
place of death. More research is required into long-term care availability in more deprived areas, 
access to those services and education surrounding preferred place of care. 
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1A.5 Chinese People within End of Life Care in Community Settings: A Scoping Review 
Susan Zhao, University of Warwick 
Jeremy Dale,  Rachel Potter 
Problem  
End of life (EoL) care is becoming a global challenge and a public health issue as a large number of 
people involved and unmet needs population (WHO, 2014). Promoting community based EoL care 
helps reach people who are in needs. Culture has a profound influence on our understanding of what 
is appropriate care for patients at the end of life, however the evidence base is paucity, particularly in 
Chinese cultural background. The researches focused on Chinese people within end of life care in 
community settings are under-resourced. It’s needed to assess the breadth of a body of literature in 
this area and identify gaps in existing literature.  
Approach 
A systematic scoping review was carried out to address the identified review question--’What does 
know about Chinese people within EoL care in community settings?’. This approach enables to 
systematically assess the breadth of a body of literature in this particular research area. It’s 
particularly useful when mapping broad areas of research and helping to identify gaps in existing 
literature. Using this approach, we conducted systematic searches following search strategy, 
reviewed, categorised and synthesised a large volume of published research on Chinese people 
within end of life care in community settings. Quality assessment was not conducted.  
Findings  
The results indicate the number of publications by year (1993-Feb 2019), the location of publications, 
the methods of published studies, the areas of studies focused on, and the participants of studies in 
the available published literature.  
Consequences  
The existing literature of this research area varies in the amount of researches conducted, the 
methods’ application, the focused study areas and the characters of participants in different location. 
The results suggested that research evidences are needed in caring for Chinese people within EoL in 
community settings in different country context. The identified gaps of the literature in different 
location enable researchers to develop future research based on their own country context. 
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1A.6 How do we offer Improved Access with limited staff? 
Kim Harman, Bath Enhanced Medical Services+ 
Julia Griffiths, Dan Smith, Roger Stead 
Problem  
The demand for Primary care services are increasing, more people are working, the increase in 
demand is acutely seen in working-age populations.  
Approach 
The Improved Access service is designed to provide GP Practices with an additional option when they 
are unable to offer a suitable appointment during their own opening times. It is not an alternative to 
the usual GP Practice. We use local staff to make the most of their knowledge. Currently employing 
23 GPs, 17 nurses and 9 receptionists. 4 practices cover the Bath & NE Somerset (BaNES) 
geographical area as hosts; in Bath city, Paulton and Keynsham.  As most practices use SystmOne 
this is our Electronic Medical Record System (EMRS) of choice. This allows booking directly into the 
service by the practice, increasing confidence by patients, plus clinical notes to be both 
accessed/updated in real time. When booking an appointment, the Practice asks for consent to share 
the individual’s medical records with the service.  Appointments are available Monday-Friday 18:00-
21:00, Saturday/Sunday 08:00-12:00, with appointments available up to 4 weeks in advance. We 
monitor the presenting problems by splitting into general/mental 
health/dermatology/gynaecology/acute/systemic illness/MSK. The clinicians can refer for further 
investigations and to other services. The EMRS ‘task’ method is used to inform home practices of 
attendance/outcomes.  
Findings  
Clinics have recently run at 91% of booking capacity, GP appointments 90%, nurse 70%. The wait for 
an appointment is most commonly 2 days, 61% of patients seen within 3 days of request. We have 
monitored which practices refer, the number of patents, total, and from each practice. All practices 
refer. The numbers of patients aged 0-16y and >65y has always been low compared to 17-65y. The 
number using the service has been steady since February 2019 (means 0-16y 77/month, 17-65y 
717/month, >65y 137/month).  More females (+/-30%) use the service than males, mirroring primary 
care nationally, the pattern of use paralleling each other. The main presenting problems are 
(excluding general problems) Dermatology and MSK - Mar-Sept 2019 550 and 509 patients, 26% 
receive prescriptions, 5% further investigations, 3% secondary care referrals. Patient satisfaction 
survey results continue to show 100% positive rates, with a mean return rate of 31%.  
Consequences  
Those practices that historically did not use SystmOne at the beginning of the project have a reduced 
uptake but since they have changed access use has increased.  The host practices use the service 
more -the surroundings for patients may play a part as the staff vary. NHS England and the CCG 
have suggested considering providing additional sessions to better meet the contractual obligation of 
95hours per week - current mean 81hrs. To increase staffing, we may consider using ANPs to 
compliment to GPs to assist with prescribing. The presenting problem use shows we need to employ 
staff with Dermatology and MSK skills. 
 
  
13 
 
1B.1 Acceptability, understanding and experience of diagnostic tests for prostate cancer: a 
qualitative study with GPs 
Samuel W D Merriel, University of Exeter 
Dr Alice Forster, Dr Steph Archer, Mr David Eldred-Evans, Mr John McGrath, Prof Hashim Ahmed, 
Prof Willie Hamilton, Dr Fiona Walter 
Problem  
Multiparametric MRI (mpMRI) is a new diagnostic test for prostate cancer, and is now recommended 
by NICE prior to prostate biopsy. Diagnostic accuracy studies show mpMRI can improve biopsy 
accuracy and avoid potentially unnecessary biopsies, but other important aspects of implementing 
mpMRI as a new diagnostic test have not been examined. There are no studies assessing 
acceptability of mpMRI for prostate cancer with any theoretical underpinning. There are very few 
studies exploring GP’s understanding of diagnostic tests for prostate cancer. The aim of this study is 
to understand, from the perspective of GPs, the acceptability of mpMRI as a diagnostic test for 
prostate cancer.  
Approach 
This qualitative study employed semi-structured interviews with GPs who have referred men with 
suspected prostate cancer for further investigation in the last 12 months. GPs were recruited via the 
NIHR Clinical Research Network in South-West England and London. Interviews were conducted in-
person or via telephone, and all were conducted by SM. They were audio recorded, and transcribed 
verbatim. A thematic analysis approach has been taken, both inductively by generating codes and 
themes from the data and deductively using Sekhon’s Theoretical Framework of Acceptability (TFA). 
The analysis team (SM, FW, and SA) discussed and refined the codes and themes to produce a 
thematic map, based on the early interviews. This study has ethical approval from the NHS Health 
Research Authority and the NHS South West - Frenchay Research Ethics Committee.  
Findings  
11 GPs have been interviewed, with a spread of age (38-46 years) and gender (6 female). All 
interviews have been conducted, recorded and transcribed. Early analysis found there was a range of 
views regarding the potential for GPs to utilise mpMRI in the diagnosis of prostate cancer in primary 
care; some GPs felt it should remain a secondary care test whilst others could see GPs using it in the 
future. GPs raised some concerns about the cost and availability of mpMRI. Further analysis of the 
interviews, and application of Sekhon’s TFA will be conducted prior to SW SAPC.  
Consequences  
The new NICE recommendations do not specify whether mpMRI should be performed in primary or 
secondary care. Given the potential to reduce unnecessary prostate biopsies and the apparent 
acceptability of mpMRI to patients and clinicians, mpMRI could one day be used in primary care in the 
assessment of men with possible prostate cancer to reduce urgent urology referrals and avoid 
prostate biopsy complications. Financial, resource, and workforce implications for the NHS would 
need to be considered prior to GP access to mpMRI. 
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1B.2 Oesophagogastric cancer: Timeliness of diagnosis in patients with pre-existing disease 
Sarah Price, University of Exeter 
Sarah Price, Willie Hamilton 
Problem  
Pre-existing conditions may complicate cancer diagnosis by presenting diagnostic alternatives for 
cancer symptoms or by competing for clinical attention. This study investigated associations between 
time to oesophagogastric cancer diagnosis and (a) pre-existing conditions providing plausible 
diagnostic alternatives to cancer; and (b) number of pre-existing conditions. Oesophagogastric cancer 
was studied because of its poor 1-year survival (42%) and the unknown impact of pre-existing 
conditions on the diagnostic process.  
Approach 
This primary care study used Clinical Practice Research Datalink data with English cancer registry 
linkage. Patients were aged ≥55 with an incident diagnosis of oesophagogastric cancer between 
01/01/2012 and 31/12/2017. Diagnosis date was the earliest recorded CPRD or Registry diagnostic 
code. The index date was assigned as when patients met criteria for investigation in National Institute 
for Health and Care Excellence referral guidelines for suspected oesophagogastric cancer. It was 
determined from the patient’s age and the presence of codes for dysphagia, haematemesis, upper 
abdominal pain, weight loss, nausea, vomiting, dyspepsia, or reflux. CPRD records in the 2 years 
before the index date were searched for diagnostic codes for pre-existing conditions listed in the 
Quality and Outcomes Framework, or which provided plausible diagnostic explanations for the cancer 
symptoms.  Time from index date to diagnosis was modelled using an accelerated failure time model, 
reporting time ratios (TR) with 95% confidence interval (CI). Predictors included cancer site (stomach 
or oesophagus), age, sex, pre-existing condition count, an “alternative-explanations” variable where 
pre-existing condition(s) offered diagnostic alternatives at the index date. Interaction terms were 
sought by separate cancer site.  
Findings  
3,806 (69.0% male) patients were studied, of whom 1,982 (68.8% male) met NICE criteria for 
investigation. Mean (standard deviation) age at diagnosis was 74.6 (9.5) and 72.9 (10.0) years, 
respectively, for stomach (n=526/1,982, 26.5%) and oesophageal (n=1,456/1,982, 73.5%) cancers. At 
least one pre-existing condition was diagnosed in 317/526 (60.3%) stomach and in 794/1,456 (54.5%) 
oesophageal cancer patients, of which 73/526 (13.9%) and 143/1,456 (9.8%), respectively, provided 
plausible diagnostic alternatives. Having 2 or more pre-existing conditions was associated with longer 
time to diagnosis for stomach (TR 1.55, CI 1.14 to 2.10, p=0.005), and with shorter times for 
oesophageal (0.64, 0.45 to 0.91, p=0.012) cancer. Having alternative explanations was moderately 
associated with longer time to diagnosis for oesophageal cancer (1.52, 1.01 to 2.30, p=0.045), and 
with shorter times for stomach cancer (0.64, 0.45 to 0.92, p=0.015).  
Consequences  
The results suggest that pre-existing conditions complicate the diagnostic process for 
oesophagogastric cancer. The diagnostic process may be lengthened for stomach cancer by 
increasing count of conditions, and for oesophageal cancer by the presence of plausible diagnostic 
alternatives. The interpretation of shortening times to diagnosis may not reflect improved patient 
outcomes where patients present very late in their disease (“sick-quick”). 
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1B.3 Guideline discordant diagnostic care: when do primary care referrals not reflect 
guidelines for suspected cancer? 
Gary Abel, University of Exeter 
Bianca Wiering, Georgios Lyratzopoulos, John Campbell, William Hamilton 
Problem  
A key service aimed at improving UK cancer survival rates (through improved diagnostic timeliness) is 
the fast-track referral system known as the two-week wait pathway. Guidelines advise general 
practitioners which patients warrant a two-week wait referral. However, guidelines are only effective to 
the degree that they are implemented. This study aims to investigate how often GPs follow the referral 
guidelines and whether certain types of patients are more or less likely to be referred.  
Approach 
We used linked primary care (Clinical Practice Research Datalink) and secondary care (Hospital 
Episode Statistics) data. Patients presenting with any one of 6 symptoms (haematuria, rectal 
bleeding, breast lump, post-menopausal bleeding, dysphagia or anaemia) for the first time during 
2014-2015 were included (for ages where NICE guidelines recommend two-week wait referral). For 
patients presenting with haematuria, either the second or third GP visit was defined as the index 
consultation where patients had received treatment for urinary tract infection during earlier visits. A 
composite outcome of a two-week wait referral or urgent referral was used since both reflect the need 
for an urgent clinical assessment. Multilevel logistic regression was used to investigate whether the 
tendency to refer varies symptoms and patient characteristics (age, gender, ethnicity, comorbidities 
and deprivation level). Further analyses investigated whether patients not receiving a referral were 
diagnosed with cancer within one year of the index consultation.  
Findings  
Preliminary results for referrals made within 14 days of first presentation with a recorded symptom 
indicate a high percentage of patients do not receive a two-week wait or urgent referral, varying from 
81.8% (rectal bleeding) to 33.3% (breast lump). There is evidence that referrals are associated with 
age and comorbidities (p<0.001), with young patients and patients with comorbidities less likely to 
receive a referral. Associations between patient characteristics and referrals differ by symptom. More 
deprived patients with breast lumps, female patients with anaemia or haematuria and non-white 
patients with rectal bleeding were less likely to receive a referral. Furthermore, interim findings 
suggest that around 2.3% of patients not receiving a referral were later diagnosed with cancer.  
Consequences  
Guideline recommended actions often do not occur for patients presenting with common possible 
cancer symptoms. Given that a significant number of such patients go on to be diagnosed with 
cancer, better adherence to referral guidelines could potentially improve the cancer diagnostic 
process for many people. Appreciating which patient groups are at greater risk of non-referral against 
guideline recommendations can help target improvement efforts. For example, these findings may be 
used by schemes such as CRUK cancer facilitators and Macmillan GPs to directly influence practice. 
Alternatively, they could inform educational materials and novel interventions targeting early 
diagnosis. 
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1B.4 Acceptability, understanding and experience of diagnostic tests for prostate cancer: a 
qualitative study with patients 
Samuel W D Merriel, University of Exeter 
Dr Alice Forster, Dr Steph Archer, Mr David Eldred-Evans, Mr John McGrath, Prof Hashim Ahmed, 
Prof Willie Hamilton, Dr Fiona Walter 
Problem  
Multiparametric MRI (mpMRI) is a new diagnostic test for prostate cancer, and is now recommended 
by NICE prior to prostate biopsy. Diagnostic accuracy studies show mpMRI can improve biopsy 
accuracy and avoid potentially unnecessary biopsies, but other important aspects of implementing 
mpMRI as a new diagnostic test have not been examined. There are no studies assessing 
acceptability of mpMRI for prostate cancer with any theoretical underpinning, and questions remain 
about men’s experience of undergoing the test and their understanding of the results. The aim of this 
study is to understand, from the perspective of patients, the acceptability of mpMRI as a diagnostic 
test for prostate cancer. 
Approach 
This qualitative study employed semi-structured interviews with men referred from primary care with 
suspected prostate cancer who have undergone mpMRI as part of their diagnostic work-up. Men were 
recruited from two hospital sites (Exeter and London), via outpatient ‘Two-Week Wait’ clinics. 
Interviews were conducted in-person or via telephone, and all were conducted by SM. They were 
audio recorded, and transcribed verbatim. A thematic analysis approach has been taken, both 
inductively by generating codes and themes from the data and deductively using Sekhon’s 
Theoretical Framework of Acceptability (TFA). The analysis team (SM, FW, and SA) discussed and 
refined the codes and themes to produce a thematic map, based on the early interviews. This study 
has ethical approval from the NHS Health Research Authority and the NHS South West - Frenchay 
Research Ethics Committee. 
Findings  
20 men have been interviewed for this study, with a range of ages (47-80 years) and geographical 
regions (10 urban; 10 rural); most have a white ethnic background (16 White British; 4 BME). Many 
men were philosophical about receiving a diagnosis of prostate cancer (“It is what it is”), although 
some felt it significantly impacted on their life and their health. mpMRI meets many of the constructs 
in Sekhon’s TFA. It has a low Burden and good Self-Efficacy (“It’s an easy test to take”), as well as 
high Intervention Coherence (“I think I knew pretty well what it was for”) and Perceived Effectiveness 
(“The MRI scan found some areas that were, let’s say, suspicious…”). 
Consequences  
The new NICE recommendations do not specify whether mpMRI should be performed in primary or 
secondary care. Given the potential to reduce unnecessary prostate biopsies and the apparent 
acceptability of mpMRI to patients and clinicians, mpMRI could one day be used in primary care in the 
assessment of men with possible prostate cancer to reduce urgent urology referrals and avoid 
prostate biopsy complications. Financial, resource, and workforce implications for the NHS would 
need to be considered prior to GP access to mpMRI. 
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1C.1 EMPATHICA - Developing an Empathy and Optimism training tool for Healthcare 
Practitioners 
Kirsten A. Smith, University of Southampton 
Felicity Bishop, Hazel Everitt, Leanne Morrison, Jeremy Howick, Kirsten A. Smith, Stephanie Hughes, 
Jane Vennik, Emily Lyness, Mohana Ratnapalan, Hajira Dambha-Miller, Christian Mallen, Paul Little, 
Lucy Yardley 
Problem  
Osteoarthritis (OA) pain is common, costly, and challenging to manage in busy primary care settings. 
Recent research suggests that patients experience less pain after consulting practitioners who show 
empathy and encourage optimism about treatment. 
Approach 
We are developing an online training tool using the Person-based Approach to teach practitioners 
(GPs, physiotherapists, and nurses) how to show more empathy and encourage patients to have 
positive yet realistic expectations. To do this, we first explored the literature on practitioner 
communication skills, conducting: 1. A content analysis on interventions to increase empathic 
communication among practitioners ; 2. A content analysis on interventions to evoke positive 
expectations of treatment outcomes among patients; 3. A meta-ethnography to synthesize evidence 
on patients’ and practitioners’ perspectives on communication in primary care OA consultations. We 
then conducted interviews with practitioners to explore the barriers and facilitators to online training in 
empathy and optimism. 
Findings  
We brought this evidence together with a behavioural analysis to develop guiding principles and a 
logic model to inform our intervention development. We then developed the training tool, using think-
aloud interviews to iteratively refine the content to improve its acceptability to practitioners. We filmed 
consultations using the guidance in our training tool and collected patient views to ensure the 
messages of our training tool were acceptable to patients. In 2020 we will conduct a feasibility trial in 
10 GP practices with up to 280 patients to explore the feasibility of the training and how to trial it most 
efficiently. 
Consequences  
We hypothesize that our training tool will increase perceived empathy, improve patient optimism 
about the outcome of their treatment and reduce pain in OA patients; it may also lead to improved 
consultation and health outcomes for patients consulting with other conditions in primary care. 
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1C.2 Continuing Professional Development for General Practitioners in Myanmar: a pilot 
programme 
Kerran Kandola, NHS Thames Valley and Wessex Leadership Academy 
Myint Oo 
Problem  
The Myanmar Government has ambitiously strategised to achieve Universal Health Coverage by 
2035. A key factor in the success of this will be improving the quality of general practice which 
currently is highly variable. Currently, no formalised system of revalidation exists for clinicians and so, 
engagement with continuing professional development (CPD) activities is sporadic. 
  
The goals of this three month pilot CPD programme were to train general practitioners (GPs) in three 
key areas; (i) how to record their CPD activities and maintain a portfolio logbook, (ii) how to reflect on 
their learning, and (iii) how a future formalised CPD credit system could work. 
Approach 
Sixty one GPs were recruited in March 2019 and given training on the above. Logbooks were 
provided to complete as they attended a simultaneous three-month GP training course organised by 
the GP Society of Myanmar (GPSM). At the end of the pilot the GPs were asked to submit a survey 
alongside their logbooks for evaluation, these were marked and individualised feedback given. 
Findings  
100% of GPs agreed the pilot helped them to understand how to maintain a CPD logbook and they 
would now be more likely to continue to do so (retention rate of 67%). Most GPs (95%) also 
understood the level of importance of keeping a record of CPD activities as being “extremely” or 
“very” important. Finally, all GPs surveyed felt a credit reward system, used as evidence of CPD 
participation, would positively influence their future engagement with CPD. 
Consequences  
Improving general practice is a key component in helping Myanmar develop its healthcare system; 
one step required is making engagement with CPD compulsory for the revalidation of clinicians in 
order to encourage active participation in this life-long learning process. The GPSM have already 
begun taking steps to implement this, and the above pilot CPD programme advocates in favour of the 
importance and likelihood of success of doing so. 
  
19 
 
1C.3 GP trainees’ and First5’s preparedness for complaints 
Olivia Jagger, University of Southampton 
Hazel Everitt, Catherine Woods 
Problem  
Complaints about doctors are rising. NHS Digital data reported 94,637 complaints in primary care in 
2017/18, a 14.6% increase over 2 years.. Wessex GP Education Unit identified preparedness for 
complaints as a gap in their Vocational Training Scheme (VTS). Effectively responding to complaints, 
demonstrating learning from complaints and managing the personal impact of complaints are 
competencies in the GP curriculum. However, GPs often report feeling unprepared for managing 
complaints in practice. This is important because there is a growing body of evidence that complaints 
can negatively impact doctors mental health, wellbeing, professional performance and career choices, 
with implications for patient care and workforce retention. The transition from trainee to qualified GP is 
recognised as a challenging and stressful career stage, transitioning from a supportive well-protected 
environment to independent practice. Newly qualified GP’s are a vulnerable group at higher risk of 
mental illness and burnout through pressures of work. One in four GPs accessing the national GP 
health service are First5’s. An NHS England review into complaint handling in general practice 
identified a need to improve support for GP’s through education in complaints management before 
they qualify. The aim of this study is to understand GP trainee and First5’s experiences of, attitudes 
towards, impact of and perceived preparedness for complaints and importantly, how they could be 
better prepared.  
Approach 
Qualitative semi-structured interviews with 15-30 GP trainees and First 5’s in Wessex are planned. A 
topic guide has been developed, informed by the literature and expert opinion and trialed in 2 
interviews. Interviews will be audio-recorded, transcribed, anonymised and imported into NVivo and 
thematic analysis undertaken.  
Findings  
Ethical approval has been sought and preliminary results will be presented at the conference.  
Consequences  
Little is known about GP trainees experiences of, the impact of or their perceived preparedness for 
complaints. Findings will inform development of an educational intervention within Southampton VTS 
to improve GP trainees’ preparedness for complaints. 
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1C.4 What do medical students expect from primary care teaching? 
Zoe Brown and Lucy Jenkins, University of Bristol 
Zoe Brown, Lucy Jenkins 
Problem  
Concerns remain about the declining workforce in general practice. Educators must do their utmost to 
guarantee medical students a positive introduction to general practice. Medical schools’ curricula and 
LOs are aligned with GMC guidance and mapped to Outcomes for graduates; how does this line up 
with students’ expectations? Our aims were to determine what students believe their learning 
objectives in primary care teaching should be, to decide if we are teaching them what they want to 
know, and to develop primary care aspects of the University of Bristol’s medical school curriculum. 
Students can give a unique perspective on “curriculum-inaction” and the hidden curriculum. Results 
from our research can be fed into development of the new, evolving curriculum at the University of 
Bristol, and also nationally. There is potential for an impact not only on medical education, but the 
future of recruitment in general practice. 
Approach 
220 third-year students were emailed a survey using SurveyMonkey, with Likert scales and white 
spaces; 37 completed it. 220 GP teachers from CAPC were emailed a similar survey; 59 completed it. 
Findings  
Quantitative and qualitative data was obtained and analysed. Students and teachers were asked to 
select LOs they felt should be in the curriculum. Reassuringly, students and GP teachers were in 
agreement that LOs within the current curriculum are relevant for them. There were discrepancies, the 
biggest of which was "spend time with practice and district nurses": 83.1% of GP teachers felt this 
should be in the curriculum; 43.2% of students agreed. Interestingly, the LO "describe the other 
systems that provide open access health care in the UK" was only selected by 42.4% of GP teachers 
and 46.0% of medical students. Medical students were asked ‘what do you expect from primary care 
teaching?’ A word cloud was produced following thematic analysis of white space answers, with 
consultations, insight into being a GP, and common conditions as the 3 main themes. Medical 
students were asked, ‘do you think you have enough exposure to general practice throughout your 
degree?’ 55.6% said yes, 19.4% said no, and 25.0% were not sure. 
Consequences  
The surveys produced a large amount of rich data, a great source for further analysis in future. This is 
an important area of research which needs exploring further, not only for UoB, but all medical 
students. The statistic of 55.6% of students agreeing they have enough exposure to general practice 
is reassuring - or arguably, is it worryingly low? Until the workforce issues are resolved, the question 
remains - are we getting it right? Results will be discussed with UoB as the new curriculum is 
developed, which involves students becoming more exposed to general practice throughout their 
degree. There is scope to revisit this with future cohorts of medical students to see if teaching 
matches their expectations. 
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1C.5 The Development of Palliative Care Education and Training for General Practitioners in 
Yangon, Myanmar: a workshop success 
Kerran Kandola, NHS Thames Valley and Wessex Leadership Academy 
Myint Oo 
Problem  
Palliative care is an important but often overlooked component of primary care. It is a rapidly 
developing specialty yet, one third of the world still lack any community palliative care services, and 
suffer serious health suffering, particularly at the end-of-life, as a result. In Myanmar, the early 
emergence of palliative care is occurring with the first Palliative Care outpatient department opening 
two years ago, however, no formal community-based services yet exist. Present challenges include, 
cultural taboos, resource scarcity, restrictions around opioid prescribing and inadequate education 
and training. The goal of this quality improvement work was to improve understanding and approach 
towards palliative care by General Practitioners (GPs) in Yangon. 
Approach 
An initial primary survey was performed amongst 42 GPs across three different locations (Yangon, 
Mandalay and Meiktila) in March 2019 demonstrating a gap in current training needs and confirming a 
willingness by GPs for this to be improved. A two-day workshop, the first ever of its kind, was 
subsequently designed and held in May for twenty local GP’s consisting of lectures and interactive 
sessions delivered in Burmese. Topics for the workshop included; what is palliative care?, recognising 
palliative symptoms, management of pain, management of common end-of-life care symptoms, 
breaking bad news and psychosocial and spiritual support. 
Findings  
Improvement in knowledge and confidence and, changes in attitude towards palliative care were used 
as measures of success. A forty two question true/false-style quiz was distributed pre- and post-
workshop; this demonstrated a mean total score improvement of 15% post-workshop. Self-reported 
confidence rating scores regarding confidence when (i) managing palliative or end-of-life care 
patients, (ii) providing holistic care and (iii) breaking bad news increased by a mean of 25%. 
Consequences  
The greatest outcome from this workshop by far was the enthusiasm and awareness it generated; it 
highlighted the importance of developing this area of training for general practitioners in Myanmar. 
Support was also gained from the President of the Myanmar Medical Association whom delivered an 
opening speech at the workshop despite initially having reservations about developing this area. 
Ultimately, the positive feedback from the workshop behaved as an advocate leading to the 
introduction of a regular palliative care lecture into the Myanmar Diploma in Family Medicine 
curriculum. It has also spurred a new group of GPs to further this work and turn the workshop into a 
regular teaching event. 
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1D.1 A meta-analysis over multiple thresholds to compare two prediction rules for acute 
pharyngitis 
Brian Willis, University of Birmingham 
Dyuti Coomar, Mohammed Baragilly 
Problem  
Centor’s score and McIsaac’s score are two rules commonly used to diagnose Group A beta-
haemolytic streptococcus (GABHS) infection. However, McIsaac’s score applied to primary care has 
not been meta-analysed; the scores have not been compared by meta-analysis; and a model which 
may handle all the data reported at multiple cut points has not been used. The aim was to compare 
the performance of Centor’s score and McIsaac’s score in diagnosing patients with GABHS 
presenting to primary care with pharyngitis  
Approach 
Medline, Embase, PsychoInfo, Google and the references from two published reviews were searched 
for relevant citations. Searches were restricted between 1980 and February 2019. Studies were 
included if they were: a cross-sectional study; patients with a sore throat were recruited from a 
primary care population; the study evaluated Centor’s or McIsaac’s score; GABHS infection was the 
target diagnosis; the reference standard was a culture throat swab; complete 2 x 2 tables across 
multiple thresholds were reported. Selection was conducted independently by two reviewers. Data 
were extracted according to PRISMA-DTA guidance by two independent reviewers. The risk of bias 
and applicability of results were assessed using the QUADAS-2 tool. A novel meta-analysis random 
effects model which incorporates data at multiple thresholds was used to synthesise estimates. The  
main outcomes were a summary receiver operating characteristic (SROC) curve,  the area under the 
curve statistic and a calibration plot corrected for optimism.  
Findings  
10 studies on Centor’s criteria and 8 on McIsaac’s score were included. In both sets of studies the 
prevalence of GABHS ranged between 4 and 44%.  Two SROC curves were synthesised and the 
area under curve, C statistics for McIsaac’s score and Centor’s score were 0.7052  and 0.6888 
respectively. The p-value for the difference (0.0164) was 0.353, suggesting the SROC curves for the 
tests are equivalent. Both scores demonstrated poor calibration. Both rules provide only fair 
discrimination of those with and without GABHS infection. McIsaac’s score and Centor’s score appear 
broadly equivalent in performance. The poor calibration for a positive test result suggests other point 
of care tests are required to ‘rule in’ GABHS. However, with either rule a score of zero may be 
sufficient to ‘rule-out’ infection.  
Consequences  
This comparative meta-analysis demonstrates that Centor’s score and McIsaac’s score have broadly 
similar performance characteristics in diagnosing GABHS in primary care. Neither score is sufficiently 
accurate to rule in GABHS infection and if applied as recommended could lead to over 1 in 2 patients 
being prescribed antibiotics inappropriately. Other point of care diagnostics that augment these 
scores are needed if rates of inappropriate antibiotic prescriptions are to be reduced. However, a 
score of zero (or less) in either rule potentially has a role in ruling out GABHS infection in primary 
care. 
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1D.2 A mixed-methods evaluation of a novel microbiological point-of-care test for patients with 
respiratory tract infections in primary care 
Tanzeela Y Khalid, University of Bristol 
Lorna Duncan, Hannah V Thornton, Gemma Lasseter, Alastair D Hay 
Problem  
Microbiological point-of-care tests (MPOCTs) are advocated to improve antibiotic prescribing in 
primary care, where 75-80% of all NHS prescribing takes place. MPOCTs have recently become 
available for respiratory tract infections (RTIs) but their use has yet to be evaluated in primary care. 
We aimed to assess if, when and how primary care clinicians use a novel respiratory MPOCT, and to 
understand their perceptions of MPOCT use.  
Approach 
We provided four GP practices serving a diverse population of 84,000 patients with the BioMérieux 
BioFire FilmArray® respiratory MPOCT, each for 6-8 weeks. Patients were eligible if aged >3 months 
and attending with any acute (≤28 days) suspected RTI. Before testing, clinicians recorded patient 
characteristics and diagnosis, antibiotic prescribing intention and perceived benefit of antibiotics. Dual 
throat and nose swabs tested for 17 respiratory viruses and three atypical bacteria. After viewing 
results, clinicians re-reported diagnosis and perceived antibiotic benefit. 22 practice staff were 
interviewed to obtain their views of the test, and perceptions regarding its potential for routine use.  
Findings  
42 clinicians were trained of whom 20 (15 GPs plus 5 nurses) recruited 93 (45 plus 48) patients. 
Clinicians estimated they recruited one in every three eligible patients. Median participant age was 29 
(range 0.5 to 83) years and 57% were female.  Staff spent a median of 2.72 minutes setting up the 
test, which then took 65 minutes to run per sample. 71% were tested <4 hours and 90% <24 hours. 
All were tested <72 hours, the maximum time required for sample stability. Of the 93 samples tested: 
34 (37%) reported no pathogen; 54 (58%) detected at least one virus of which one also reported the 
presence of one atypical bacterium; two samples found atypical bacteria; and three were 
inconclusive. Clinical certainty in the patient’s diagnosis was higher when the test returned a positive 
result for the detection of a pathogen compared to when negative (p<0.001) and diagnostic certainty 
significantly increased after test use (p=0.03). Clinicians were more likely pre-test to predict the 
patient would benefit from antibiotics than post-test (p=0.02). Clinical diagnoses changed in 23% of 
patient’s post-test but <10% were contacted to change their treatment plan. Qualitative staff 
interviews revealed the test was easy to use and liked, with clear clinical potential, but limitations 
included sample processing time, one-at-a-time processing and the absence of testing for typical 
respiratory bacteria.  
Consequences  
This novel respiratory MPOCT was popular with clinicians and used in a wide variety of patients. 
MPOCTs could positively impact clinical decision making and antibiotic prescribing, but a randomised 
controlled trial is needed to establish if they can safely improve patient outcomes. They are more 
likely to be used if faster, and a greater number of samples can be simultaneously processed. 
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1D.3 Development of the Birmingham Lung Improvement Studies (BLISS) prognostic score for 
COPD patients in primary care: data from the Birmingham COPD cohort 
Andrew P Dickens, University of Birmingham 
Rachel E Jordan, David Fitzmaurice, James Martin, Alice Sitch, Jon G Ayres, KK Cheng, Brendan G 
Cooper, Amanda Daley, Alexandra Enocson, Sheila Greenfield, Kate Jolly, Sue Jowett, Martin R 
Miller, Richard D Riley, Stanley Siebert, Robert A 
Problem  
COPD patients in primary care have high rates of hospital admissions. Prognostic scores could be 
used to guide management of COPD patients and reduce risk of hospital admission, but existing 
scores do not perform well enough and are not used in practice. We aimed to develop a new 
prognostic score that was practical for use in the primary care setting.  
Approach 
Using data from the Birmingham COPD cohort we developed and internally validated the new BLISS 
prognostic score to predict respiratory admissions in 2-years from 23 candidate predictors. 1558 
patients on COPD registers of 71 GP practices and 331 newly-identified patients from a linked case-
finding trial were included and their self-reported and clinical data were combined with routine hospital 
episode statistics. The primary outcome was the record of at least one respiratory admission within 2 
years of cohort entry (May 2012-June 2014). The model was developed using backward elimination of 
variables with p<0.157. Missing data were imputed using chained equations. Discrimination and 
calibration were assessed. Bootstrapping was used for internal validation, adjusting for overfitting and 
deriving optimum-adjusted performance statistics.  
Findings  
Median (min, max) follow up was 3.0 years (1.8, 3.8). Of the 23 candidate predictors, 6 variables were 
retained in the final model: age, CAT score, respiratory admissions in the previous 12m, BMI, 
diabetes, FEV1% predicted. After adjustment for optimism, the model showed promising 
discrimination in predicting risk of respiratory admissions by 2 years (c-statistic=0.73 (95%CI 0.70, 
0.77). The BLISS score showed promising performance in predicting respiratory admissions 
compared with existing published scores.  
Consequences  
All 6 variables are readily available in primary care records or would be easy to collect, and a simple 
computer programme could calculate the score. Important next steps are external validation in other 
settings, proposing and evaluating a model of use to guide patient management and exploration of 
the best ways to implement the score in primary care practice. 
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1D.4 Professionals’ views on using point-of-care CRP testing and delayed antibiotic 
prescriptions: a focus group study in high antibiotic prescribing general practices 
Sarah Tonkin-Crine, University of Oxford 
Dr Anne Campbell, Dr Monsey McLeod, Prof. Alison Holmes, Prof. Sarah Walker, Prof. Chris Butler, 
Dr Sarah Tonkin-Crine 
Problem  
Clinical trials have shown that the use of point-of-care (POC) C-reactive protein (CRP) tests and 
delayed/back-up prescriptions are effective strategies to reduce antibiotic use for self-limiting 
respiratory tract infections in primary care. These strategies may be particularly helpful to (further) 
reduce antibiotic use in general practices that remain high-prescribers of antibiotics. However, the 
implementation and routine use of both of these strategies in England remains low. This study aimed 
to explore the views of professionals from high antibiotic prescribing general practices on the use of 
these strategies, including barriers and facilitators influencing their uptake.  
Approach 
This was a qualitative study. The 20% (139) highest antibiotic prescribing practices in the West 
Midlands, England, were selected and invited to a focus group. Focus groups were conducted in 
practices by two researchers, were audio-recorded and transcribed verbatim. The transcripts were 
coded in NVivo and analysed using thematic analysis.  
Findings  
Nine practices participated with 50 professionals (3-11 per practice), including 30 GPs, 2 nurse 
prescribers, 1 pharmacist prescriber and 17 other staff (e.g. healthcare assistants, receptionists). The 
focus groups were between 50 and 90 (mean 70) minutes. The key findings included: (1) Tensions 
between professional role and CRP testing; prescribers reported clinical judgment (based on holistic 
examination and history) as central to their role, training and experience. Thus, they were unclear how 
POC CRP testing fits in the routine primary care consultations. They were also unsure when and how 
to use POC CRP testing. (2) Influences on using delayed antibiotic prescriptions; these included 
practice context (e.g., rural, dispensing practice), perceptions of a purpose of delayed prescriptions 
(e.g., safety-netting), and beliefs about how patients use them. (3) Professionals perceived both 
strategies as potentially helpful tools to negotiate treatment decisions with patients and help maintain 
patient satisfaction. (4) They reported ambivalent views about usefulness of these strategies in 
reducing antibiotic use, and were concerned about potential negative consequences (e.g., increasing 
patient expectation for CRP tests or delayed prescriptions, consultations, costs).  
Consequences  
Addressing barriers to, and concerns about, using POC CRP testing and delayed antibiotic 
prescriptions may help increase uptake of these strategies and optimise antibiotic use. These findings 
were used to inform development of resources to support the implementation and use of these 
strategies in high antibiotic prescribing general practices. 
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1D.5 Perspectives on laboratory tests in chronic disease monitoring: preliminary results from 
a survey among GPs across UK 
Martha MC Elwenspoek, University of Bristol 
Martha MC Elwenspoek, Ed Mann, Katharine Alsop, Rita Patel, Jessica C Watson, Penny Whiting 
Problem  
We have shown previously that current recommendations in UK guidelines for monitoring chronic 
diseases are largely based on expert opinion. Due to a lack of robust evidence on optimal monitoring 
strategies and testing intervals, the guidelines are unclear and incomplete. This uncertainty may 
underly variation in testing that has been observed across the UK between GP practices and regions.  
Approach 
Our objective was to better understand GP perspectives on laboratory tests in chronic disease 
monitoring, the workload, and how confident GPs are in ordering and interpreting these tests. We 
designed an online survey that was promoted on social media and in newsletters targeting GPs.  
Findings  
The survey has been completed by 525 GPs of which 69% had more than 10 years of experience as 
a GP. Over half of respondents reported that they spend over 45 mins per day reviewing laboratory 
results, with 28% spending over an hour. The majority of respondents reported that they think we 
currently do too many tests to monitor chronic diseases. There was acceptance that monitoring for 
chronic disease can be harmful for patients with 29% saying they thought it would frequently be 
harmful. There was also substantial variation in what tests GPs routinely or sometimes offer for 
hypertension, type 2 diabetes and chronic kidney disease, especially around liver function tests, full 
blood count, lipid profile, thyroid function tests and cholesterol. Only 52% felt confident in what to do 
with abnormal incidental findings picked up during chronic disease monitoring.  
Consequences  
Although these are only preliminary findings, the response rate is high for a survey of busy clinicians, 
suggesting that optimising testing in primary care is an important topic for GPs. These results confirm 
the variation that has been observed in test ordering data. The results also show that most GPs spent 
a significant part of their day ordering and interpreting monitoring tests. The lack of confidence in 
knowing how to act on abnormal test results underlines the urgent need for robust evidence on 
optimal testing and the development of clear and unambiguous testing recommendations. 
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2A.1 Do digital-first consultation models reduce or increase GP workload? 
Chris Salisbury, University of Bristol 
Mairead Murphy, Polly Duncan 
Problem  
All general practices will be required to offer online and video consultations by April 2021, and the use 
of telephone consultations is also increasing. Some practices have introduced a digital-first model, 
whereby patients are expected to use these consultation modes before having a face-to-face 
consultation only when necessary. These developments are justified by claims that they will both 
increase access for patients and help GPs to manage their workload, which could allow them to give 
more time to patients with complex needs. But are these aims compatible or contradictory? 
Approach 
We conducted a modelling study using data from published studies of online, telephone or video 
consultations in general practice. Through a systematic literature review we identified studies 
providing quantitative data about use of digital-first access models for unselected patients requesting 
a general practice consultation for any problem. We sought estimates about the following variables: 
the proportion of consultations managed digitally, the proportion of digital consultations completed 
without a subsequent consultation, the proportion of subsequent consultations conducted by 
telephone rather than face-to-face, consultation duration, and changes in demand after introduction of 
a digital-first model. We used the data from the review as inputs to a dynamic model in Excel which 
enabled us to estimate the overall impact on GP workload. The model provided a base-case estimate 
using evidence from the published studies and graphically demonstrates how workload varies under 
different plausible scenarios. 
Findings  
Under most plausible scenarios, digital-first approaches to accessing primary care are likely to 
increase GPs workload. They could decrease workload if their duration is shorter, and a higher 
proportion of digital consultations are managed without a subsequent face-to-face consultation, than 
observed in most published studies. An important determinant of workload is whether digital-first 
approaches increase or reduce overall demand for GP, but there is little robust evidence about this 
question. 
Consequences  
Digital-first consultations to primary care are likely to increase GP workload unless stringent 
conditions are met, so how they are implemented is crucial. If they do increase workload they may still 
be justified, but this should be based on evidence about the benefits in relation to the costs, rather 
than assumptions about reductions in workload. Improvements in access from digital-first 
consultations could mean GPs devoting more of their time to younger and healthier patients, which 
could reduce the time available for older and sicker patients who need face-to-face care. Given this 
potential for increasing health inequalities, and increased workload at a time of GP shortages, these 
initiatives should be rolled out in a staged way alongside careful evaluation. In particular, we need 
long term studies from natural experiments on how changes in access to care are associated with 
changes in general practice workload. 
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2A.2 Awareness and use of online appointment booking in general practice: analysis of GP 
Patient Survey data 
Mayam Gomez Cano, University of Exeter 
Helen Atherton, John Campbell, Abi Eccles, Jeremy Dale, Leon Poltawski, Gary Abel 
Problem  
General practices are required to provide online booking to patients in line with policy to digitise 
access. Online booking services offer the option of booking an appointment 24/7 using the internet. 
However, uptake of online booking by patients is currently low and there is little evidence about 
awareness and use by different patient groups. 
Approach 
As part of the OBoE study, we performed a secondary analysis of GP Patient Survey data (2018) 
making use of two questions, one asking about awareness of online booking of appointments and 
another asking about use. Multivariate logistic regression was used to examine associations between 
both awareness and use in relation to age, gender, ethnicity, deprivation, the presence of a long-term 
condition, long-term sickness and being deaf. Comparison of models accounting for and not 
accounting for clustering by practice was used to illustrate the extent to which disparities reflect the 
clustering of certain types of patients in practices where awareness and use of online booking is high 
or low for all patient groups. 
Findings  
Of 647,064 patients answering the relevant question, 277,278 (43.3%) reported being aware of being 
able to book appointments online. In contrast, only 14% (93,671 /641,073) reported having actually 
booked an appointment online. There was evidence of variation by all factors considered. In 
particular, strong deprivation gradients in both awareness and use were evident (e.g. most vs. least 
deprived quintile OR for use=0.63 95%CI 0.61-0.65). There was a strong drop off in both awareness 
and use in patients over 75 (e.g. 85+ vs. 65-74 years OR for awareness=0.33 95%CI 0.32-0.35). 
Patients with long-term conditions were more aware and more likely to use online booking, however, 
deaf patients were less likely to be aware, but more likely to use online booking (not-deaf vs deaf OR 
for awareness= 0.78, 95%CI 0.70-0.86, OR for use= 1.29, 95%CI 1.14-1.46). Adjustment for practice 
suggest that around a third of the deprivation gradient in awareness and a fifth of the deprivation 
gradient in use is attributable to deprived patients being clustered in practices with low awareness/use 
for all patients. 
Consequences  
Whilst over 40% of patients know that they can book appointment online, the number that actually do 
so is far lower. Furthermore, awareness and use of online appointment booking varies by patient 
group. Some of this variability is reassuring, for example that patients with long-term conditions are 
using the service, whilst other variability is more concerning, for example the strong deprivation 
gradient and drop off in old age. With the constant push for online services within the NHS, practices 
need to be aware that not all patient groups will book appointments online and that other routes of 
access need to be maintained to avoid widening health inequalities. 
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2A.3 Primary care community hubs - what are they for, what do they look like and do they 
work? A rapid review. 
Lorna Duncan, University of Bristol 
L. Duncan, C. Salisbury, N. Roberts, S. Purdy, P. Bower, M. Moore, G. Feder,  A.L Huntley 
Problem  
Improving access to general practice and other primary care services is a key concern for policy-
makers and practitioners. In the last decade several schemes, including the Primary Care Access 
Fund (PCAF), have been put in place at least in part to achieve this. The Primary Care Community 
Hub (PCCH) is one model to have been developed in this way and our review aimed to identify the 
aims, design model(s) and evidence for the effectiveness of these PCCHs in England.  
Approach 
Customized searches with a five year time limit were performed in MEDLINE and Google Scholar.  
Six websites (The Kings Fund, NHS England, NHS Improvement, NICE, the RCGP, and the BMA) 
were also searched. Titles and abstracts, and full papers were screened for inclusion by one 
researcher and checked by another. Included papers gave a descriptive account, or described a 
planned investigation or study of a PCCH in England. One reviewer will extract data into a customized 
table and assess the quality of included papers using the CASP and MMAT appraisal tools as 
appropriate, with verification of a 10% random sample by a second member of the team.  
Findings  
Our searches yielded 1777 citations, the majority of these from the six organisational websites. Forty 
full papers were assessed for inclusion and data is currently being extracted from 22 papers (9 
national and 12 local evaluations, and one qualitative study). Two indicated evaluations were not 
received even with the use of FOI requests. The quality of the evaluations seen has been variable. 
Our assessment of PCCHs was complicated where such hubs have been set up concomitant to one 
or more other changes in local service delivery, with the changes having been evaluated as a whole. 
In addition, a PCCH may have been set up under one scheme (i.e. the PCAF) and then continued 
with modifications under a subsequent/ overlapping scheme with a modified goal such as the 
development of integrated care. Nonetheless, evidence for the effectiveness of specific PCCHs has 
been obtained in a small number of evaluations, with some common themes apparent.  
Consequences  
Although evidence for the effectiveness of specific PCCHs has been obtained in a small number of 
evaluations, cost effectiveness and generalisability is less clear. In some evaluations it was not 
possible to specifically evaluate PCCH(s) as a component within a broader scheme of changes; and 
not all anticipated evaluations could be obtained. In order to ensure policy goals such as improved 
access to primary care services can be achieved effectively, it is essential that rigorous evaluation of 
all relevant changes are made and that such evaluations of publicly funded models are shared 
publicly. 
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2A.4 Work in progress: Mind the Gap: Understanding the implications of the digital divide on 
healthcare inequalities during the NHS digital transformation, for patients with long-term 
conditions. 
Ben Ainsworth, University of Bath 
Charlotte Dack, Kate Binnie, Laura Colebrooke, Harry Evans, Sabrina Grant, Gemma Lasseter, Jiedi 
Lei, Barbara Silarova, Sophie Turnbull 
Problem  
The recently published NHS Long Term Plan aims to ‘transform healthcare in the digital age’ - to 
deliver world-class healthcare in the 21st century focusing on personalised medicine in GP practices 
and social care. With 307 million face-to-face patient consultations conducted annually in GP 
practices, using digital tools such as patient self-management interventions and online consultation 
tools promise cost- effective solutions to support patients with long-term health conditions. However, 
people with low socioeconomic status (SES) are more likely to lack the basic digital skills required to 
benefit from digital transformation. 15.6 million people in the UK have limited or no digital skills, and 
are more likely to have low SES. Furthermore, people with low SES are 50% more likely to have a 
long-term health condition, and those with chronic conditions tend to experience more symptoms and 
worse health outcomes. Utmost care must be taken that the ‘digital divide’ - between the people who 
have the digital skills to engage with digital transformation, and those who do not - does not cause or 
exacerbate healthcare inequalities. The aim of this research is to 1) understand how and when 
healthcare professionals (HPs) are using digital healthcare tools with patients and 2) to identify 
barriers and opportunities that can be addressed in order to prevent digital transformation widening 
healthcare inequalities.  
Approach 
Study 1: We are conducting telephone and in-person semi-structured interviews with 15-30 HCPs in 
primary care, to explore their experiences of using digital healthcare tools for patients in practice and 
the barriers and opportunities in relation to the digital divide. HCPs will be recruited through 
snowballing advertising and opportunistically through professional networks. Participants will be 
purposively sampled in order to ensure appropriate representation of HPs working in areas of social 
deprivation. Data Analysis: Interview transcripts will be anonymised. Data will be coded by the 
research team independently and discussed to reach a consensus. Coded data will be organised and 
analysed using thematic analysis. Study 2: The results of study 1 will inform the development of a 
quantitative online survey to explore the key themes (barriers, issues, opportunities etc.) identified in a 
larger sample of HCPs. HCPs will be recruited using advertising on social media(‘snowballing’), and 
through HCPs networks.  
Findings  
Current project status: We are currently recruiting and interviewing HCPs until the end of December 
2019. Analysis of the data is planned to be completed by February 2020.  
Consequences  
We plan to discuss our findings with HCPs and healthcare commissioners and with voluntary and 
community sector organisations. This will help us identify key priorities to conduct further in depth 
mixed-methods research to explore this topic in more detail, with the ultimate aim of informing 
materials that will help the digital transformation benefit all patients. 
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2A.5 Improving patient access to primary care through a nurse triage system. 
Megan Elliott, University of South Wales 
Sian Jones, Chris Johnson, Carolyn Wallace 
Problem  
A General Practice workforce crisis is emerging, with fewer medical professionals training as General 
Practitioners (GPs) and more GPs working part-time and planning to retire early. This is particularly 
problematic in Powys, with 80% of current GP partners over age 50 and poor uptake of new GP 
positions. Optimising the workforce, by changing the way that primary care services are run, could 
help to resolve the imbalance between GP supply and demand. Use of the nurse triage system in 
primary care means that only patients who need to see a doctor are seen by the GP, whilst the rest of 
the patients have their needs met accordingly by other healthcare professionals or services. 
Approach 
Nurses at the GP practices used the Egton Medical Information Systems (EMIS) Web clinical system 
to conduct the triage process. An EMIS clinical template was created for the nurses to capture data in 
the clinical system to log the type of triage, consultation and outcome. From this, an EMIS Web report 
for triage appointments between December 2015 and November 2017 was used to review the South 
Powys cluster Nurse Triage pilot, and an EMIS Web report for between March 2017 and October 
2017 was used for reviewing Total Nurse Triage. These reports were used to identify: 
» The number of triage appointments where the EMIS clinical template was used. 
» The type of triage encounters. 
» Clinical outcome of the triage encounter. 
» Manual collection of the clinical outcome of each triage consultation if the nurse did not use the 
EMIS clinical template. 
» Age and sex of patients accessing both of the nurse-led triage services. 
 
Findings  
Less than half (45.47%) of triage encounters were referred on for contact with the GP, resulting in 
avoidance of 13,113 GP appointments over the pilot period. The remainder of patients were offered 
advice, a prescription or sick note, an appointment with a nurse, a referral for further care or an 
immediate referral to emergency services. The Total Nurse Triage system was also effective in 
reducing GP routine appointment waiting times and identifying clinical priorities to be seen urgently. 
Consequences  
Demand on GPs is reduced by referring patients to GPs only when necessary, and otherwise meeting 
patient needs through alternative service provision. Patient clinical outcomes data from a two-year 
pilot were used to evaluate the nurse triage systems. Benefits of the system are: 
1. Patients can access immediate support from a nurse, including advice, prescriptions or referrals, 
without having to wait days/weeks for a routine GP appointment. 
 2. Reduced pressure on GP services, resulting in shorter waiting times for patients and GPs having 
more time to dedicate to patients with more complex needs. 
3. Total Nurse Triage can identify high-risk individuals who need more urgent attention than a routine 
appointment, and refer patients for immediate attention where necessary. 
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2B.1 Views and experiences of managing eczema: systematic review and thematic synthesis 
of qualitative studies 
Emma Teasdale, University of Southampton 
Emma Teasdale, Ingrid Muller, Katy Sivyer, Daniela Ghio, Kate Greenwell, Sylvia Wilczynska, 
Amanda Roberts, Matthew Ridd, Lucy Yardley, Kim S Thomas, Miriam Santer 
Problem  
Eczema is a common skin condition that has a substantial impact of quality of life. The main cause of 
treatment failure is under-usage of topical treatments. Increasingly, qualitative approaches have been 
adopted to explore people’s perceptions of eczema and eczema treatment. Synthesising qualitative 
studies can provide a comprehensive overview of existing literature, greater understanding of 
people’s perspectives and experiences and can inform clinical practice. We sought to synthesise 
existing qualitative studies exploring the views and experiences of people with eczema and 
parents/carers of children with eczema about the condition and its treatment.  
Approach 
We systematically searched four databases (MEDLINE, PsycINFO, CINAHL and EMBASE) from the 
earliest date available to February 2019. Papers were selected that primarily focused on views and 
experiences of eczema and eczema treatments, and barriers / facilitators to eczema self-
management. We excluded papers that focused solely on models of health service provision or the 
views and experiences of health professionals. No language restrictions or date limits were placed on 
the search. Reference lists of selected papers were searched for additional relevant papers. Two 
authors and two additional research assistants performed assessment of study quality and data 
extraction. A thematic synthesis approach was followed to synthesise the findings.  
Findings  
We identified and synthesised 39 papers (reporting 32 studies) from 13 countries that had explored 
the views and experiences of 1,007 participants including 405 parents of children with eczema, 252 
people with eczema and 350 online forum users. Four main analytical themes were highlighted 1) 
Eczema not viewed as a long-term condition, 2) Hesitancy about eczema treatments, particularly 
topical corticosteroids 3) Significant psychosocial impact of eczema not acknowledged by others and 
4) Eczema information and advice perceived as insufficient, inconsistent and conflicting. Our findings 
suggest that people with eczema and parents of children with eczema experience frustration at having 
to manage a condition that is seen as mundane and insignificant but that has a significant 
psychosocial impact and is difficult to manage (due to hesitancy about treatment, especially in the 
long-term and misperceptions about the chronic nature of eczema). This frustration appears to be 
exacerbated by experiences of conflicting and inconsistent information and advice, from both health 
professionals or friends, family and others.  
Consequences  
To our knowledge there has been no previous synthesis of qualitative studies in this area. Our novel 
work suggests that clinicians need to address eczema treatment beliefs and concerns, and 
emphasise the ‘control not cure’ message to support effective ongoing self-management. There is 
also a need for health professionals to acknowledge the significant psychosocial impacts of eczema 
and provide clear consistent information and advice or signpost towards credible information. This 
may address people’s concerns that distress caused by the condition is not taken seriously. 
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2B.2 What are the barriers to treatment use amongst parents/carers of children with eczema 
and young people with eczema: questionnaire survey in primary care, secondary care and 
social media 
Katy Sivyer, University of Southampton 
Katy Sivyer, Daniela Ghio, Beth Stuart, Ingrid Muller, Kate Greenwell, Emma Teasdale, Sylvia 
Wilczynska, Miriam Santer 
Problem  
Eczema is very common in childhood and often persists into adulthood. The main treatments are 
emollients and topical corticosteroids, although low adherence is a common cause of treatment 
failure. Previous research has focused on concerns about topical corticosteroids but there may be 
other barriers to treatment adherence. This study aimed to explore prevalence of barriers and 
concerns around using both emollients and topical corticosteroids amongst parents/carers of children 
with eczema and young people with eczema.  
Approach 
Parents/carers of children aged 12 or less with eczema (N=259) and young people aged 13 to 25 with 
eczema (N=103) completed a cross-sectional survey through primary care mail-out (N=331), 
secondary care opportunistic recruitment (N= 20) and through social media (N=11).  The survey 
comprised self-report measures assessing: eczema severity; medication use; sociodemographics; 
concerns and beliefs about the necessity of treatments (Beliefs about Medicines Questionnaire; BMQ) 
and common barriers to using treatments (Problematic Experiences of Therapy Scales; PETS). The 
PETS has four subscales measuring: barriers related to symptoms (e.g. symptoms aggravated by 
treatment); uncertainty about how to use treatment; doubts about treatment efficacy; and practical 
problems (e.g. forgetting). The BMQ and PETS assessed both topical corticosteroids and emollients.  
Findings  
Emollients: Preliminary analysis suggested that for parents/carers and young people with eczema the 
biggest barrier to using emollients was practical (e.g. lack of time, or forgetting): with 61% of 
parents/carers and 84% of young people reporting some practical difficulties. In both groups, the 
overall belief that emollients are necessary outweighed concerns about emollients; mean=3.80 
(SD:0.82) versus mean=2.43 (SD:0.89) for parents/carers, and mean=3.71 (SD:0.86) versus 
mean=2.63 (SD:0.94) for young people. 
Topical corticosteroids: Amongst parents/carers the biggest barrier to using topical corticosteroids 
were doubts, e.g. 55% reported some doubts that the treatment was right for their child. However, 
overall beliefs about the necessity of topical corticosteroids and concern scores were equal; 
mean=3.04 (SD:1.12) versus mean=3.04 (SD:0.95). Compared to emollients, topical corticosteroids 
were rated as less necessary and concerns were rated more highly. In contrast, young people rated 
practical difficulties as their biggest barrier to using topical corticosteroids e.g. 87% reported some 
practical problems (e.g. lack of opportunity). Amongst young people, overall necessity score for 
topical corticosteroids marginally outweighed concerns about using them; mean=3.32 (SD:0.92) 
versus mean=3.00 (SD:0.99).  
Consequences  
These results suggest differences between parents/carers and young people in how they perceive 
topical treatments for eczema and experience barriers to their use, leading to implications for support 
needs. Future analyses will examine differences between parents/carers and young people, and how 
different beliefs/barriers and eczema severity are related to use of emollients and topical 
corticosteroids. 
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2B.3 – Withdrawn 
2B.4 Validation of the RECAP measure of eczema long-term control 
Alisha Bhanot, University of Bristol 
Tim J Peters, Matthew J Ridd 
Problem  
Research comparing the effectiveness of different eczema treatments is limited by inconsistency in 
both outcomes assessed and the measures used. HOME (Harmonising Outcome Measures for 
Eczema) is an international collaboration established to agree a core set of outcomes to be reported 
in all trials of eczema treatments. RECAP is a patient-reported outcome measure of eczema control, 
one of four key domains recommended by HOME.  This is the first study to independently assess the 
validity and reliability of RECAP.  
Approach 
Two online questionnaires (baseline and follow-up) were administered two weeks apart. The online 
questionnaires included RECAP and validated scales of eczema severity (POEM) and quality of life 
(PROMIS). People with eczema, or carers of children with eczema, were recruited through social 
media and by engagement with patient charities/organisations.  
Findings  
Data from 380 baseline (57.4% adults) and 188 follow-up (58.5% adults) questionnaires were 
analysed. RECAP had a high (99.7%) completion rate with a good distribution of scores and internal 
consistency (Cronbach’s alpha adults=0.89, children=0.92).  Almost half of participants thought 
RECAP appeared to measure long-term control.  Hypothesised associations between RECAP and 
eczema severity, global self-rated eczema control, quality of life, self-reported change in severity of 
eczema, and change scores for RECAP and POEM were observed as expected.  RECAP had a high 
intraclass correlation coefficient (adult=0.85, child=0.89). RECAP appears to have good acceptability, 
validity, test-retest reliability and responsiveness to change. Further work is required to investigate its 
validity in community and clinic populations.  
Consequences  
HOME VII consensus meeting took place in Japan in April 2019 and data from this study informed the 
decision to recommend RECAP as one of two measures of long-term control to be collected in all 
future trials of eczema treatments. RECAP may also be used in a clinical setting to assess patients’ 
control of their eczema. 
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2B.5 How does the elicitation and exploration of parent treatment preferences effect the 
conduct of primary care trials with children: a secondary qualitative analysis of baseline visits 
within the Best Emollient for Eczema (BEE) trial. 
Grace Boyd, University of Bristol 
Eileen Sutton, Matthew Ridd 
Problem  
Recruitment to randomised controlled trials (RCTs) should only occur when there is ‘equipoise’ - 
uncertainty over the most effective treatment - and when potential recruits have been given sufficient 
information to make an informed choice to consent to participation. The BEE trial a pragmatic, 
individually randomised trial evaluating the effectiveness of four types of emollient (lotion, cream, gel, 
ointment) for childhood eczema. Currently there is no evidence that one formulation is superior and 
there are wide variations in which emollient are recommended. The lack of clinical consensus adds to 
parental confusion and likely results in poor disease control. Parents of children recruited to BEE 
already have prior experiences of emollients but may not understand that equipoise exists around 
their relative effectiveness or acceptability and may have their own treatment preferences.  
Approach 
Overall objective:  To explore the role of parent and children’s treatment preferences in a primary care 
trial of four different types of emollient for children with eczema. Aims: To use audio-recordings of 
baseline appointments from the BEE trial to: 1. Examine when and how parent preferences are 
elicited, expressed and responded to, 2. Explore how the nature or timing of preference elicitation 
affects perceived understanding of participant in trial, willingness to give consent and subsequent 
actions, 3. Compare how different research nurses communicate clinical equipoise, random allocation 
to treatment arms and the importance of adherence to treatment, 4. Identify possible reasons for not 
adhering to allocated treatment or withdrawal from the trialA framework will be used to purposively 
sample participants across each of the three trial centres, including interviews from each research 
nurse at various points in the trial timeline, to reflect experience and trial staff turnover. Secondary 
criteria will also be considered including participant age, eczema severity and ethnicity. The interviews 
will be transcribed verbatim and analysed thematically, using an adapted framework approach. NVivo 
will be used to facilitate data management and coding.  
Findings  
Work in progress.  
Consequences  
To date, qualitative research within trials undertaken in primary care have not specifically focused on 
prior treatment preferences and how they influence recruitment, the consent process or engagement 
in the trial. Ultimately understanding how patient preferences impact trials is essential given that 
ultimately trials may observe a treatment effect, or absence thereof, as a result of patient preferences 
rather than as a therapeutic effect. 
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2B.6 The Eczema Care Online (ECO) trial RCT protocol: how clinical and cost-effective are two 
online interventions to support eczema self-care? 
Mary Steele, University of Southampton 
M. Santer, KS.Thomas, L. Yardley, P.Little, HC. Williams, I. Muller, JR.Chalmers, P. Leighton, M. 
Ridd, S. Lawton, B.Stuart, G. Griffiths, J. Nuttall, T. Sach, S. Langan, A. Roberts, A. Ahmed, K. 
Greenwell, K. Sivyer, J. Hooper, S. Wilczynska 
Problem  
Eczema is a common skin condition characterised by itchy skin and dryness. Eczema can lead to 
sleep loss and poor quality of life. A common cause of poor control of eczema is the underuse of 
effective treatments. Reasons for underuse include: concerns about safety of treatments, time 
consuming treatments, and insufficient or conflicting advice about how to use treatments.  
Approach 
We have developed two online interventions to support self-care for people with eczema; one for 
young people aged 13-25 years and one for parents and carers of children aged 0-12 years. The 
interventions support self-management of eczema using interactive features and tailored content 
delivered in a series of modules.  The interventions have been developed following evidence- (e.g. 
systematic reviews), theory- (e.g. behavioural analysis, logic model) and person-based (using iterative 
qualitative methods) approaches. Designed using open-source software tools, these online 
interventions can be accessed from mobile devices and computers. The trial websites also offer 
participants the opportunity to complete consent, baseline and all follow-up questionnaires online over 
a 52-week period. Design: This study comprises two randomised controlled trials to assess the 
effectiveness of:1.the ECO intervention in young people with eczema aged 13-25 years, 2. the ECO 
intervention in parents and carers of children with eczema aged 0-12 years. Both trials will include an 
internal pilot phase and nested health economic and process evaluation studies. Participants: 400 
participants will be recruited into the trial from GP surgeries across three sites; Southampton, 
Nottingham and Bristol. Recruitment will run until end of June 2021.Participants will be invited to 
participate if they: are a young person aged 13-25 years or a parent/carer of a child aged 0-12  years, 
have a recorded diagnosis of eczema in their GP records and have obtained a prescription for this in 
the past 12 months. Potential participants with a POEM score less than 5 will be excluded as having 
very mild or quiescent eczema. Intervention and comparator: Participants will be randomised to one of 
two groups: 1.Intervention: Usual care plus immediate access to the online intervention, 2. Control: 
Usual care (with access to the online intervention after 52 weeks of follow-up). The primary outcome 
for both trials will be eczema severity over 24 weeks measured by 4-weekly Patient-Oriented Eczema 
Measure (POEM) which measures frequency of symptoms. Secondary outcomes include: Quality of 
Life, long-term eczema control, itch intensity measure, enablement, service use and medication use.  
Findings  
If these interventions prove to be effective, health professionals would be encouraged to recommend 
their use as part of standard care.  
Consequences  
Improved self-care has the potential to benefit patients and carers through improved control of 
eczema and to the NHS through leading to more appropriate eczema care. 
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2C.1 Domestic violence screening in pregnancy and postpartum in Coventry and 
Warwickshire; an investigation into barriers. 
Caitlin Edwards, University of Warwick 
Problem  
Domestic violence (DV) is a significant problem in the UK; on average 2 women are killed by their 
partner or ex-partner every week in England and Wales. Pregnancy is identified as a particularly 
vulnerable time for women and for 30% of women who experience domestic violence in their lifetime, 
the first incident occurred in pregnancy. Domestic violence poses a substantial risk of harm to mother 
and baby. Pregnancy is also a time of increased engagement with healthcare professionals and 
screening for domestic violence in pregnancy is included in NICE guidelines for antenatal care. In 
practice it is often found that screening is not routinely implemented and barriers to screening have 
been researched globally with key themes emerging. These themes have not been explored at a local 
level in Coventry and Warwickshire. This project intends to explore these barriers locally and further 
contribute to wider discussion about how domestic violence screening can be supported and 
facilitated across the UK. 
Approach 
This project is a qualitative study involving semi-structured interviews with 18 midwives currently 
employed in antenatal and postpartum care. The midwives were recruited via email with a request to 
participate in the study and the study was also advertised at two midwifery training days at the local 
trust. Recruitment was voluntary and involved midwives working in primary and secondary care. The 
interviews consisted of 6 open questions exploring the themes established in pre-existing literature. 
The interviews were audio recorded and transcribed verbatim. The data collected was free text and 
required qualitative analysis. It was coded using both a deductive and inductive method to allow for 
exploration of unexpected findings coupled with predetermined themes. A framework approach was 
used. 
Findings  
This project is ongoing and data analysis is in progress. However key themes have already emerged 
from the data and will be subject to further analysis. The established themes are 1. Training on DV, 2. 
Types of questions asked in screening, 3. Factors that influence asking the questions 4. How to 
respond to a disclosure. There are subthemes within these. The themes concur with the global 
findings into barriers to screening for domestic violence but there are also some new associated 
themes highlighting how these barriers come into play at a local level and within the context of the 
local primary care structure. 
Consequences  
Although ongoing, the implications for future practice are emerging. There is a clear need for further 
specific training on domestic violence screening for all of those involved with the care of women in 
pregnancy. There are substantial structural barriers to screening which could be addressed with 
further review of practice. More support needs to be in place to facilitate domestic violence screening 
and this has implications for future practice and training. 
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2C.2 Domestic abuse (DA) amongst female doctor parents: a qualitative study. 
Emily Donovan, University of Southampton 
Dr Merlin Willcox and Dr Sara Morgan 
Problem  
Violence against women is described by WHO as “a global health problem of epidemic proportions". 
Recently there has been a push by the government to support doctors’ wellbeing, recognising that 
doctors have a particular set of risk factors that make them more vulnerable than the general 
population to stress. However, there has not been any discussion surrounding the problem of DA 
amongst female doctors, the lack of support many face and the unique challenges that female doctor 
victims of DA may face compared to the general public. There is a paucity of data in this area. Of the 
few studies done, results show a substantially higher prevalence of DA amongst female health 
professionals compared to the general population .We have conducted a literature review and have 
not found any studies on this subject other than a personal account of a female doctor on their own 
experience of DA. 
Approach 
Semi-structured interviews have been conducted with a 18 participants identified on the Facebook 
group ‘The Solo Project’, a group for single doctor parents who are single through choice, break up of 
relationships or bereavement. Further interviews are scheduled to take place before the SW SAPC 
conference, until saturation of data is reached, at approximately 25-30 participants.  
Findings  
More than 100 female doctor parents have been identified and are willing to participate in this study. 
Common themes emerging are: many of the perpetrators of DA are also doctors, women felt 
unsupported by their work and many felt unable to disclose DA. Very few were aware of NHS policies 
in place to support employees affected by DA. Some women have felt that a culture of bullying during 
junior doctor years meant that bullying at home by their partners was normalised. Some felt they have 
received inadequate support from social services, the courts and other doctors due to their being a 
doctor and they feel that early opportunities to help and support them leave an abusive relationship 
were missed. Many have been reliant on charities due to being left in financial hardship after 
relationship breakups, having to work less than full time due to childcare commitments and costly 
court fees. 
Consequences  
There is a lack of publicity regarding the problem of DA amongst female doctor parents, and a lack of 
support in place for them. The problem of many of the perpetrators also being doctors raises other 
important issues. More research is needed in this area to understand the scale of the problem, and to 
put measures in place to support our doctor workforce. The British Medical Association are very 
interested in this research which may lead to a quantitative study to enable the BMA to allocate 
financial support to support doctor victims of DA. 
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2C.3 What are women's experiences of the IRIS programme? A thematic analysis of free text 
quotations from service users for the year April 2018 - March 2019 
Sophie Lloyd, University of Bristol 
Sophie Lloyd, Medina Johnson, Gene Feder, Natalia Lewis 
Problem  
Identification and Referral to Improve Safety (IRIS) is a general practise-based training support and 
referral programme aimed at women who are victims of domestic violence and abuse (DVA). The 
effectiveness associated with IRIS has been previously demonstrated in a randomised control trial 
(Feder et al. 2011). Since the trial, IRIS has been implemented in over 40 localities in England and 
Wales as of October 2019. IRISi is a social enterprise which was launched in 2017 to expand 
commissioning of IRIS across the UK. IRISi carries out annual national reports about IRIS 
implementation. Reports include a feedback questionnaire with free text comments completed by 
female patients referred to the IRIS programme. The aim of this student research project was to  
explore the experiences of the IRIS programme by women who had been referred to an IRIS 
advocate-educator from general practice.  
Approach 
We conducted descriptive and secondary thematic analysis (as outlined by Braun and Clark, 2006) of 
166 free text comments from IRIS service users who completed a feedback form in the year April 
2018 - March 2019.  Comments were manually coded. First, we established whether comments were 
positive, negative, mixed positive and negative, or neutral/irrelevant. Comments classified as 
neutral/irrelevant were not included in further analysis. Second, we coded comments according to 
recurring words and topics. We developed 41 codes. Codes with similar meaning were then combined 
into 11 sub-themes and four themes. Following completion of the qualitative analysis, the frequency of 
comments per code and theme was calculated in order to identify which experiences were most 
common amongst service users.  
Findings  
Almost all service users described positive experiences of the IRIS service. There were only three out 
of 166 comments classified as negative, and one mixed comment identified in the primary coding. The 
main themes from the positive comments included: women felt supported by the IRIS service, women 
felt empowered as a result of IRIS, women felt that they and their children  were safer as a result of 
IRIS and women had improved mental and/or physical health as a result of IRIS.  
Consequences  
This research of female patients’ experiences suggests that IRIS is an effective and powerful 
mechanism for improving the lives of women who are victims of DVA. In particular, supporting and 
empowering women to bring about changes in order to increase their safety and improve health. 
Patient’s voices can play an important part in expanding IRIS; this study can be used alongside the 
IRIS National Report 2019 to demonstrate the positive impacts of IRIS on service users to 
commissioners and/or clinicians. 
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2C.4 How does the media effect domestic violence in India? 
Samya Sarfaraz, University of Bristol 
Problem  
India was named as the most dangerous country for women with regards to risk of harassment, 
human trafficking, domestic servitude and the dangers women face from cultural, tribal and traditional 
practices in 2018. An estimated 27.5 million women experience sexual violence in the sub-continent. 
The root cause is likely situated within the home, due to a structurally violent society. With widespread 
exposure from, for example, “daily soaps” on television there are many other factors which may be 
enforcing traditional gender norms and in turn perpetuating violence. This study aims to understand 
how different forms of media are influencing society, especially the adolescent populations , shaping 
their views of relationships and how this has an impact on the prevalence of domestic violence.  
Approach 
There are two key components if this study. The first is a secondary thematic analysis of a pilot study 
conducted in Lucknow, Uttar Pradesh in April 2019. The state was chosen as it has the highest 
number of rape cases in the country and Lucknow as the capital, being majorly affected. Primary 
qualitative data was collected in the form of 15 semi-structured interviews with teachers, NGO 
workers and paediatricians to understand why sex and relationship education (SRE) programs are not 
being implemented in this area, especially as education programs have been highlighted as a key 
intervention to reduce the rates of domestic violence by the World Health Organization. The second 
aspect of this study is to review the current literature. Online databases Science Direct, Medline 
(OvidSP) and Web of Science will be searched, the relevant papers with their findings will be 
analysed using the Cochrane GRADE system to assess the quality of evidence. These results will be 
synthesised in order to offer possible policy recommendations on what can be done to improve the 
current situation.  
Findings  
The results of the pilot study, strongly highlighted that “media”-  in the form of films, books and social 
networking sites -  plays a vital role in how intimate relationships are perceived, established and 
experienced by adolescents. Additionally cultural stigma around sex and rigid gender roles are 
preventing the implementation of education programs which seek to promote “healthy relationships”, a 
vital intervention in reducing domestic violence. Parents are also a barrier as they feel ill equipped to 
discuss these issues with their children. Currently 10 relevant papers have been identified in the 
search.  
Consequences  
The Lucknow Adolescent Health Group part of the Uttar Pradesh branch of the Indian Academy of 
Paediatrics have been involved with the pilot study and recommendations of this work are currently 
being passed on to them. Results of this study will also be feedback, especially as they are working 
on a national level to increase awareness around this topic. 
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2D.1 The At-Risk Registers Integrated into primary care to Stop Asthma crises in the UK 
(ARRISA-UK) trial: Has the ARRISA-UK intervention led to perceived improvements in the 
management of ‘at-risk’ asthma patients in primary care? 
Saumil Hiremath, University of Exeter 
Saumil Hiremath, Rachel Winder, Leon Poltawski, Sarah Morgan-Trimmer, On behalf of the ARRISA-
UK trial team 
Problem  
There are an estimated 334 million asthma sufferers worldwide and most morbidity and mortality due 
to asthma should be preventable. The ARRISA-UK cluster-randomised control trial is evaluating 
across 275 GP practices whether a practice-level intervention reduces the proportion of ‘at-risk’ 
asthma patients experiencing asthma-related A&E attendances, hospitalisations or death over 12 
months, compared to usual care. The intervention involved identifying and adding flags to the records 
of at-risk asthma patients, and staff representatives completing online training to support 
implementation of agreed practice-wide actions in response to the flags. The student-led study 
reported here is part of a wider process evaluation and investigates staff perceptions of the ARRISA-
UK intervention, including reported changes in their care of at-risk asthma patients following the 
intervention.  
Approach 
The study uses data collected via online questionnaires sent to staff representatives at all 
participating intervention practices at the end of the 1-year study follow up. Questions were tailored to 
the participant’s role in the practice and comprised Likert-type and free-text responses. Quantitative 
and qualitative (e.g. content) analyses of data are being conducted to generate descriptive statistics 
and themes from the responses about the intervention’s acceptability, feasibility and impact in 
managing at-risk asthma patients, and whether practices would continue using the intervention. Data 
from staff in different roles, and across different types of practices will also be compared to explore 
any potential differences in perceptions.  
Findings  
Of the 129 intervention practices remaining in the study and sent a questionnaire (93% of total), 121 
(94%) responded, returning 288 questionnaires from staff representatives to date (data collection is 
ongoing until end of November). Practices returned between 1 and 6 questionnaires, with 27% from 
GPs, 25% from nurses, 19% from practice managers, 13% from administrative staff, 5% from 
pharmacists or dispensers, 3% from receptionists, 2% from healthcare assistants and 7% from others.  
Detailed findings on perceptions of the intervention, reported impacts on the care of at-risk asthma 
patients and any identified areas for improvement amongst these different staff groups will be 
presented.  
Consequences  
Findings from this study will shed light on potential mechanisms of action of the ARRISA-UK 
intervention which can be explored in further analyses when objective data on care processes and 
outcomes are available. Any identified differences in perceptions between staff in different roles and 
across different practices can be used to inform how any future implementation of the intervention can 
be improved to make it feasible, acceptable and useful to all staff groups and practices. 
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2D.2 Retrospective treatment outcome study of treatment seeking for cough in China 
Xiao-Yang (Mio) Hu, University of Southampton 
Ru-Yu Xia, Yu-Tong Fei, Beth Stuart, Lily Lai, Andrew Flower, Paul Little, Bertrand Graz, Jian-Ping 
Liu, Michael Moore, Merlin Willcox 
Problem  
This online survey aimed to explore treatment-seeking behaviour for cough in China. In particular, it 
aimed to identify the patterns of participants’ use of antibiotics, modern medicine, Chinese herbal 
medicine (CHM), and other treatments for cough; to identify which commonly used treatments for 
cough are associated with the best outcomes in the Chinese population; and to examine whether the 
use of some patented CHM is associated with a reduction in antibiotic use.  
Approach 
Potential participants were recruited through a social media platform (WeChat) with a QR code to the 
online survey developed using Wen Juan Xing survey. Retrospective clinical information was 
collected on patients who: either were experiencing or had experienced cough in the last 6 weeks; 
had taken oral medicines (modern medicine or CHM, either self-care or given by health care 
professionals), or non-medical approaches to help with the cough. The survey contained key 
questions on participants’ sociodemographics and basic lifestyle information on smoking; and key 
questions such as: What treatment(s) did you/ the patient use for the last episode of cough? What 
was the progress (cured/better, same/worse)? How much did each treatment help with the cough 
symptom? Did you / the patient take antibiotics during the course of cough? Have you / the patient 
experienced any adverse events during your course of treatment?  
Findings  
The survey was circulated with data collection between January and February in 2019. 26756 
participants were recruited, among which 25597 (95.7%) experienced acute cough with an average 
severity score of 5.34 on a 0-10 numerical rating scale. Only a small minority had any symptoms of 
lower respiratory tract infections and most had symptoms of upper respiratory tract infections. Of 
these participants, 45.3% used antibiotics, 39.4% used Chinese herbal medicine, 27.1% used non-
antibiotic medications, and 20.9% used non-medical interventions. The top five antibiotics used were 
Amoxicillin, Ceftizoxime, Ampicillin, Cefoxitin and Cefuroxime. Only about 50% actually took 
antibiotics following recommendation from a doctor. Near half of the participants got their antibiotics 
from a drug shop (49.4%), followed by public community health centre 32.0%, traditional Chinese 
medicine hospital 27.1%. 4140/10074 (41.1%) participants had subsequently used antibiotics after 
taking CHM, while 4730/6947 (68%) after taking non-antibiotic medications.  
Consequences  
Although a series of antimicrobial stewardship guidelines and policies have been released in China 
since 2011, there was a high level of antibiotic use in acute cough, which in the majority of cases was 
probably unnecessary and potentially harmful. CHM may be a potential way of reducing the use of 
antibiotics in acute cough and our findings identified a few promising remedies worth further 
exploration on their effects and safety. A large number of patients seek antibiotics from easily 
accessible drug shop which is often less strictly regulated and may provide inadequate quality of care. 
There is a need to regulate drug shop practices of prescribing and selling antibiotics 
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2D.3 – Withdrawn 
2D.4 The At-Risk Registers Integrated into primary care to Stop Asthma crises in the UK 
(ARRISA-UK) trial: How has the ARRISA-UK intervention been experienced and acted upon by 
different types of GP practices? A longitudinal, comparative case study 
Charlotte Reburn, University of Exeter 
Charlotte Reburn, Leon Poltawski, Rachel Winder, Sarah Morgan-Trimmer, On behalf of the ARRISA-
UK trial team 
Problem  
Most deaths and hospitalisations due to asthma are preventable. The ARRISA-UK study is a cluster-
randomised control trial across 275 GP practices evaluating whether a complex, practice-level 
intervention reduces the proportion of ‘at-risk’ asthma patients experiencing asthma-related A&E 
attendances, hospitalisations or death over 12 months, compared to usual care. The student-led 
study reported here is being conducted as part of a nested process evaluation of the ARRISA-UK 
intervention. It aims to describe in depth how the intervention was experienced and acted upon in 
different practices, and explore how contextual factors (e.g. practice characteristics) influenced this.  
Approach 
Intervention practices were supported in identifying and adding flags to at-risk asthma patients’ 
records. Staff representatives (including receptionists, nurses, GPs and pharmacists) participated in 
online training which culminated in generation of practice-specific action plans for management of at-
risk asthma patients that practices were left to implement. For a purposively selected subsample of 4-
6 practices that differ in terms of key practice characteristics, quantitative (e.g. training records, Likert-
type questionnaire responses) and qualitative data (e.g. action plans, free-text questionnaire 
responses, focus groups) collected for the process evaluation are being analysed and integrated to 
(1) describe in depth how these practices engaged with the ARRISA-UK intervention, up to and 
including writing an action plan, (2) describe practices’ implementation of the action plan, and (3) 
explore any linkages between engagement, implementation and practice characteristics (e.g. practice 
size, area deprivation).  A longitudinal comparative case study approach will generate a detailed 
picture of different practice experiences and make comparisons between them.  
Findings  
Initial findings from the 128 intervention practices which activated flags for at-risk asthma patients 
(92% of total) indicate wide variations in practice characteristics (e.g. list size 1667-32,868 patients, 1-
121 at-risk asthma patients identified), the type and number of staff completing training (median 3, 
range 1-9) and content of action plans (median 22, range 5-38 action points per practice, most 
representing agreed actions for receptionists and clinicians in response to flags). The impact of these 
differences on experiences of the intervention and implementation of action plans were apparent in 
focus groups with 17 practices. Further analyses and integration of quantitative and qualitative 
findings from up to 6 of these practices are underway. These case studies will be presented to 
provide detailed illustrations of differing patterns of engagement with the intervention and 
implementation of action plans, and how contextual factors have influenced these.  
Consequences  
Identified differences in how different GP practices respond to and act upon the ARRISA-UK 
intervention could impact on its effectiveness. These findings could therefore highlight potential 
mediators and moderators of patient care and outcomes for exploration when full follow up data are 
available and indicate ways to improve any future implementation of the ARRISA-UK intervention in 
different types of practice. 
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2D.5 EXCALIBUR: Treating Acute EXacerbation of COPD with Chinese HerbAL MedIcine to aid 
AntiBiotic Use Reduction 
Tom Oliver, University of Southampton 
Tom Oliver, Xiao-Yang Hu, Merlin Willcox, Nick Francis, Mike Thomas, Beth Stuart, Gareth Griffiths, 
Jessima Hunter, Neville Goward, Mike Moore 
Problem  
Antimicrobial resistance is rising and is linked to prescribing in primary care. Acute Exacerbation of 
Chronic Obstructive Pulmonary Disease (AECOPD) accounts for over two million antibiotic 
prescriptions each year in the UK with over 70% of patients presenting with an AECOPD being 
prescribed antibiotics. However, many exacerbations are triggered by non-bacterial causes (e.g. viral  
infections, environmental factors) and there is evidence that many patients in primary care with 
AECOPD do not benefit from antibiotic treatment. Identifying a safe and effective method of symptom 
control could possibly reduce antibiotic use for AECOPD. Shufung Jiedu (SFJD), a patented 
Traditional Chinese Medicine consisting of 8 herbs, is already widely used in China for the treatment 
of respiratory infections. Preliminary research in China suggests that in combination with usual care it 
can reduce the risk of relapse and duration of hospitalisation in patients with AECOPD. We think that 
the addition of SFJD to standard care may aid patients to recover faster and so reduce the number of 
antibiotic courses prescribed. EXCALIBUR is a Phase III feasibility trial with the objective to determine 
the feasibility of conducting a full trial of SFJD in addition to best current practice for AECOPD in UK 
primary care.  
Approach 
EXCALIBUR is a multicentre, double-blind, randomised placebo-controlled feasibility trial, 
incorporating a nested qualitative study. Patients, aged ≥40 years with a clinical diagnosis of COPD, 
will be invited to participate if they present to their GP with a current AECOPD (≤21 days) with at least 
one of increased sputum purulence, sputum production or breathlessness for which the GP is 
considering use of antibiotics. 80 participants from 10 GP practices, will be randomised to one of two 
groups: 1) Control: Usual care plus placebo capsules 2) Intervention: Usual care plus SFJD capsules. 
In addition to the above, GPs will be able to offer one of 3 antibiotic options: 1) Immediate 2) Delayed 
3) None Delayed prescribing would be encouraged when appropriate. Participants will complete a 
symptom/treatment diary for up to 28 days and quality of life questionnaires at intervals over 12 
weeks following randomisation. A medical note review to record subsequent visits to GP with 
AECOPD and prescribed medication and hospital admissions within 12-week follow up period will be 
undertaken. Qualitative interviews will be conducted with eligible patients to get feedback from 
patients on the feasibility of undertaking a full RCT and to determine the barriers to the 
implementation of a delayed antibiotic prescription and use of herbal medication.  
Findings  
The trial is scheduled to open to recruitment in April 2020. Trial results will inform the design of the full 
RCT.  
Consequences  
If this feasibility study leads to a successful full RCT that shows SFJD is an effective treatment for 
AECOPD, prescription of antibiotics for AECOPD may decline. 
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2D.6 What clinical signs, symptoms, and investigations are associated with poor prognosis in 
children with respiratory tract infections? 
George Edwards, University of Oxford 
Alastair Hay, Stephen Campbell, Louise Newbould, Rebecca Morris, Gail Hayward 
Problem  
Demand for NHS services is at an all-time high and continues to rise. A key contributor is 
consultations for children with respiratory tract infections (RTI).  Understanding which features are 
associated with poor prognosis in children with RTI is the first step in developing interventions for 
parents to reduce potentially unnecessary healthcare attendances in this patient group.  
Approach 
Systematic literature review  
Findings  
We found 27 studies met our inclusion criteria with a range of settings, populations, conditions, study 
designs, and outcomes. There were no studies in a home setting. In children presenting with signs of 
an RTI, we found that respiratory signs, vomiting, fever, signs of dehydration, and low oxygen 
saturations are associated with an increased odds of hospitalisation. Findings on ear examination was 
associated with a reduced odds of hospitalisation in this population. In children presenting with 
bronchiolitis, low oxygen saturation, reduced food and fluids intake, a high respiratory rate, an 
accessory muscle score ≥6/9, and tachycardia were associated with increased odds of hospitalisation. 
In patients presenting with laboratory confirmed influenza abnormal lung auscultation or x-ray, fatigue, 
tachycardia, respiratory distress, and shortness of breath were associated with increased odds of 
hospitalisation. Where associations were found, the absolute risk of hospitalisation remained small. 
Headache, congestion, and chills were association with a reduced odds of hospitalisation. There was 
little evidence of signs, symptoms, or investigations associated with death, re-consultation, antibiotic 
prescription, and prolonged symptoms. The available evidence was of a low to medium quality with a 
third of studies at risk of bias from confounding.  
Consequences  
There is limited evidence for factors associated with poor prognosis in children with RTI, and no 
studies have explored factors which can be assessed by parents in the home. Evidence quality is 
limited by retrospective design of studies, lack of clarity with regard to prognostic factor measurement, 
and full reporting of data. Where evidence was available, the absolute risk of poor prognosis was 
small. Prospective studies asking whether symptoms, such as breathing difficulty or ‘a temperature’, 
can predict prognostic outcomes in the home setting would be the most relevant for parents. 
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3A.1 “If it’s less than twenty, you can turn around and say “computer says no”“; Clinician 
perspectives on access to CRP testing in primary care out of hours bases. 
Sharon Dixon, University of Oxford 
Margaret Glogowska, Phil Turner, Gail Hayward 
Problem  
Point of care CRP testing has been advised by NICE to support antibiotics prescribing decisions in 
LRTI. However, implementation has been limited. Antibiotic prescribing in OOH primary care shows 
an increasing trend with time. CRP may be a useful tool to guide prescribing decisions in a clinical 
context where doctors are dealing with uncertainty, are unfamiliar with the patients and under 
pressure to see patients quickly  
Approach 
This paper reports on the qualitative component of an on-going mixed-methods evaluation of a study 
in which point of care CRP testing was made available to clinicians working in Care UK OOH bases. 
We undertook semi-structured interviews with clinicians working in the out of hours bases with access 
to the CRP testing, with the use of a topic guide. Interviews were transcribed verbatim and analysed 
thematically. Ten interviews have been conducted to date, with further interviews planned. To date, 
we have spoken to 8 GPs and 2 ANPs, including those who use CRP testing never, sporadically and 
often.  
Findings  
Clinicians reflected on the role of CRP in supporting clinical assessment, with perspectives ranging 
from CRP test results supporting confidence in decision making, to uncertainty about how CRP test 
results sit within the hierarchy of components comprising clinical assessment. Clinicians who used the 
tests explained how the results supported communication with patients, in the context of antibiotic 
stewardship. CRP results offered a neutral way for the clinician to decline to prescribe antibiotics, 
especially when the patient wanted or expected antibiotics  (“it’s difficult to fight with concrete 
science”) . We heard accounts about how the guidance about what to do in the CRP middle range 
supported the greater use of delayed prescriptions. Challenges to using CRP testing included the 
difficulty of maintaining training and awareness amongst a varied and variable staff team, who work 
irregular shifts across different bases, the pressures of time and workload in OOH settings, and 
concerns about leaving patients in clinical rooms to use a central machine. Having an HCA to do the 
test, or desktop POC equipment in each room were identified as changes that could mitigate against 
this.  
Consequences  
Uncertainty about the value (and potential risks)of CRP testing in a holistic clinical assessment limited 
uptake for some clinicians we spoke to. Training, resource and time-pressure issues reduced usage 
for some, which could be potentially mitigated against, including HCA support to do the test, desk-top 
equipment, and strategies for on-going training. The clinicians we spoke to valued having CRP results 
as a tool support their decisions to not prescribe antibiotics, in the face of what they perceived as 
patient expectations: “it has taken the no-antibiotics sting out of a lot of consultations”. This could be a 
powerful motivator for supporting uptake. 
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3A.2 To what extent do patients and GPs have a shared understanding of blood testing in 
primary care? 
Jessica Watson, University of Bristol 
Chris Salisbury, Willie Hamilton, Penny Whiting, Jon Banks 
Problem  
Rates of blood testing are increasing in primary care, with significant implications for NHS costs and 
GPs workload. Increased testing rates are not mirrored by increased rates of disease, suggesting 
non-medical reasons such as patient or GP expectations may be important. There is increasing 
awareness about the importance of shared decision making in medicine, but most research focuses 
on treatment decisions rather than investigations. The aim of this research is to compare patients’ and 
GPs’ experience, expectation and understanding of testing, in order to improve communication and 
promote patient engagement.  
Approach 
Six general practices were recruited, reflecting a range of socioeconomic and demographic 
characteristics. Patients were recruited at the time of blood testing by phlebotomists or GPs. 
Qualitative interviews were undertaken with patients at two time points: (a) at or soon after their blood 
test and (b) after they had received their test results. We also undertook interviews with the patients’ 
GPs who requested the tests. This gave us paired data which enabled to us to examine areas of 
congruence and dissonance between GPs’ and patients’ expectations, experience and understanding 
of testing.  
Findings  
22 patient and 21 GP interviews have been either booked or completed, out of a target of 30 patients 
and 30 GPs. Early findings indicate a lack of shared understanding and a mismatch between patients’ 
and doctors’ expectations of testing. Patients are frequently unaware which tests have been done and 
why. Patients have high expectations of tests; expecting them to provide diagnostic certainty without 
mistakes, whereas doctors expectations are more modest. Whilst doctors tend to be reassured by 
normal results, patients with ongoing symptoms may find normal results unhelpful. Patients’ 
expectations that tests will provide answers can be frustrated by a lack of communication about test 
results.  
Consequences  
The results have implications, not just for shared decision making, but more fundamentally, informed 
consent. Misunderstanding and a lack of communication around testing and test results can lead to 
uncertainty, anxiety and frustration for patients. Promoting a shared understanding and shared 
decision making could help rationalise testing, potentially reducing unnecessary investigations and 
improving patient-centred care. 
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3A.3 Non-contact thermometers: a method comparison study assessing agreement with 
electronic axillary and infrared tympanic thermometers. 
Gail Hayward, University of Oxford 
Jan Y Verbakel, Fatene Abakar Ismail, George Edwards, Kay Wang, Susannah Fleming, Gea A 
Holtman, Margaret Glogowska, Elizabeth Morris, Kathryn Curtis, Ann van den Bruel 
Problem  
Temperature measurement is commonly performed in children aged 5 and under in primary care and 
is an important component of guidelines for management of acute illness in this age group. Currently 
either axillary or tympanic thermometers are used. Non-contact infra-red thermometers (NCITs) have 
the potential to reduce both the distress of the child and the risk of cross-infection. However our 
systematic review found limited evidence of comparative accuracy to standard methods. We aimed to 
compare two different NCITs to axillary and tympanic thermometers in children aged 5 and under 
presenting to primary care.  
Approach 
We performed a methods comparison study comparing 2 different NCITs (Thermofocus and Firhealth) 
to axillary and tympanic thermometers in children aged 5 or under attending the GP with an acute 
illness. Measurements were made in a pre-determined order using a random number generator. We 
evaluated reproducibility and sensitivity for fever of 38 °C or more using the axillary thermometer.  
Parents and children used scales to rate their discomfort.  
Findings  
401 children were recruited with median age 1.6 years (IQR 0.79-3.38). Our primary outcome was the 
comparison between the Thermofocus NCIT and axillary thermometer. The mean difference between 
the two methods was -0.14°C (95% CI -0.21 - (-0.06)), with the lower limit of agreement being -1.57°C 
(95% CI -1.69 - (-1.44)) and the upper limit 1.29°C (95% CI 1.16 - 1.42). Similar agreement was seen 
for the Firhealth NCIT. The Thermofocus had a sensitivity for fever (38°C using axillary measurement) 
of 29.3% (95% CI 16.1 - 45.5). The Firhealth had a sensitivity of 4.9% (95% CI 0.6 - 16.5). 
Reproduciblity was acceptable for both NCITs. The majority of parents found all methods acceptable, 
although discomfort ratings were highest for the axillary thermometer.  
Consequences  
Temperature measured using an NCIT can vary by more than 1°C  compared with measurements 
from currently recommended thermomter types, and sensitivity for fever was poor for both non-
contact thermometers. However the agreement between axillary and tympanic thermometers and 
core body temperature has also been shown to be poor. There is a clear opportunity for new 
technology to improve the accuracy of non-invasive temperature measurement. 
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3A.4 Rapid antigen test to detect strep A infection in patients with sore throat: evidence from a 
pathfinder NHS Sore Throat Test & Treat service in community pharmacies in Wales 
Efi Mantzourani, Cardiff University 
Rebecca Cannings-John, Harry Ahmed, Kerry Hood, Anne Marie Cunningham, Emma Williams, 
Cheryl Way, Andrew Evans 
Problem  
Background: A pathfinder Sore Throat Test and Treat service (STTT) was rolled out in 56 community 
pharmacies in Wales in November 2018, as part of a wider approach to safely rebalance 
management of uncomplicated conditions from GPs to community pharmacists. STTT included 
clinical assessment of patients 6 years and over, using clinical scoring criteria (Centor and/or 
FeverPAIN), a rapid antigen detection test (RADT) to detect strep A infection when threshold scores 
are met, and allowance for antibiotic supply in the pharmacy, in line with NICE guidance1, if the test is 
positive. Aim: To explore the added value of RADT for group A streptococcal infections in people with 
a sore throat, as part of the STTT service in community pharmacies  
Approach 
Methodology: Secondary data analysis of STTT consultation data between November 2018 (date the 
service went live) and March 2019, obtained from Choose Pharmacy, the national IT platform used in 
98% community pharmacies in Wales to record services. Data were analysed using Microsoft Excel®. 
No ethical approval was required for the study.  
Findings  
Results: A total of 1,235 patients met the clinical scoring criteria to be offered RADT within the study 
period. A total of 901/1235 patients (73%) did not receive an antibiotic supply as they had a negative 
result from their RADT. Of the 334 (27%) that did receive an antibiotic this rate varied by their clinical 
score from 12% (58/481) in those with FeverPAIN score of 2 to 71% (60/84) in those with a 
FeverPAIN score of 5. When we only consider Centor score 3 or 4 and FeverPAIN score 4 or 5, the 
corresponding number is 181/368 patients (49.2%).  
Consequences  
Conclusion: Data from the first five months of the pathfinder service suggests that almost half of the 
patients who would have been offered an immediate antibiotic or back-up antibiotic prescription 
according to NICE guidance, were not offered antibiotics as the RADT results were negative. This 
preliminary data suggests that RADT may play a role in antimicrobial stewardship, by reducing the 
number of antibiotics prescribed for sore throat symptoms.1. NICE guideline [NG84]. Sore throat 
(acute): antimicrobial prescribing. January 2018. Available at: https://www.nice.org.uk/guidance/ng84 
50 
 
3A.5 Impact of a Pathfinder Sore Throat Test & Treat service in community pharmacies on GP 
sore throat related consultation rates 
Efi Mantzourani, Cardiff University 
Rebecca Cannings-John, Haroon Ahmed, Kerry Hood, Andrew Evans, Emma Williams, Cheryl Way 
Problem  
Workload in General Practice has increased substantially over the last decade. As a result, there is 
increasing interest in widening the roles of other primary care health professionals who can safely and 
effectively meet the needs of patients who would traditionally see a GP. Community pharmacists are 
key members of the primary care healthcare team and can help to provide sustainable services for a 
range of minor illness presentations. One of the conditions whose management could be transferred 
to community pharmacies to ensure timely access to services, is uncomplicated sore throats. A 
pathfinder Sore Throat Test and Treat service (STTT) was rolled out in 56 community pharmacies in 
Wales in November 2019. One of the aims was to safely rebalance management of uncomplicated 
sore throats between GPs and community pharmacies. The aim of this study was to explore the 
feasibility of measuring changes in sore throat consultation rates in general practice, in areas where 
the STTT service was piloted. 
Approach 
A national GP audit tool, Audit+, was used to obtain data for Read-coded GP sore throat related 
consultations, between November 2018-March 2019, for one GP practice adjacent to four community 
pharmacies in which the STTT service was available (list size=10220). Data were analysed using 
Microsoft Excel® and IBM SPSS® v23 to obtain descriptive statistics and undertake more detailed 
statistical comparisons. The study was registered with NHS Research and Development departments. 
Findings  
It was feasible to extract sore throat consultation data from the GP practice prescribing system using 
Audit+. Monthly sore throat consultation numbers were used to estimate the average consultation rate 
per month for the study practice before the introduction of STTT. Sore throat consultations rates 
decreased from 0.71/1000 patients in March 2018 (prior to STTT) to 0.36/1000 patients in March 
2019 (4 months after STTT). The number of sore throat related GP consultations during the study 
period was lower than the lower band of the 95% confidence interval band calculated from the 
average consultation rate per month for 2014-18, per 1000 patients (average for March: 0.72). 
Consequences  
Our findings suggest it is feasible to look at individual case studies of Read-coded consultations in GP 
surgeries. Preliminary data suggests that the new service may have a role in rebalancing 
management of uncomplicated sore throats within primary care. We will build on this work using 
interrupted time series methods and locality level data to look at trends in quinsy rates and sore throat 
consultation rates before and after implementation of STTT. 
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3A.6 Diagnosis of peripheral arterial disease in primary care: a survey of general practitioners 
in England 
Judit Konya, University of Exeter 
STJ McDonagh, G Abel, K Boddy, CE Clark 
Problem  
Lower extremity peripheral arterial disease (PAD) has a global prevalence of 10%. PAD is associated 
with reduced quality of life and physical functioning, and may lead to critical limb ischaemia, limb loss 
or death. PAD therefore represents a substantial economic and health care burden. The condition is 
under-diagnosed, perhaps due to the variability of leg symptoms presented. The EuroPAD group 
comprises PAD guideline authors, vascular and primary care experts from 10 European countries. 
This group conceived and developed a survey for a Europe-wide assessment of current primary care 
approaches to detecting and monitoring PAD. This study seeks to understand general practitioners’ 
(GPs) usual approaches to the diagnosis and follow-up of PAD in England, using an online, country-
specific, version of the EuroPAD survey. We aim to survey the current practices of GPs in England in 
suspecting, assessing and diagnosing PAD. We will compare aggregated responses with current 
standards and guidelines, explore trends in responses according to practice demographics, and link 
responses to current Quality and Outcomes Framework (QOF) indicator achievements for PAD, to 
describe factors associated with high or low-level achievement. 
Approach 
The online survey will be distributed via email to GPs using various means: the local Clinical 
Research Network (CRN), newsletters for Royal College of General Practitioners (RCGP) Faculties, 
Local Medical Committees and the RCGP Rural Forum Google Group. Postal reminders may also be 
distributed. We aim to finish data collection by March 2020. Responses will be summarised as either 
mean and standard deviations, or median and inter-quartile ranges according to normality of the data. 
Demographic and QOF characteristics of responding and non-responding practices will be compared 
using t-tests, Mann-Whitney or Ï‡2 tests, as appropriate. QOF data will be compared with survey 
responses using Pearson’s correlation coefficients or t-tests for unadjusted comparisons, and 
adjusted for practice-level demographics using mixed effects logistic regression. We aim to obtain 300 
responses, which will give 90% power (p<0.05) to detect a difference of 3.5 % between QOF reporting 
of anti-platelet prescribing as one indicator of care. 
Findings  
The survey will open in November 2019; analyses and results will be presented at the conference. 
Consequences  
Our findings will offer insight into current PAD management in English primary care settings. These 
results will be merged with other national surveys led by the EuroPAD investigators and contribute to 
a Europe-wide report that can guide future policy. The results will provide an evidence base to inform 
the design of future interventions with the aim of improving approaches to diagnosing and monitoring 
PAD. We will discuss our findings with our Patient Participation (PPI) Group prior to dissemination to 
ensure that interpretation and presentation of results are meaningful to service users. 
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3B.1 Primary care streaming in emergency departments and perceived mechanisms for 
effectiveness 
Michelle Edwards, Cardiff University 
Rebecca Sherlock, Alison Cooper, Freya Davies, Adrian Edwards 
Problem  
To manage increasing demand on UK emergency and unscheduled health care services, policy has 
promoted the streaming of patients presenting to emergency departments (EDs) with non-urgent 
problems to primary care services. Currently little is known about the different contexts in which 
primary care streaming is operated, its effectiveness in directing patients to the most appropriate 
clinician and the impact on flow and waiting times.  
Approach 
Using realist methods we aimed to explore the effectiveness of primary care streaming. We visited 13 
hospitals and conducted non-participant observations and semi-structured interviews with staff and 
patients. Data consisted of field notes and audio-recorded interviews. Transcripts were coded in 
NVivo v12 and analysed to produce context, mechanism and outcome configurations to help explain 
how streaming works in different contexts and what mechanisms are perceived to lead to 
effectiveness outcomes.  
Findings  
Primary care streaming was perceived to help improve flow and waiting times in some settings 
because GPs saw patients with minor illness and made quick assessments without the need for 
investigations, enabling ED doctors to focus on more acutely unwell patients. In other settings where 
there was low demand from patients with primary care problems, there was less perceived 
improvement on flow. In more integrated services, with a shared governance structure and where 
there were good working relationships between ED and primary care clinicians, streaming was 
perceived to be more effective in terms of patients being streamed to the most appropriate clinician, 
GPs often saw a wider range of patients More experienced nurses working in a streaming or triage 
role were perceived to be effective in streaming patients to the most appropriate clinician because 
they had more skills and knowledge to support clinical decision-making. Nurses who had knowledge 
of primary care and of the skillset of primary care clinicians working in the ED were also perceived as 
more effective.  Some higher band nurses also improved waiting times and flow because they could 
prescribe, order X-rays, discharge patients or redirect them to their own GP. Clear guidance and 
training was perceived as essential in streaming patients to primary care clinicians and a lack of 
guidance and miss-matched governance where the services were provided and managed separately 
was found less effective. Less experienced nurses with less knowledge, skills and confidence to 
support streaming decisions were perceived as less effective in streaming patients to the most 
appropriate clinician and took longer in undertaking streaming assessments, contributing to delays in 
waiting times and flow.  
Consequences  
Effectiveness of streaming relies on experienced nurses, using clear guidance based on the local 
service, support and training. An NHS Trust managed service, a shared governance structure and a 
good working relationship between the ED and primary care clinicians improved effectiveness. 
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3B.2 How are paramedics deployed in general practice and what are the perceived benefits 
and drawbacks? A mixed methods scoping study 
Matthew Booker, University of Bristol 
Schofield B, Voss S, Proctor A, Benger JR, Coates D, Kirby K, Purdy S 
Problem  
General Practice in the United Kingdom faces continuing challenges to balance a workforce shortage 
against rising demand. The NHS England General Practice (GP) Forward View proposes 
development of the multi-disciplinary, integrated primary care workforce to support front-line service 
delivery, including the employment of paramedics. However, very little is known about the safety, 
clinical or cost effectiveness of paramedics working in general practice. Research is needed to 
understand the potential benefits and drawbacks of this model of workforce organisation. The aim of 
this study is to understand how paramedics are deployed in general practice, and to investigate the 
theories and drivers that underpin this service development.  
Approach 
This was a mixed methods study using a literature review, national survey and qualitative interviews. 
The study was conducted in three phases: 1) A mapping exercise which involved a systematically 
search scoping review of the literature review and web-based survey of paramedics, and staff working 
with them, in general practice. 2) Meetings with Key Informants to locate existing theories about the 
intended outcomes of deploying paramedics in general practice. 3) Semi-structured qualitative 
interviews with stakeholders to examine the underlying assumptions about how different approaches 
to paramedic deployment are intended to work.  
Findings  
There is very little evidence on the safety and cost effectiveness of paramedics working in general 
practice. The findings from this study indicate significant variation in the types of models adopted and 
disparity in a number of areas. The majority of models reported include home visits as a key feature. 
However, the type of patients seen and conditions treated vary significantly. Nonetheless, there is a 
largely positive view of this development and a perceived reduction in GP workload. However, some 
concerns centre on the time needed from GPs to train and supervise paramedic staff.  
Consequences  
The contribution of paramedics in general practice has not been fully evaluated. There is a need for 
research that takes account of the substantial variation between service models to fully understand 
the benefits and consequences for patients, the workforce and the NHS. 
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3B.3 Are National Early Warning Scores calculated in primary care associated with clinical 
outcomes during subsequent secondary care admissions? 
Lauren Scott, University of Bristol 
Niamh Redmond, Alison Tavare, Hannah Little, Seema Srivastava, Anne Pullyblank 
Problem  
The National Early Warning Score (NEWS) is calculated from a series of physiological observations 
and was developed as a standardised measure to aid recognition of patient deterioration. NHS 
England has mandated the use of NEWS, more recently NEWS2, in acute settings, and 
recommended its use in pre-hospital settings including primary care. However, there is reluctance 
from General Practitioners (GPs) to adopt NEWS/NEWS2 as there is little evidence about its 
effectiveness in this setting. This study aimed to assess whether NEWS calculated and 
communicated by GPs at the point of referral into hospital was associated with speed of movement 
through the care pathway and clinical outcomes in secondary care.  
Approach 
Between July 2017 and December 2018, data were prospectively collected for 13,047 GP referrals 
into acute care. Multivariable linear and logistic regression models were used to assess associations 
between NEWS values recorded by GPs and 1) process measures including time from referral to 
hospital arrival and time from hospital arrival to medical review and 2) clinical outcomes including 
length of hospital stay (LOS), Intensive Care Unit (ICU) admission, sepsis and mortality.  
Findings  
Overall, 42% of patients had NEWS=0-2, 17% had NEWS=3-4, 11% had NEWS=5-6, 8% had 
NEWS=7+ and 22% had NEWS=NR (not recorded). Higher NEWS values were associated with 
increased LOS, ICU admissions, sepsis (suspected and diagnosed), and mortality (2-day and 30-
day); decreased time from referral to arrival for patients conveyed by ambulance; and decreased time 
from arrival in hospital to medical review. The relationship between NEWS and conveyance time for 
patients using transport other than ambulance was unclear. On average, for patients referred without 
a NEWS value, most clinical outcomes were comparable to patients with NEWS=3-4; times from 
hospital arrival to medical review were longer for patients with NEWS=NR than for any calculated 
NEWS value.  
Consequences  
Our findings that NEWS values calculated in primary care are associated with clinical outcomes in 
subsequent secondary care admissions should go some way to increase GPs’ trust in using NEWS 
(now NEWS2) as a common language to communicate patient acuity to ambulance and hospital staff. 
GPs should be reassured that when used in conjunction with clinical judgement, calculating NEWS in 
primary care can improve clinical processes of assessment and treatment for patients. 
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3B.4 PERCH - Preliminary Exploration of the Role of paramedics in Care Homes 
Mark Kingston, Swansea University 
Alison Porter, Leigh Keen, Stephanie Green 
Problem  
Almost half a million people live in care homes in the UK. General practices have a duty to deliver 
primary care for residents, but many struggle due to high demand and staff shortages. Meanwhile, 
ambulance services are seeing an increase in 999 calls from care homes. In addressing these 
challenges, one emerging approach is to involve paramedics in proactive support to care homes, part 
of a larger scale shift towards paramedics undertaking non-emergency primary care and community 
based work. Yet such major workforce changes require urgent evaluation to understand implications 
for care home residents and staff, and for health services. Care homes are an under-researched 
environment, despite high health and social care needs of residents.  We aimed to explore the role of 
paramedics in non-emergency care in care homes to support the design and delivery of portfolio 
research in this emerging, and important, area.  
Approach 
 We convened a Research Development Group of care home, ambulance service, health 
board, primary care, public and academic representatives, and: 
 Conducted fact finding visits and calls to sites where paramedics already provide non-
emergency care to care home residents. 
 Examined data on 999 calls to the Welsh Ambulance Services Trust (WAST) from care 
homes. 
 Surveyed ENRICH (Enabling Research in Care Homes) Network care homes in Wales 
and the West Midlands to seek views on the potential role of paramedics working 
proactively in care homes. 
 Held a stakeholder workshop to identify and explore the issues that stakeholders deemed 
important in this work.  
 
Findings  
We identified multiple sites in England and Wales where paramedics provide planned and proactive 
rather than emergency care in care homes. Operating models varied with paramedics employed by 
ambulance services, health boards or general practices. Data on 999 calls from over 300 care homes 
in Wales confirmed call rates of up to 20 per month per home and high conveyance rates (over 60%). 
Our survey, with responses from 50 managers confirmed interest in the approach. Managers thought 
paramedic skills were well suited to assessing residents, identifying issues, improving care and 
avoiding admissions. They foresaw benefits to inter-professional working, clinical support and person 
centred care. However, they raised concerns over professional boundaries and clarity of roles and 
policies. These messages were reinforced in our stakeholder workshop, where the value of timely 
rapid assessment was highlighted, along with challenges of funding and governance.  
Consequences  
The role of paramedics is shifting rapidly into dedicated primary and community work, including care 
home settings. It is imperative that research is aligned and informs evidence based practice. We plan 
to take forward the findings by developing PERCH2, a feasibility study evaluating the impact of 
paramedics working in this way. 
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3B.5 Senior clinical and business managers’ perspectives on how different funding 
mechanisms and models of employing GPs in or alongside EDs influence wider system 
outcomes. Qualitative Study. 
Mazhar Choudhry, Cardiff University 
Pippa Anderson, Michelle Edwards, Alison Cooper, Adrian Edwards 
Problem  
Emergency Departments (EDs) across England and Wales are facing increasing pressures, with 
attendances rising and waiting time targets being missed. In England, NHS policy has been 
implemented to tackle this by introducing GPs in or alongside EDs to see non-urgent patients and free 
up ED staff. This policy was backed by £100 million in capital investment. However, wide variation 
exists in the funding streams utilised for the continued operational costs of these services, how they 
are operationalised and what outcomes they achieve.  
Approach 
We are completing a qualitative study exploring the perspectives and experiences of senior clinical 
and business managers to explore and examine the influences of different funding models of 
employing GPs in or alongside EDs on quality of care, targets and wider system outcomes. 13 Type 1 
EDs in England and Wales, operating 3 different models or controls, were selected for the study. We 
purposively sampled senior clinical and business managers, defined as those within each site with an 
intimate knowledge of the funding structures in the primary care services. Data from 30 respondents 
at 11 sites have so far been collected. 30-60-minute semi-structured interviews of respondents, either 
in groups or one-to-one, conducted by a single researcher, were transcribed and are being coded 
using NVivo. Data will be thematically analysed.  
Findings  
The results of this student BSc project will be available by March 2020. Primarily, the study will 
examine perspectives on different funding models and how these are thought to influence wider 
system outcomes. As secondary outcomes the study will examine the role that sources of staffing 
play in influencing these outcomes, and also report on the experiences, challenges and responses in 
the services from the different models of employing GPs in or alongside EDs.  
Consequences  
Findings will feed into a wider study commissioned by the National Institute of Health Research 
(NIHR) to build an evidence base (also patient experience, cost-effectiveness, patient safety) around 
this policy and inform NICE guidelines and healthcare policy. 
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3C.1 Characteristics, service use and mortality of clusters of multimorbid patients in England: 
a population-based study 
Rupert Payne, University of Bristol 
Yajing Zhu, Duncan Edwards, Jonathan Mant, Steven Kiddle 
Problem  
Multimorbidity is one of the principal challenges facing health systems worldwide. To help understand 
the changes to services and policies that are required to deliver better care, we investigated which 
diseases co-occur and how combinations are associated with mortality and service use.  
Approach 
We used linked primary and secondary care electronic health records contributed by 382 English 
general practices to the Clinical Practice Research Datalink (CPRD). The study includes a 
representative set of multimorbid adults (18+ years old) with two or more long-term conditions 
(N=113,211). Clinical diagnoses were based on a list of 38 conditions (Barnett, 2012). A random set 
of 80% of the multimorbid patients (N=90,571) were stratified by age and clustered using latent class 
analysis, with consistency of results checked in the remaining 20% of multimorbid patients 
(N=22,640). Associations between multimorbidity clusters, demographics and outcomes were 
quantified using generalised linear models.  
Findings  
Multimorbid patients aged 18-44 years old with psychoactive substance misuse were found to have a 
mortality rate 18 times higher than their non-multimorbid peers. Three distinct types of cardiovascular-
related clusters were identified in patients 65+ years old, related to cardiovascular risk factors, 
established cardiovascular disease, or cardiovascular disease with chronic pain and mental illness; 
the latter cluster had the highest rates of primary care consultations. The majority of 85+ year old 
multimorbid patients belonged to a cluster with low service use and mortality in that age range. 
Clusters characterised by physical-mental health co-morbidity, and respiratory disease with co-
morbidity, were common across all age strata. A physical-mental health cluster of 65-85 year olds had 
a higher 2-year mortality rate (8.4%) than a cardiovascular risk factor cluster (4.7%).  
Consequences  
This work has highlighted major targets for public health and healthcare, including younger patients 
with psychoactive substance misuse whose risk factors make them potentially amenable to 
intervention. The association between older age, multimorbidity and mortality seems to be related to 
cardiovascular disease, pain, respiratory disease and their comorbidities. 
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3C.2 'Bridging Gaps'- use of a coproduction approach to improve experiences accessing 
primary care for women with complex needs 
Helen Mcgeown, University of Bristol 
Lesley Wye, Michelle Farr, Helen Cramer, Lucy Potter (PI) 
Problem  
Women with complex needs, such as addiction, homelessness, and domestic and sexual violence, 
experience extreme health and social inequality and have low engagement with mainstream health 
services. There is little existing research on effective interventions to target these issues, and 
research has thus far been led by the agendas of commissioners, clinicians and researchers rather 
than those of women with complex needs themselves.  
Approach 
Intervention: The project was developed through collaboration between women with complex needs, 
clinicians, and academics using a coproduction approach.  Dr Lucy Potter is an academic GP working 
at a specialist health and welfare organisation for women with complex needs. Women using this 
service felt that it would be helpful to ‘ come together’ to discuss their experiences of accessing 
mainstream healthcare and how these could be improved. This led to creation of a peer advocacy 
group of 10 women with complex needs.  Along with Dr Potter, Dr Lesley Wye was invited to  
participate in the group, bringing expertise in coproduction and health services research.  Preliminary 
groupwork involved women meeting with ‘friendly’ GPs and commissioners to learn more about health 
services. The group also shared their experiences of accessing GP care, which involved being treated 
in a ‘prejudiced’ and ‘judgmental’ way. They decided to tackle this by developing and delivering 
interactive educational sessions for GPs and GP receptionists in a project titled ‘Bridging Gaps’.  
Sessions aim to develop mutual understanding and foster more positive interactions between primary 
care providers and women with complex needs. The group will also produce a training video for 
health and social care professionals. Support in development of these interventions is currently being 
provided through ‘storytelling workshops’ delivered by Clare Murphy, a professional storyteller with 
experience of working with  excluded groups. Evaluation: Ethnographic observation of groupwork 
(including the storytelling workshops), and the educational sessions in primary care will be carried out 
by an evaluation team consisting of Dr Helen Cramer and  Dr Michelle Farr (experts in qualitative 
health and social science research), and Dr Helen McGeown, a GP Academic Clinical Fellow. 
Interviews will be held with women in the group and GP staff receiving the educational sessions. 
Findings will feed into a ‘social impact framework’ , to capture changes arising from co-production in 
terms of the impact on individuals, groups and organisations.  
Findings  
The women have thus far developed their understanding of health services, their confidence in 
sharing their stories, and their sense of agency in creating change.  
Consequences  
We hope that use of the social impact framework will demonstrate the value of a coproduction 
approach as a way to meaningfully involve service users as drivers of multi-level change. This ranges 
from individual empowerment to potential whole systems change, and improved equity of primary 
healthcare provision. 
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3C.3 What is the role of primary care in reducing the decline in physical function and physical 
activity in people with long-term conditions? Findings from realist synthesis involving theory-
building workshops, systematic and iterative literature searches 
Rebecca-Jane Law, Bangor University 
Law, R; Williams, L; Burton, C; Hall, B; Langley, J; Partridge, R; Hiscock, J; Morrison, V; Lemmey, A; 
Cooney, J; Lovell-Smith, C; Gallanders, J; Williams, N 
Problem  
Declining physical function and physical activity in people with long-term conditions can cause 
deteriorating physical, social and psychological health, and reduced independence. In line with the 
renewed declaration from the World Health Organisation, primary care is well placed to empower 
individuals and communities to reduce this decline. However, current evidence suggests the best 
approach is uncertain and the complexities of the needs of people with long-term conditions and of 
primary care service delivery requires further investigation. Therefore, this study aims to unpick this 
complexity and develop evidence-based recommendations about how primary care can facilitate 
improved physical function and physical activity for people with long-term conditions.  
Approach 
Realist evidence synthesis combining evidence from varied sources of literature with the views, 
experiences and ideas of stakeholders. Established realist methods will develop and refine theories 
about improving physical function and promoting physical activity for people with long-term conditions. 
In particular, what works (or does not work), for whom and in what circumstances. We have used 
LEGO® SERIOUS PLAY® as a participatory method for two theory-building stakeholder workshops, 
enabling expression and creativity through building models and sharing. These included 13 health 
and social care professionals, 10 people with long-term conditions and the two lead researchers. We 
have also incorporated expertise and perspectives from the public contributors on our study team as 
well as members of our international external Project Advisory Group. The initial theory areas have 
informed the literature review and the programme theories developed from the literature will inform 
three co-design workshops for a primary care service innovation.  
Findings  
Initial overarching theory areas from the stakeholder workshops include the promotion of physical 
literacy and organising care according to the International Classification of Functioning. These can be 
applied at the level of the individual patient, and further sub-divided into physical, psychological and 
social components, the individual health professional, the practice, and then wider programmes and 
localities. For example, value and responsibility for physical activity and function, enjoyment and 
identity, as well as social support have been identified so far. Following initial title and abstract 
screening of 20,436 articles, the literature search has identified 2069 articles, which are being 
selected for inclusion according to relevance and theoretical richness. Selected studies are being 
mapped against our initial theory areas from which we will develop our final programme theories that 
will be described in terms of contexts, mechanisms and outcomes.  
Consequences  
This work is important because shifting the emphasis of long-term condition management away from 
the diagnosis and categorisation of disease towards the promotion of physical activity has the 
potential to improve physical functioning and independent living. It will have important implications for 
practice, primary care education and policy. 
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3C.4 What are the challenges to managing multimorbidity in the elderly, from both GP and 
patient perspectives? 
Emily Brown, University of Exeter 
L Poltawski, E Pitchforth, S Richards, J Campbell, J Butterworth 
Problem  
The prevalence of multimorbidity in the elderly is high and is predicted to rise. Providing clinical care 
to this patient group places a large demand on the healthcare system. Shared-decision making is a 
recognised feature of good quality clinical care. However, older patients are often less involved in 
decision-making about healthcare compared to younger patients. We explored the challenges of 
managing multimorbidity in the elderly, from the perspectives of GPs and patients, with a focus on 
shared-decision making.  
Approach 
Qualitative focus groups with older patients with multimorbidity and with GPs. Eight patients and eight 
GPs from four GP practices in Devon. A facilitator guided discussion in separate patient and GP focus 
groups. Constant comparative technique with a deductive framework, coding inductively for analysis.  
Findings  
GPs expressed concerns around the complexity of managing multimorbidity in the context of clinical 
uncertainty and a perceived scarcity of relevant guidelines. They felt pressure to use condition-
specific guidelines and feared medico-legal consequences if they didn’t. Both GPs and patients 
identified time-pressures and a lack of continuity of care as potential barriers to shared-decision 
making, and acknowledged the importance of the doctor-patient relationship in overcoming perceived 
barriers. Further barriers to shared-decision making were identified as a lack of patient empowerment, 
GP reluctance to allow shared-decision making, unconsciously incompetent GPs in regard to shared-
decision making and patient perception that their GP did not allow shared-decision making.  
Consequences  
The management of multimorbidity in the elderly requires ‘the art of medicine’. However, in an age 
where evidence-based medicine is prioritised, and there are difficulties with access to primary 
healthcare, GPs require further support to provide good quality care for this vulnerable patient group. 
Development is needed in the understanding and practise of shared-decision making by both GPs 
and the elderly with multimorbidity. 
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3C.5 How do we evaluate social prescribing interventions: a utilisation-focused approach 
Emma Ladds, University of Oxford 
Trish Greenhalgh 
Problem  
The surge of social prescribing in primary care reflects its recent promotion within national UK policy. 
Interventions support collaboration between individuals, families, and stakeholders to improve self-
management of problems resulting from socioeconomic factors. Some evidence suggests social 
prescribing can reduce pressure on healthcare services, build up the local community, and produce 
economic benefits. However, schemes tend to be heterogenous, localized and small scale, and 
subject to influence from stakeholders and external factors. This complexity makes it challenging to 
meaningfully evaluate the impact of interventions. However, the rising prevalence, popularity, and 
financial resourcing of social prescribing heightens the importance of developing effective methods for 
doing so.  
Approach 
Live Well in Braunton [LWIB] is an independent networking initiative in North Devon that aims to 
improve community wellbeing. In this study we are using a mixed-methods utilisation-focused 
approach to evaluate LWIB to better understand the intervention and utility of this method. Working 
closely with practitioners and the users of our findings, this reciprocally reactive strategy aims to 
minimize the translation gap between research and practice. Outcomes derived from stakeholder 
interviews and the Common Outcomes Framework will provide quantitative and qualitative data about 
processes and impact on individuals, health service use and the local community. Thematic and 
contribution analysis will be used to provide a narrative and explanatory assessment of the 
intervention and determine the extent to which it is responsible for observed impacts.  
Findings  
For local stakeholders, important outcomes reflected personal wellbeing and community development 
above health service use. Qualitative findings were valued above quantitative. However, financial 
backers mandated objective wellbeing scales and numerical process data. All interviewees 
recognized the value and importance of meaningful evaluation. Collecting and analysing data is 
challenging. Data collection tools developed for social prescribing may be too costly for individual 
projects. Following fundraising, a user-specific database is in development for LWIB to facilitate this. 
Close relationships with practitioners are essential to enable rigorous, unbiased data collection and 
generate the deeper contextual understanding required for meaningful qualitative analysis. However, 
this is time and resource intensive, which is frequently inadequately recognized by many social 
prescribing commissioners.  
Consequences  
Meaningful evaluation must be acknowledged as a crucial component of social prescribing. 
Generating useful findings for practitioners and funding stakeholders should allow for effective 
adaptation of processes and outcomes should offer narrative and explanatory value. Relationship 
development, data collection and analysis are time and resource intensive, and this needs to be 
recognized at the planning and funding stages. Given the complexity of social prescribing, it is likely 
evaluations will inadequately capture the entirety of impacts - positive and negative. Openly 
acknowledging this whilst transparently demonstrating any narrative attempt at generating useful, 
contextually grounded knowledge i.e. through utilization-focused methods, may be the most 
appropriate and meaningful approach. 
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3C.6 Can a Primary Care Network deliver the NHS Long Term Plan? 
Kim Harman, Bath Enhanced Medical Services+ 
Kathryn Burbridge, Chris Clapp, Lizzie Doman, Elaine Smith, Roger Stead 
Problem  
How does a Primary Care Clinical Network with common policies, deliver the NHS Long Term Plan? 
General practices have limited spare-time and energy to invest in creating Primary Care Network 
(PCNs). Working as a PCN has also introduced challenges for staffing/clinical governance including 
policies/procedures. The challenge is even greater with Primary Care investment being low and 
increasing patient complexity. We recognized the need to work in a common-way in many areas. To 
facilitate developing our PCN and amalgamating our processes we employed a Project Manager to 
support the Clinical Director/Practice Managers.  
Approach 
The Project Manager was able to spend time understanding the expected work of the PCN and 
support mechanisms e.g. the shared income stream, the Additional Roles Reimbursement Scheme 
supporting the CDs in decision making.  The service specification that funds the PCNs could also be 
developed sharing ideas to improve/develop Directed Enhanced Services, or find existing services.  
Where policies/procedures required a common approach e.g. Adverse Weather/Business Continuity 
Planning the Project Manager amalgamated existing documents producing common/single 
documents. Sharing good practice/learning ensured learning quickly and efficiently. It was recognized 
some areas may be different. GDPR required common documents to be produced to allow data 
sharing if patients were to be able to be seen at any site, including privacy statements and Data 
Protection Impact Assessments. Mapping back office staff skills allowed planning for ‘neighbourhood’ 
working in Business Continuity Plans. Audit work to support QoF submissions/NHS DSPT could be 
benchmarked and compared. The Project Manager was able to direct/administer all audits.  
Findings  
The Project Manager Found, and understood the funding available to support the PCN and funded 
new roles - doing things differently/preventing illness and tackling health inequalities/getting the most 
out of taxpayers investment in the NHS Developed and share new policies/protocols and ensure old 
ones were up-to-date - backing our workforce. Shared good practice and find new ways of ensuring 
compliance with many common submissions and processes in Primary Care e.g. NHS DSPT, SARs, 
PatientOnLine preparation, safeguarding returns - making better use of data and digital 
technology/getting the most out of taxpayers investment in the NHS. This allowed the practices to 
continue to function with little disturbance to the delivery of care, often improving back office service 
delivery.  
Consequences  
The Project Manager allowed CD and Practice Managers to continue to spend time doing their usual-
work ensuring they were able to give more time and energy to the PCN when required.  To maintain 
independence but work together using a third party to review ways of working and find new/improved 
systems has made amalgamation less fraught.  Moving forward with joint working now trust has been 
developed will be easier. 
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3D.1 Group-delivered interventions to improve control of blood pressure in hypertension 
Nataliya Makukha, University of Exeter 
Nataliya Makukha, Sinead TJ McDonagh, Christopher E Clark 
Problem  
High blood pressure (hypertension) is the most common chronic condition presented in primary care 
and is the leading, global cause of cardiovascular disease and events. Interventions to improve the 
control of blood pressure and subsequent cardiovascular risk are therefore important. We have found, 
in a large ongoing systematic review, that pharmacist- and nurse-led interventions improve 
hypertension management, particularly if clinicians are able to recommend or prescribe changes in 
medication, deliver face to face consultations and undertake monthly follow-up until blood pressure 
targets are achieved. Individual patient interventions are time-consuming for the clinician and 
therefore group interventions may be a more efficient, and cost-effective, way to improve 
hypertension management. However, evidence from previous studies of group-based hypertension 
interventions is equivocal and therefore there is a need to summarise the current literature before 
recommending any changes to clinical practice. Aim: To determine if group-based hypertension 
interventions can achieve improved outcomes for hypertensive individuals compared to usual care or 
no intervention.  
Approach 
Systematic review, meta-analysis and narrative synthesis, where appropriate. We searched 
MEDLINE, Embase, CENTRAL and CINAHL to 30th August 2019 for randomised controlled trials 
comparing group-based interventions for adults (> 18 years) with treated or untreated hypertension, 
with either no intervention or usual care in primary, outpatient or community care settings. Data on 
type of group intervention (e.g. dietary, educational, lifestyle or medicine optimisation), definition of 
hypertension, blood pressure measurement method, change in systolic or diastolic blood pressure 
and attainment of targets, cost of interventions and study level demographics will be extracted to a 
standard proforma by two reviewers. Pooled estimates of changes in blood pressure will be calculated 
and compared between types of interventions, care setting and disease subgroups using meta-
analyses in random effects models and narratively synthesised where applicable. Statistical 
heterogeneity of pooled blood pressure changes will be quantified using I2 statistics and explored 
using sensitivity analyses and meta-regression of study level variables. Study quality will be judged 
using the Cochrane Risk of Bias (RoB2) tool and publication bias will be assessed using funnel plots 
and quantified using Egger’s tests.  
Findings  
After duplicates were removed, 3746 unique citations reporting group hypertension interventions were 
screened and 228 full texts are currently being reviewed. Results from this ongoing systematic review 
and meta-analysis will be presented at the conference. This study is registered with PROSPERO: 
CRD42019145126.  
Consequences  
We anticipate that our results will inform future strategies and guidelines to enable a more efficient 
and cost-effective approach to managing hypertension in primary, community and outpatient care 
settings. 
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3D.2 Arm Based on LEg blood pressures (ABLE-BP): Can leg blood pressure measurements 
predict brachial blood pressure? An individual participant data meta-analysis from the 
INTERPRESS-IPD Collaboration 
Sinead McDonagh, University of Exeter 
James Sheppard, Fiona Warren, Kate Boddy, Leon Farmer, Philip Lewis, Rachel Baumber, Una 
Martin, Christopher E Clark 
Problem  
Hypertension, a key modifiable risk factor for the prevention of stroke, is diagnosed and managed 
using blood pressures (BP) measured on the upper arm. Amputations, altered muscle tone after 
stroke or limb deformities can prevent accurate measurement of brachial BP and cardiovascular risk 
estimation, thus placing a cohort with known vascular risks at a disadvantage. Leg BP measurement 
is often used as a practical alternative to brachial measurement, but limited data exist to guide 
clinicians’ interpretation of leg BP values in terms of hypertension diagnosis and treatment. Findings 
from our study-level systematic review and meta-analysis suggested that, on average, systolic BP 
was 15 mmHg higher in the leg than the arm. However, substantial heterogeneity between 
contributing studies existed, due to factors such as BP measurement method and patient 
characteristics, limiting applicability of this finding to individuals. Using arm and leg BP data from the 
Inter-arm BP difference individual participant data (INTERPRESS-IPD) Collaboration, which holds 
34,543 individual records from 15 international studies, we now aim to:1) Examine the relationship 
between arm and leg BP.2) Develop and validate a multivariable model predicting arm BP from leg 
BP.3) Investigate the prognostic role of leg BP in cardiovascular event and mortality risk prediction.  
Approach 
In an observational cohort design, IPD meta-analyses will be undertaken to explore the cross-
sectional relationships between arm and leg BP in one- and two-stage multivariable models. Using 
hierarchical linear regression models with participants nested by study, we will investigate the 
association between arm and leg BP and participant characteristics. Planned predictor variables will 
include age, sex, body mass index, cardiovascular disease risk (defined by various cardiovascular 
risk scores), past medical history and use of antihypertensive medication. Prognostic models will also 
be derived for all-cause and cardiovascular mortality and cardiovascular events. Heterogeneity will be 
assessed using I2 and tau2. Study quality will be assessed using a modified version of the Quality In 
Prognostic Studies tool.  
Findings  
Arm and leg BP records exist for 34,543 individuals (mean age: 61.7 years, mean arm 
systolic/diastolic BP at baseline: 138/79 mmHg, 52% female). A total of 20,576 (59.6%) have 
hypertension, 5,433 (15.8%) have diabetes and 7,565 (22.3%) have cardiovascular disease (including 
2,233 (6.5%) with stroke or transient ischaemic attacks and 1,145 (3.6%) with peripheral artery 
disease). The median follow-up period is 8.5 years, with 3,870 (11.6%) participants experiencing 
cardiovascular events and 3,096 (9.0%) dying within 10 years. Further analyses are underway and 
arm-leg BP models will be presented at the conference.  
Consequences  
We will provide the first evidence-based method for estimating individual brachial systolic BP, and 
cardiovascular risk, from leg BP measurements. Our findings will support clinicians and patients in 
detecting and managing hypertension more effectively, where leg measurements are required. 
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3D.3 Home and Online Management and Evaluation of Blood Pressure (HOME BP): Main 
results from a randomised controlled trial 
Richard McManus, Universities of Oxford 
Paul Little, Beth Stuart, Katherine Morton, James Raftery, Jo Kelly, Katherine Bradbury, Jin Zhang, 
Shihua Zhu, Elizabeth Murray, Carl R May, Frances S Mair, Susan Michie, Peter Smith, Rebecca 
Band, Cathy Rice, Jacqui Nuttall, Adam Geraghty, Bryan William 
Problem  
High blood pressure is the leading risk factor for cardiovascular disease world wide yet remains poorly 
controlled in perhaps a third of individuals. We have previously shown that a manual method of 
patient self-management in hypertension is effective but it has proven hard to implement due to the 
training and paper work required. Digital interventions provide a potential means to improve chronic 
disease management cost-effectively whilst improving patient engagement. The HOME BP trial aimed 
to test such an intervention in the context of self-monitoring and guided self-management of 
hypertension.  
Approach 
622 patients with treated but poorly controlled hypertension (>140/90mmHg) were randomised to 
either self-monitoring of blood pressure (BP) with a digital intervention or usual care using clinic blood 
pressure. The digital intervention provided feedback of BP results to patients and professionals with 
optional lifestyle advice and motivational support. Target blood pressures for hypertension, diabetes 
and over 80’s followed UK national guidelines. The primary outcome was difference in systolic blood 
pressure after one year, adjusted for baseline blood pressure, blood pressure target, age and 
practice, with multiple imputation for missing values. Registration: The HOME BP trial is registered at: 
ISRCTN13790648  
Findings  
After one year, data were available from 552 (88.6%). Blood pressure dropped from 151.7/86.4mmHg 
to 138.4/80.2mmHg in the intervention group and 151.7/85.3mmHg to 141.8/79.8mmHg in the usual 
care group giving a mean difference in blood pressure of -3.53 (95% confidence interval -6.19, -0.86) / 
-0.55 (-1.89, 0.80) mmHg. Results were similar in the complete case analysis and adverse effects 
were similar between groups. Within trial costs showed an incremental cost effectiveness ratio of of 
£11 (6, 29) per mmHg reduction.  
Consequences  
A digital intervention for the management of hypertension utilising self-monitored blood pressure led 
to significantly lower blood pressure than usual care using clinic blood pressure at modest 
incremental cost. The HOME BP digital intervention, combined with self-monitoring, has the potential 
to provide cost-effective support for both patients and professionals in lowering blood pressure and is 
now suitable for widespread implementation in primary care. 
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3D.4 Patients’ views about screening for atrial fibrillation (AF): a qualitative study in primary 
care 
Christopher Wilcox, University of Southampton 
Mark Loan, Stephanie Hughes, George Lewith, Michael Moore, Paul Little, Miriam Santer 
Problem  
Atrial fibrillation (AF) is a common heart rhythm irregularity, affecting around 10% of people aged over 
65 in the UK. AF is associated with an increased risk of stroke, which is substantially reduced by 
anticoagulation. As a significant proportion of AF is paroxysmal and can be asymptomatic, it can often 
go undiagnosed. There has therefore been much recent debate about routinely screening for AF in 
the UK, with commissioned pilot schemes, ongoing large clinical trials, and the emergence pf 
inexpensive consumer single-lead electrocardiogram (ECG) devices that can be used to detect AF. 
There is however a sparsity of qualitative data in the literature on patient beliefs and attitudes towards 
screening for AF. Our aim was to explore patients’ views and understanding of AF and AF screening, 
in order to determine acceptability, and help inform future recommendations.  
Approach 
The current qualitative study was nested within the Screening for Atrial Fibrillation using Economical 
and Accurate TechnologY (SAFETY) study, a large primary care AF screening trial undertaken across 
three GP practices in the Wessex area. A convenience sample of 34 of the 418 trial participants not 
known to have AF from a single GP surgery were invited to take part in interviews, and 15 (44%) 
agreed to participate. A semi-structured interview guide was used flexibly to enable the interviewer to 
explore any relevant topics raised by the participants. Interviews were recorded, transcribed verbatim, 
and analysed using inductive thematic analysis in NVivo 10.  
Findings  
Of the 15 participants, four were male (27%) and the average age was 68 years. Participants 
generally had an incomplete understanding of AF and conflated it with other heart problems, or with 
raised blood pressure. Few acknowledged its association with risk of stroke or developing clots. With 
regards to their views on screening, many raised positive opinions regarding the potential for early 
detection and treatment of AF. Few participants considered anxiety and the cost of implementation, 
however none acknowledged potential harms associated with screening, such as potential for 
inaccurate results (e.g. false negatives), side effects of anti- coagulation treatment, or the risk and 
inconvenience of further investigations. The screening devices in the SAFETY trial were generally 
well accepted, and participants were generally in favour of engaging with prolonged screening if it 
were recommended to them by a healthcare professional.  
Consequences  
Our study highlights that there may be poor understanding (of both the nature of AF and potential 
drawbacks of screening) amongst patients who have been screened for AF. Further work is required 
to determine if resources including decision aids (which have been used successfully in other 
screening programmes) could address this important knowledge gap, improve clinical informed 
consent for AF screening. 
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3D.5 Systolic inter-arm blood pressure difference and cognitive decline: Findings from the 
INTERPRESS-IPD Collaboration 
Christopher E Clark, University of Exeter 
Christopher E Clark, Kate Boddy, Fiona C Warren, Sinead TJ McDonagh, Sarah Moore, Victor 
Aboyans, Lyne Cloutier, Richard J McManus, Angela C Shore, Rod S Taylor, John L Campbell 
Problem  
Hypertension and dementia are associated with older age and with each other. As the populations 
age, numbers of individuals living with dementia will rise, representing substantial costs and care 
burdens for society. Currently, there are no interventions to halt established cognitive decline, 
therefore approaches focus on prevention. Systolic inter-arm difference in blood pressure (IAD) and 
cognitive decline are both associated with cardiovascular disease. We therefore propose, and 
recently published initial evidence for, associations of IAD with prospective cognitive decline. We now 
present findings from the Inter-arm blood pressure difference individual participant data Collaboration 
(INTERPRESS-IPD), examining associations of IAD with development of mild cognitive decline (MCI) 
and dementia.  
Approach 
Individual participant data meta-analyses: we examined time to event data for new diagnoses of MCI 
and dementia, according to IAD status in univariable and multivariable Cox regression models, 
stratified by study. Multivariable analyses were adjusted for systolic blood pressure, age, sex and 
highest educational attainment. We also examined changes in Mental State Examination (MSE) 
scores, with adjustment for all of the above and duration of follow up.  
Findings  
Mean age was 66.2 (SD 11.9) years, 55% of participants were female, 84% were of White ethnicity 
and mean systolic IAD was 7.0 (7.5) mmHg. During 10 years of follow up, there were 273 (5.9%) new 
diagnoses of MCI among 4,635 participants, from 3 cohorts. In univariable analyses, MCI was 
associated with a systolic IAD ≥ 5mmHg (Hazard Ratio (HR) 1.34 (95%CI 1.04 to 1.72); p=0.022) and 
IAD ≥ 10mmHg (HR 1.33 (1.03 to 1.73); p=0.032). After adjustment, the associations remained: HR 
1.31 (1.02 to 1.67; p=0.036) for IAD ≥ 5mmHg and HR 1.29 (0.99 to 1.68; p =0.056) for IAD ≥ 
10mmHg. No significant associations were observed above an IAD of 10mmHg. There were 95 
(2.0%) new diagnoses of dementia during follow up; no associations were observed between 
diagnosis of dementia and IAD.MSE scores were recorded for 2,709 participants in 3 cohorts; 419 
(15.5%) showed clinically meaningful reductions (i.e. ≥ 5 points) during follow up. Decreases were 
associated with an IAD ≥ 5mmHg (p=0.004) and IAD ≥ 10mmHg (p=0.006) on univariable analyses. 
After adjustment the association with an IAD ≥ 5mmHg remained (p=0.033); age and educational 
attainment attenuated the association with an IAD ≥ 10mmHg (p=0.11).  
Consequences  
We present the first time-to-event analyses of development of MCI with IAD. These data provide 
additional evidence that systolic IADs ≥5mmHg and ≥10mmHg are associated with development of 
MCI in a pooled cohort of >4,000 participants. Work to enlarge the dataset and extend these analyses 
continues. Measurement of blood pressure in both arms is recommended and is straightforward; 
confirmation of these findings could inform individualised treatment decisions to minimise risk of future 
cognitive decline. 
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3D.6 Two year outcomes of patients with newly diagnosed atrial fibrillation: UK findings from 
the GARFIELD-AF registry 
Patricia Apenteng, University of Warwick 
Saverio Virdone, David Fitzmaurice 
Problem  
Atrial fibrillation (AF) increases the risk of stroke fivefold and the risk of death twofold. Anticoagulation 
therapy reduces the risk of stroke (and systemic embolism, SE) and death at the cost of an increased 
risk of bleeding. The last decade has seen the refinement of stroke and bleeding risk stratification 
schemes and the emergence of non-VKA anticoagulants (NOACs) which provides a wide range of 
anticoagulant options.  These developments transformed the management of AF, however, there is 
limited real-world evidence of the clinical outcomes of the current management of AF.  
Approach 
The Global Anticoagulant Registry in the FIELD (GARFIELD-AF) registry is a prospective, 
observational, multi-centre, international study of patients with newly diagnosed AF with ≥1 additional 
risk factor for stroke.  UK participants were recruited in primary care, and diagnosed with AF between 
2011 and 2016.  We investigated the two-year event rates for all-cause mortality, stroke/systemic 
embolism (SE) and major bleeding in the UK cohort.  Event rates were calculated per 100 person-
years of observation with corresponding 95% confidence intervals (CI); only the first occurrence of 
each event was taken into account.  
Findings  
A total of 3572 UK participants were prospectively enrolled in five sequential cohorts. At baseline, the 
mean age (SD) was 74.8 (9.0) years, and 41.7% of participants were females. The mean (SD) 
CHA2DS2VASc and HAS-BLED scores were 3.3 (1.5) and 1.6 (0.9) respectively. At diagnosis 64.7% 
received anticoagulant therapy (45.7% VKA and 19% NOAC, with or without an antiplatelet), 20.7% 
received an antiplatelet only, and 13.3% received neither anticoagulant nor antiplatelet therapy. At 
two-year follow up, the rates (95% CI) of all-cause mortality, stroke/SE, and major bleeding were 4.13 
(3.68 to 4.65), 1.65 (1.37 to 1.99), and 0.78 (1.37 to 1.99) per 100 person-years respectively.  
Cardiovascular death occurred at a rate of 1.10 (0.88 to 1.39) per 100 person-years and constituted 
26.7% of deaths.  Non-cardiovascular death occurred at a rate of 2.15 (1.83 to 2.53) per 100 person 
years and constituted 52% of deaths. The remaining deaths (22.2%) were of undetermined cause.  
Ischemic stroke accounted for 3.2% of all known causes of death.  
Consequences  
In this contemporary AF study population, death remains the most frequent outcome, occurring at 2.5 
times the rate of stroke/SE and over 5 times the rate of major bleeding.  Compared with patients in a 
US AF registry (ORBIT AF) diagnosed between 2010 and 2011, our study population has a lower 
mortality rate (4.13 vs 5.43 per 100 person years), similar stroke rate (1.65 v 1.57 per 100 person 
years) and lower rate of major bleeding (0.78 vs 3.32 per 100 person-years).  This suggests an 
improved prognosis of patients with AF with maintained clinical benefit of stroke reduction but less 
harm from serious bleeding. 
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4A.1 Effectiveness of physical activity promotion and exercise referral in primary care: a 
systematic review and meta-analysis of randomised controlled trials 
Jean-Pierre Laake, University of Warwick 
Joanna Fleming 
Problem  
Physical inactivity is the fourth leading risk factor for global mortality. Reducing sedentary behaviour 
and increasing physical activity are efficacious for improving many physical and mental health 
conditions including cardiovascular disease, type 2 diabetes and depression. Reducing sedentary 
behaviour and increasing physical activity can also be effective at reducing obesity, however 
sedentary behaviour and reduced physical activity are also associated with mortality independently. 
Despite this most adults in the UK do not currently meet the UK Chief Medical Officers’ guidelines for 
weekly physical activity. As most adults visit their general practitioner at least once a year, the primary 
care consultation provides a unique opportunity to deliver exercise referral or physical activity 
promotion interventions. Synthesising the most up to date literature is required in order to gain a 
better understanding of the most effective methods for supporting patients to participate in more 
physical activity. This is systematic review of randomised controlled trials for the effectiveness of 
physical activity promotion and referral in primary care.  
Approach 
This study is ongoing and is currently at the screening stage. A comprehensive literature search of 
Embase, MEDLINE (Ovid), Web of Science (Core Collection), SCOPUS, CINAHL, PsycINFO and The 
Cochrane Library (CENTRAL) has been conducted for studies with a minimum follow-up of 12-months 
that report physical activity as an outcome measure (by either self-report or objective measures) 
including an intention to treat analysis. Rayyan software was used to facilitate blind screening. The 
authors have independently screened papers by title and abstract. On completion authors will 
independently: screen paper by full text, assess studies for inclusion, appraise for risk of bias and 
extract data. The quality of the evidence will be assessed using the GRADE (Grading of 
Recommendations Assessment, Development and Evaluations) approach. The primary outcome will 
be participation in physical activity at 12-months. Pooled effects will be calculated using random 
effects models. The protocol is registered with PROSPERO the international prospective register of 
systematic reviews, ID CRD42019130831.  
Findings  
At present the combined searches have returned 13,626 results. After the removal of duplicate 
records 6,372 unique titles and abstracts remain. These will be independently screened by the 
authors. The full results of the systematic review and meta-analysis will be reported early next year.  
Consequences  
This systematic review and meta-analyses will summarise the evidence for the effectiveness of 
physical activity promotion and referral as interventions for improving physical activity, as well as 
whether studies using objective measures of physical activity have similar effects to those studies 
using self-report measures. This knowledge has importance for primary care clinicians, patients and, 
given the focus of the recent NHS long term plan on preventive medicine, for those making policy 
decisions. 
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4A.2 What influences men's engagement with weight loss services? A qualitative study. 
Megan Elliott, University of South Wales 
Dr Fiona Gillison, Prof Julie Barnett 
Problem  
Engagement of men with commercial and UK NHS weight loss services is low, and few studies report 
on why this may be. However, evidence shows that men who do participate in weight loss 
programmes tend to lose as much, or more weight than women. The present study aimed to explore 
men’s experiences and expectations of mainstream weight loss services in the UK, following referral 
from a medical professional, particular in relation to barriers and motivators.  
Approach 
Semi-structured interviews were conducted with 18 men with a BMI over 25kg/m2 including those 
who had, and had not, attended group-based or one-to-one weight loss services. Interviews were 
analysed using thematic analysis.  
Findings  
Two themes were identified; Fear as a motivation for change (1) and Attitudes towards existing weight 
loss services (2). Within theme two, two subthemes were identified; ‘Female dominated services’ and 
‘Incompatibility of existing services for men’. The findings suggest that fear, as a result of a medical 
diagnosis or referral is a mechanism for motivating men to engage with weight loss services. This was 
often augmented by awareness of other people’s experiences of poor health due to their weight. The 
gender imbalance and attitudes towards existing weight loss services deterred men from engaging 
with or continuously attending sessions. This imbalance resulted in feelings of self-consciousness, 
shame and a perceived stigma for men using weight loss services. These experiences highlighted the 
importance of providing services which align with men’s preferences to promote engagement.  
Consequences  
A medical diagnosis or referral serves as a strong motivator for men to engage with weight loss 
services by invoking fear of negative consequences of not losing weight. This has implications for 
medical professionals in primary care raising the issue of weight, providing referrals and encouraging 
engagement of men in weight loss services. Men perceived weight loss services to be feminised 
spaces, in which they felt self-conscious and out of place. As a result, men were deterred from 
engaging and considered their options were limited. Involving men in research, service design and 
evaluation is key to improving their engagement and weight loss. 
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4A.3 Engagement of parkrun event teams in linking with GP practices to support patient and 
staff participation in local 5km events 
Joanna Fleming, University of Warwick 
Professor Jeremy Dale, Chrissie Wellington 
Problem  
Increasing physical activity is a priority, both in the treatment of and prevention of disease. In 2018, a 
joint collaboration was launched between parkrun and the Royal College of General Practitioners 
(RCGP), encouraging the linking of GP practices with their local 5km parkrun event(s). parkrun has 
the advantage that it is already firmly established across the UK, enabling participants to 
automatically become part of a supportive community. Over 1300 GP practices in the UK are now 
registered with the scheme, but little is known about the engagement of parkrun event teams. This 
study aims to investigate the involvement of parkrun event teams in the parkrun practice initiative. In 
doing so, we explore event teams’ motivations for linking with GP practices, the processes involved, 
associated challenges and suggestions for improvements. We also explore the level of awareness 
and perceptions of those event teams who have not yet linked with GP practices as part of the 
initiative.  
Approach 
An online survey (delivered using Qualitrics) was sent via email from parkrun Head Office to the Event 
Director at all UK parkrun teams (n=634) in May 2019, with a request for either themselves or one 
member of the core volunteer team to complete it.  Questions related to event details, how local 
practices have linked with the event, activities being carried out, challenges experienced and 
suggestions for improvement. It also explored awareness and perceptions among event teams not yet 
linked. Descriptive statistics were carried out for all sections of the survey. Free text comments were 
categorised and interpreted thematically.  
Findings  
A total of 322/634 (50.8%) parkrun event teams completed the survey. Event teams were supportive 
of the initiative, with a large proportion (225/322; 69.9%) linked with at least one practice.  Links were 
usually initiated by practices (187/225; 83.1%). Only a small proportion reported challenges (35/219; 
16%), including difficulty engaging with/maintaining contact with practices, and lack of time due to 
being volunteers. Event teams showed a willingness to engage in activities to support practices, such 
as mentioning the initiative in event communications and enabling practices to have an information 
stand at their event. The principal reason cited by those not yet linked was that they had not yet been 
approached by a practice (67/97; 69%).  
Consequences  
Event teams are willing to support practices and provide a welcoming environment for the initiative to 
grow and develop; though mutual engagement from both sides is required. Better communication 
about which practices are linked with an event team and how event teams can keep in contact may 
help in the continued relationship between an event and a practice 
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4A.4 Household transmission of antibiotic resistant and susceptible bacteria: a systematic 
review 
Niamh Roberts, University of Bristol 
Alastair Hay, Ashley Hammond 
Problem  
Bacterial resistance to antibiotics poses a threat to the future of modern medicine. This is a 
particularly important problem in primary care where over 70% of antibiotics are prescribed. The UK 
Government published a 5-year strategy for tackling antibiotic resistance, with two of its key aims 
being (i) gaining a better understanding of how bacteria are spread within the community, and (ii) how 
the built environment favours the spread of bacteria. This review will explore current evidence 
regarding how bacteria (either resistant or susceptible) are transmitted within the household 
environment, including any intervention studies exploring how the spread of bacteria within 
households can be prevented.  
Approach 
We systematically searched Medline and Embase for studies published between 1946 and 2019 
investigating household transmission of antibiotic resistant and susceptible bacteria. Studies were 
eligible if they investigated transmission from any source (such as humans, pets or the environment) 
to humans, or where they investigated interventions to prevent transmission of bacteria in the 
household. No restrictions were placed on study design, or language of published paper. Where 
appropriate, a meta-analysis was conducted.  
Findings  
Data collection and analysis is currently underway. Results will be presented in full at the conference.  
Consequences  
Antimicrobial resistance is a top international public health priority in medical research. This review 
will contribute to our understanding of how bacteria are spread within the community, and the effect 
that social factors such as interactions with companion animals and the wider household environment 
might have on bacterial transmission. 
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4A.5 The parkrun practice: an investigation of how GP practices use their websites in the 
promotion of parkrun to patients 
Rebecca Mensah, University of Warwick 
Rebecca Mensah 
Problem  
It is well known that physical inactivity increases the risk of numerous diseases/disorders, including 
several forms of cancer, diabetes, high blood pressure, coronary and cerebrovascular diseases, and 
obesity. There is also an association between lower levels of physical activity and an increased 
prevalence of mental health difficulties. In June 2018, the Royal College of General Practitioners 
(RCGP) partnered with parkrun UK to form the ‘parkrun practice Initiative’. parkrun is an organised, 
free, weekly timed 5km event, which it takes place in open spaces in the UK and across the world. 
The initiative aims to promote the health and wellbeing of both staff and patients. The RCGP parkrun 
practice Toolkit suggests practices can "Include a parkrun page or a link to the parkrun website on the 
practice website", but how this is done is left to the discretion of the practice. As such, this study aims 
to investigate how practices are using their practice website to promote parkrun as part of the 
initiative, including the format and content of information presented, the variety of promotion methods 
used and identifying similarities and differences between practices websites.  
Approach 
This was a qualitative examination of parkrun practice websites. A national survey carried out in 
April/May 2019 of parkrun practices in the UK asked practices to state whether they had used their 
website to promote parkrun and 114/306 practices reported doing so. The names of these practices 
were extracted and each website was subsequently searched manually. Screenshots were taken 
across all websites. A data extraction proforma was used to collect descriptive qualitative data. Data 
was uploaded into NVivo 11 software to be analysed using a thematic approach.  
Findings  
This study is ongoing and is currently at the analysis stage. Emerging themes of the types of 
information represented via GP practice websites are ‘information about parkrun/parkrun practices’, 
‘parkrun practice events and activities’, ‘addressing patient concerns’, ‘benefits (health and non-
health) of parkrun’, ‘patient and staff experiences’, and ‘practical information’. This presentation will 
describe these themes in more detail and their relevance to the promotion of the parkrun practice.  
Consequences  
This study aims to add to current knowledge about how parkrun practices are engaging in the 
initiative and in particular how they using their websites to promote parkrun to their patients. This in 
turn may help in the development of recommendations for practices to follow when promoting parkrun 
on their websites 
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4B.1 The difficulty of measuring and communicating breathlessness-a cognitive interview 
study 
Alice Malpass, University of Bristol 
Problem  
Breathlessness is a clinical problem as important as pain the predictive value of dyspnoea in 
forecasting medical needs is well known. (for example, studies show dyspnoea severity is a much 
stronger predictor of 5 year mortality than FEV1 (forced expiratory volume in 1 second). 
Breathlessness is a sensation affecting those living with chronic respiratory disease, obesity, heart 
disease and anxiety disorders. Yet most people find  breathlessness hard to describe and   clinicians 
often avoid asking about a symptom they can do nothing about.  Until recently, most measurements 
of dyspnea treated it as a single entity. A new measure, the multidimensional dyspnoea profile (MDP) 
attempts to measure the incommunicable different sensory qualities (and emotional responses) of 
breathlessness. We were curious whether the MDP could support difficulties in communication 
between GPs and their patients.  
Approach 
We conducted a cognitive interview study, asking participants to think aloud their thoughts as they 
completed a relatively new validated respiratory questionnaire. We recruited 16 adults from four 
Breathe Easy groups to take part. A purposeful sampling strategy was adopted to represent (when 
possible) different stages in the clinical encounter (for example time since diagnosis, number of 
exacerbations), as well as gender, age and ethnicity. Participants were interviewed once, lasting 
between one and three hours. Cognitive interviews were digitally recorded on an encrypted recorder 
and transcribed verbatim. Analysis used both the digital audio file and verbatim transcripts as the 
former retains important features needed for interpretative analyses (e.g. hesitations, tones of 
uncertainty, indicators of irritation). The study was informed by an interest in sensorial anthropology, 
which considers how shared cultural templates of ‘what counts as a symptom’ evolve and how (in this 
study)  the process of bodily sensations becoming symptoms may impact upon GP-patient 
communication about dyspnea.  
Findings  
Using cognitive interviews of respiratory questionnaires, we give examples of how the wording used 
to describe sensations are often at odds with the language those living with dyspnea understand or 
use. They struggle to comprehend and map their bodily experience of sensations associated with 
dyspnea to the words on the respiratory questionnaire.  
Consequences  
If tools such as the MDP are problematic in terms of capturing what is meaningful for patients living 
with breathlessness where does this leave us in terms of asking patients about dyspnea? We 
suggest, along with David Currow, the very act of acknowledging the presence and impact of 
breathlessness is, in itself, a therapeutic intervention. 
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4B.2 Practice experiences of the At-Risk Registers Integrated into primary care to Stop Asthma 
crises in the UK (ARRISA-UK) intervention: a qualitative study 
Leon Poltawski, University of Exeter 
Leon Poltawski, Rachel Winder, Sarah Morgan-Trimmer, Ann-Louise Caress, On behalf of the 
ARRISA-UK trial team 
Problem  
The ARRISA-UK study is a cluster-randomised controlled trial evaluating an intervention intended to 
reduce adverse asthma outcomes, including hospital admissions or death, by improving the 
management of at-risk asthma patients in primary care. It comprises (i) an online training and support 
package for GP practice staff representatives, (ii) creation of a practice register of at-risk asthma 
patients and an on-screen flagging system for patients on the register, and (iii) action planning for 
staff dealing with these patients. 128 practices around the UK received the intervention and used the 
flagging system for a year. The aim of this qualitative study was to provide insights into practice 
experiences of the intervention and using the flagging system.  
Approach 
As part of the ARRISA-UK study process evaluation, focus groups and individual interviews were 
conducted with staff in a sub-sample of intervention practices. A sampling frame was used to ensure 
diversity in practice size, location, area deprivation levels, and urban/rural nature. Clinical and non-
clinical staff representatives at each practice were invited to participate, and groups and interviews 
were conducted by researchers not involved in the creation or delivery of the intervention. 
Discussions were audio recorded, transcribed and analysed using a framework approach.  
Findings  
Over the period November 2018 to November 2019, 17 focus groups and 9 interviews were 
conducted with 112 staff from 18 practices in England and Scotland. Group composition varied, but 
across the sample there was representation of all staff roles (e.g. GPs, nurses, receptionists, 
pharmacists, practice managers). Most practices valued the ARRISA-UK intervention, particularly in 
raising staff awareness of at-risk asthma patients, and in prompting consistent application of clinical 
guidelines with this group. Practices differed considerably in terms of their action plans, the 
effectiveness of their dissemination of these plans, and in monitoring their implementation. Some 
focussed on changes mostly in one staff group, e.g. receptionists and the appointment systems they 
used; others instituted broader changes, e.g. in patient follow-up processes, prescription monitoring 
and addressing asthma management in all clinical consultations. Patient outcomes data were not 
available at the time of this analysis, but some staff thought that any adverse outcomes were more 
likely due to patient issues, such as poor adherence, rather than practice processes. Problems were 
identified by some practices with register accuracy and on-screen flagging.  
Consequences  
The ARRISA-UK intervention appears to be feasible and acceptable to GP practice staff, and was 
reported to stimulate changes in management of high risk asthma patients. Attitudes to the 
intervention, and the apparent extent of behaviour changes by staff, varied considerably between 
practices. Our findings can contribute to the development of recommendations that may improve the 
effectiveness of the intervention and implementation of action plans. 
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4B.3 Exploring patients experience of living with diabetes in Ecuador: preliminary results of 
focus groups. 
Jimmy Martin Delgado, Miguel Hernández University 
José Mira, Mercedes Guilabert 
Problem  
Diabetes is considered a global health problem. In Ecuador it is the second cause of death, only after 
ischemic heart disease and is the first of the chronic diseases. Driven by obesity, unhealthy lifestyles 
and increased life expectancy, diabetes carries a high disease burden, due to its prevalence, 
complications and the multimorbidity associated with this pathology that surpasses primary care 
efforts. In Ecuador, a specific Clinical Practice Guideline is applied for this pathology, but it does not 
address patient participation. The objective of this study was to explore the experience of “living with 
diabetes” of the users of the national health system of Ecuador with the intention of developing the 
first PROM tool for the Ecuadorian environment.  
Approach 
a qualitative research that included four focus groups and six semi-structured interviews with adults 
with type 2 diabetes treated in primary care. A purposive sampling strategy was used to recruit 
individuals who might be interested in discussing their life experience. All participants voluntarily 
agreed to participate and signed an informed consent, all sessions were recorded in audio and 
subsequently transcribed. In order to obtain culture, beliefs, demographic, diet, type of treatment and 
degree of engagement, participants from the highlands, coastal, indigenous population and urban or 
rural areas were included. The information was analyzed based on the following mutually exclusive 
categories: personal, social and occupational dimensions of the disease. Information capture was 
continued until data saturation was reached in all cases.  
Findings  
42 patients, 10 men and 32 women between 30 and 75 years old participated. Of these, 19 
participants belonged to rural areas and 23 participants to urban areas. Among the most prevalent 
symptoms, thirst was described as a persistent cause of discomfort, with fatigue added. The limited 
time per patient was indicated as an area for improvement, together with health education. A 
proportion of the participants accepted their pathology but not the treatment, this is motivated by a 
high prevalence of alternative treatments, the lack of information, the low level of health literacy and 
the "fear" of insulin therapy. Therapeutic goals agreed with the patients were not set. Among the main 
fears are the long-term complications (diabetic nephropathy and retinopathy) since this would detract 
from the autonomy they maintain and limit them from leading a "normal life".  
Consequences  
Developing these tools respond to the objectives of achieving patient-centered care and, therefore, 
add value to health care by expanding the indicators that monitor the quality of assistance provided. 
This type of procedure allows patients to be involved in the care process, thus establishing a 
framework to achieve better clinical results and greater patient satisfaction with the system. 
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4B.4 What is the prevalence and impact of osteoporotic vertebral fractures in older women 
with back pain? Vfrac: Population-based cohort study 
Tarnjit Khera, University of Bristol 
A. Burston, S. Davis, S. Drew, R. Gooberman-Hill, Z Paskins, T. J. Peters, J. H. Tobias & E. M. Clark 
Problem  
Osteoporotic vertebral fractures (OVF) are one of the most important fractures in older people. Such 
fractures are associated with a reduced quality of life and are an indication that affected individuals 
have high risks for future fracture. Despite this, less than one-third are diagnosed and managed 
appropriately, largely because of an absence of guidance about what clinical factors should trigger 
referral for diagnostic spinal radiographs. To help healthcare professionals particularly in primary care 
refer patients for investigation, the ‘Vfrac’ study is developing a simple clinical checklist to identify 
which older women with back pain should have a spinal radiograph to diagnose or exclude OVF. To 
date we have recruited and analysed data from the first 380 women to identify the prevalence of OVF 
in community-dwelling older women with back pain, and to identify the impact on health-related quality 
of life (HRQOL).  
Approach 
Women aged 65 and older registered with a GP in Bristol and Stoke-on-Trent were invited to take part 
by mail-out from primary care. Those who self-reported back pain in the previous 4 months were 
eligible. Participants completed a questionnaire, received a simple physical examination by a trained 
research nurse and had a spinal radiograph using standard NHS techniques. All radiographs were 
assessed for the presence or absence of OVF by a trained clinician. Self-reported HRQOL was 
assessed by a sub-section of the EQ-5D (a scale of 0=bad to 100=good). A sample size of 1633 was 
required to estimate the sensitivity and specificity of the checklist with adequate precision (5% margin 
of error around values >80%), based on a literature review that identified an assumed prevalence of 
OVF of 12%. Univariable associations between OVF and categorical variables were assessed using 
Ch-squared tests. Linear regression was used to assess association between OVF and HRQOL, and 
multivariable analyses were used to adjust for potential confounders.  
Findings  
Of 380 participants, the prevalence of OVF was 15.5%. Those with OVF were older (77.8 years ± 7.1 
vs 72.9 ± 5.5) and reported higher use of walking aids (48.3% vs 22.2%) compared with those without 
OVF. No differences were seen in walking distance, falls or smoking between those with and without 
OVF. No differences were identified in health-related quality of life between those with and without 
OVF (66 ± 24 vs 70 ±22) even after adjustment for age and mobility.  
Consequences  
15% of older women in the community with back pain have OVF. However, this is not associated with 
a reduction in health-related quality of life when compared to women with back pain due to other 
reasons. Further analysis is required once the full sample size has been collected. 
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4B.5 Academic General Practitioners as realist researchers: Lessons learned 
Freya Davies, Cardiff University 
Alison Cooper, Fiona Wood, Adrian Edwards. 
Problem  
Realist synthesis and evaluation are gaining traction in health services research and are increasingly 
recognised by funders as methods which can generate important learning by exploring complexity.  
Realist research may hold intuitive appeal for clinicians who are already familiar with the messy reality 
of clinical practice, having witnessed widely varying responses when using similar approaches with 
different patients.  As realist research is a highly interpretative process academics with a clinical 
background need to be aware of the various ways in which their role may have an influence.  
Approach 
We use this presentation to discuss reflections from two studies in which academic general 
practitioners collected and analysed realist data.   We will describe how being a clinician researcher 
influenced the interpretive processes of theory building and testing, and our suggestions on what 
clinical academics might need to consider when starting out in realist research.  
Findings  
Initial theorising was informed by our insider knowledge of the health system, and our understanding 
of what drives our own clinical decision-making.  However, we needed to actively engage with other 
stakeholders to challenge our assumptions and ensure we did not prioritise theories which resonated 
most with our own experiences. Data collection involved observing and interviewing clinicians (from 
our own and other clinical backgrounds).  We made our clinical roles clearly visible and believe this 
facilitated rapport building and encouraged engagement with the research.  Participants perceived our 
roles differently, with some appearing to be more open, while others appeared concerned about being 
judged, feeling obliged to justify to us the decisions they made. The realist teacher-learner style of 
interviewing allowed us to demonstrate that we were not looking for ‘the right answer’ but that we 
recognised and sought to explore variations in practice.  While our understanding of jargon and the 
way systems work often helped interviews to flow, we recognised that we sometimes assumed that 
we understood our colleagues’ experiences and could have missed opportunities to probe further.  
Reading our own interview transcripts, and discussing these with non-clinical colleagues helped us to 
identify these risks and adjust our interviewing style.  Observations of clinical interactions proved 
challenging, as it was difficult not to focus on what we might have done in the same situation, raising 
possible ethical dilemmas. During the analysis stage, while our understanding of context often made 
us more confident about the interpretive process of retroduction, we also risked going too far beyond 
the data, relying too heavily on our own perspectives.  
Consequences  
Reflexivity is essential for all researchers.  We present the lessons learned from our own reflections 
and are keen to hear from other clinicians to build a shared understanding of particular issues that 
‘insider researchers’ using a realist approach may need to consider. 
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4B.6 What methods are being used to create an evidence base underlying chronic disease 
monitoring in primary care? A scoping review 
Martha Elwenspoek, University of Bristol 
Lauren J Scott, Katharine Alsop, Rita Patel, Jessica C Watson, Ed Mann, Penny Whiting 
Problem  
Around 50% of laboratory testing in primary care is for monitoring chronic conditions. Substantial 
variation in test ordering between GP practices and regions suggests that many tests are being over- 
and under-used, which can cause harm to patients and increase healthcare costs. Current guidelines 
on testing lack a solid evidence base. There is currently no framework for evaluating optimal testing 
strategies and no guidance on how to generate this much needed evidence.  
Approach 
The aims of this scoping review were to map the extent, range and nature of research that provides 
evidence on optimal chronic diseases monitoring in primary care, and to identify research gaps in the 
existing literature. EMBASE, MEDLINE, and CINAHL were searched from inception to April 2019. We 
used the following eligibility criteria: studies of adult patients with chronic disease in a primary care 
setting that evaluated laboratory tests and aimed to optimise testing, find the best test or testing 
interval, show patient harms, costs, or variation related to testing. We used standard scoping review 
methods, including standardised data abstraction forms and data charting.  
Findings  
Of 94 included papers, 36% aimed to investigate test performance and 40% to describe the variation 
in monitoring. Most studies focused on diabetes (51%), followed by hypertension (11%), and 
rheumatoid arthritis (10%). The most frequently studied laboratory tests were renal function tests 
(35%), followed by HbA1c (23%). A retrospective cohort design, using routinely collected data, was 
the most commonly used study design (49%). A large proportion of studies only used descriptive 
statistics to analyse the data (28%). We identified gaps in evidence on establishing optimal testing 
intervals; strategies to optimise testing that improve patient outcomes; and harms to patients due to 
over-testing.  
Consequences  
Future studies need to address the identified gaps in the literature. Development of methodologies 
and reporting guidelines for research evaluating the use of tests for monitoring could improve the 
rigor, transparency, and reproducibility of future research in this area, and help researchers, peer 
reviewers, authors, and readers to determine the trustworthiness of the findings. In the absence of 
clear evidence, decisions around testing should be based on current guidelines, however these 
guideline recommendations should feed into, rather than override, patients’ personal preferences and 
views. 
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4C.1 Patient and Health Professional experiences of reducing antidepressant medication as 
part of the REDUCE feasibility RCT 
Samantha Williams, University of Southampton 
Claire Reidy, Hannah Bowers, Bryan Palmer, Adam Geraghty, Gerry Leydon, Carl May, Tony 
Kendrick 
Problem  
There is considerable concern about increasing antidepressant use in England. GPs are writing more 
than 60 million prescriptions a year, to around 1-in-10 adults. Some people need long-term 
antidepressants to stop them getting depressed, but a third-to-a-half could possibly stop them without 
relapsing. However, stopping can be difficult with some patients experiencing withdrawal symptoms, 
while others may be fearful that they will experience them. There are good reasons for proposing that 
antidepressants should not be continued long-term unless absolutely necessary, but patients can be 
fearful and cessation can be difficult. The NHS funded six-year REviewing long term antiDepressant 
Use by Careful monitoring in Everyday practice (REDUCE) research programme aims to identify 
feasible, safe, effective, and cost-effective ways of helping patients taking long-term antidepressants 
taper off and stop treatment, when appropriate. This Work Stream 4 (WS4) of the REDUCE 
programme aims to determine the feasibility of a randomised controlled trial of a web-based 
intervention which supports practitioners and guides patients on coming off antidepressants, together 
with telephone calls with psychological practitioners to support the patients through this process.  
Approach 
Semi-structured qualitative interviews were conducted with 18 patients and 10 health professionals 
currently taking part in the REDUCE study at different time points. Thematic analysis of these 
interviews is underway, and additional analysis is being conducted utilising Normalisation Process 
Theory (NPT).  
Findings  
A summary of findings will be reported at the conference. Early analysis suggests a positive response 
to the study from both patients and health professionals and that recruitment methods have worked 
well. Health professionals report that GP time and patient continuity were the main barriers to 
recruitment. Patients reported that taking part in the study resulted in improved motivation and 
confidence to stop antidepressants by providing the opportunity to ‘think about’ their medication and 
improve self-awareness. Some participants have also suggested that they were surprised at how 
easy cessation could be, and that the programme enabled a safe and guided approach to stopping. 
However, patients randomised to the control arm expressed some disappointment at the lack of 
support to taper off and stop antidepressant use.  
Consequences  
Findings from this study have contributed to improving the REDUCE intervention website, provision 
of phone call support, and study recruitment for the full RCT. Further NPT analysis will inform how 
implementation of the REDUCE intervention works in practice and how this can be improved and 
implemented in the next REDUCE programme Work Stream (WS5, full RCT). 
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4C.2 REDUCE antidepressant reduction feasibility RCT 
Tony Kendrick, University of Southampton 
Hannah Bowers, Samantha Williams, Claire Reidy, Beth Stuart, Adam Geraghty, Geraldine Leydon, 
Wendy O'Brien, Michael Moore, Paul Little. 
Problem  
There is concern about increasing antidepressant use, now in around 1-in-10 adults. Some people 
need long-term antidepressants to stop them getting depressed, but a third-to-a-half could possibly 
stop them without relapsing. When GPs review patients on long-term antidepressants and 
recommend that they could begin to stop taking them, only 1-in-14 is able to stop. The REDUCE 
(REviewing long term antiDepressant Use by Careful monitoring in Everyday practice) study aims to 
identify safe, effective, and cost-effective ways of helping patients taking long-term antidepressants 
taper off and stop treatment, when appropriate. REDUCE work stream 4 aimed to determine the 
feasibility of a randomised controlled trial of online interventions to support practitioners and guide 
patients on coming off antidepressants,  assess the acceptability of the Internet interventions, 
recruitment of practitioners and patients, and acceptability of planned outcome measures.  
Approach 
Inclusion criteria: Patients taking antidepressants for longer than a year for a first episode of 
depression, or longer than two years for repeated episodes of depression, who are feeling well and 
would like to consider tapering off their antidepressants. Intervention: practitioner and patient access 
to ADvisor internet programmes designed to support antidepressant withdrawal, plus three patient 
telephone calls from a psychological wellbeing practitioner (PWP). Control arm received usual care. 
Assessments: baseline, 3 months, and 6 months. Primary outcome PHQ-9 at 6 months for depressive 
symptoms, secondary outcomes discontinuation of antidepressants, social functioning, wellbeing, 
enablement, quality of life, satisfaction, and use of health services for costs. Qualitative interviews to 
gather experiences of taking part.  
Findings  
Recruitment of target of 14 practices was quickly achieved.  Recruitment of sufficient patients was 
also achieved (211 responses from 791 letters given or sent to patients (26.6%); of 80 patients 
screened, 53 (66%) were eligible, so we recruited 13 more than the target of 40. Evidence that the 
interventions were acceptable and engaging, from the 10 GP & nurse, and 18 patient interviews, and 
audio-recordings of the PWP support calls. Follow-up rate at 3 months 78.8%; at 6 months  81.6%. 
Questionnaire measures rated acceptable, and feasible in the time available.  
Consequences  
We met the funder's criteria for moving to the main trial, and we are well prepared to start WS5. The 
trial met the ACCEPT criteria for inclusion of the patients in with the main trial as an internal pilot. The 
research remains valuable, and if the findings are positive they can be readily disseminated. 
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4C.3 Therapeutic interventions to maintain abstinence from recently detoxified, alcohol 
dependence in primary care: a systematic review and network meta-analysis 
Hung-Yuan Cheng, University of Bristol 
Luke McGuinness, Roy G. Elbers, Georgina J. McAurthur, Abigail Taylor, Alexandra McAleenan, 
Sarah Dawson, Jose Lopez-Lopez, Julian P.T. Higgins, Sean Cowlishaw, Anne Lingford-Hughes, 
Matthew Hickman, David Kessler 
Problem  
Current NICE guidelines recommend that, for those with moderate to severe alcohol dependence, 
withdrawal from alcohol is followed by the offer of a combination of either acamprosate or naltrexone 
and a psychosocial intervention. However, access to these options is often limited, and treatment is 
relatively resource intensive. In this systematic review and network meta-analysis, we aimed to 
evaluate interventions that can be delivered in primary care, to determine which are most appropriate 
for implementation in UK primary care context.  
Approach 
We searched MEDLINE, Embase, PsycINFO, and Cochrane CENTRAL databases for randomised 
controlled trials (RCTs) from the earliest date to February 2018. Trial registries, ClinicalTrials.gov and 
the World Health Organization’s International Clinical Trials Registry Platform, were also searched in 
March 2018 to identify unpublished or ongoing trials. Reference lists of relevant systematic reviews 
and included studies were also searched to supplement the searches. RCTs were selected if they 
compared different interventions that could be used in primary care and reported continuous 
abstinence with at least 12-week follow-ups. The population was alcohol dependent patients who had 
detoxified recently (within 4 weeks). Abstinence and all-cause dropouts up to 12 months follow up 
were used to evaluate effectiveness and acceptance of interventions respectively.  Two reviewers 
independently extracted the data and assessed the risk of bias of included studies using the RoB 2 
tool. Network meta-analysis was performed to combine results using random effects models. Mean 
ranks of interventions, along with confidence in the evidence via the Confidence In Network Meta-
Analysis (CINeMA) tool, was used to reach conclusions.  
Findings  
A total of 16,555 unique records were retrieved and 62 RCTs (41 interventions) were included. NMA 
results based on all 62 trials showed that, compared with placebo, acamprosate (OR 1.85, 95% CIs 
1.49-2.33), sodium oxybate (OR 2.31, 1.22-4.36), quetiapine (OR 6.75, 1.18-38.05) and topiramate 
(OR 1.88, 1.06-3.34) were the only interventions associated with an increased probability of 
abstinence. Based on 60 trials reporting all-cause dropouts, the NMA results indicated potential 
reductions, compared with placebo, for acamprosate (OR 0.73, 0.62-0.86), naltrexone (OR 0.70, 0.50-
0.99), home visits (OR 0.32, 0.11-0.95), topiramate (OR 0.45, 0.24-0.83), acamprosate & nurse 
follow-ups (OR 0.21, 0.08-0.58) and acamprosate & naltrexone (OR 0.30, 0.13-0.68).  
Consequences  
Acamprosate was the only intervention with moderate confidence in the evidence of effectiveness and 
acceptance in primary care settings. It is uncertain whether other interventions can improve 
abstinence and reduce dropouts due to low or very low confidence in the evidence. More evidence 
from high quality RCTs in UK primary care is needed. 
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4C.4 How much change is enough? Evidence from a longitudinal study on depression in UK 
primary care. 
Daphne Kounali, University of Bristol 
Katherine S. Button, Gemma Lewis, Simon Gilbody, David Kessler, Ricardo Araya, Larisa Duffy, Paul 
Lanham, Tim J. Peters, Nicola Wiles, Glyn Lewis 
Problem  
The Patient Health Questionnaire (PHQ9), the Beck Depression Inventory (BDI-II), and the 
Generalised Anxiety Disorder Assessment (GAD-7) are widely used in the evaluation of interventions 
for depression and anxiety. The smallest reduction in depressive symptoms  that matters to patients is 
known as the Minimum Clinically Important Difference (MCID). Little empirical study of the MCID for 
these scales exists.  
Approach 
A prospective cohort of 400 patients in UK primary care were interviewed on four occasions, two 
weeks apart. At each time point, participants completed all three questionnaires and a ‘global rating of 
change’ scale (GRS). MCID estimation relied on the reduction in scores among those reporting 
improvement on the GRS scale, stratified by three categories of baseline severity assessed on the 
Clinical Interview Schedule (CIS-R).  
Findings  
For moderate baseline severity, those who reported improvement on the GRS had a change of 21% 
(95% confidence interval (CI) -26.7, -14.9) on the PHQ9; 23% (95% CI -27.8, -18.0) on the BDI-II and 
26.8% (95% CI -33.5, -20.1) on the GAD-7. The corresponding threshold scores below which 
participants were more likely to report improvement were -1.7, -3.5 and -1.5 points on the PHQ9, BDI-
II and GAD-7, respectively. Patients with milder symptoms at baseline require a much larger drop in 
their scores as percentage of their baseline to perceive any benefit.  
Consequences  
An MCID representing 20% reduction of their baseline scores is a useful rough guide for any of these 
scales. Treatment benefits smaller than this are unlikely to be noticed by patients at low baseline 
severity. 
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4C.5 Do primary care patients think it is important to consider anxiety separately from 
depression? 
Charlotte Archer, University of Bristol 
David Kessler, Nicola Wiles, Katrina Turner 
Problem  
Anxiety disorders are common, with a 40% increase in generalised anxiety disorder reported in the 
general population between 2007 and 2014. Despite this increase, GPs’ recording of anxiety 
disorders decreased between 1998 and 2008. This may be due to a reluctance to label patients with a 
formal anxiety disorder, or a tendency to record depression instead of anxiety, particularly if anxiety is 
comorbid with depression, which is often the case. We know little about whether patients think anxiety 
should be considered on its own.  This study explored whether primary care patients thought GPs 
should consider anxiety separately from depression, when patients present with both.  
Approach 
In-depth qualitative interviews were conducted with 20 patients, purposively sampled from GP 
practices in Bristol, North Somerset, and South Gloucestershire. Interviews were held either in person 
or over the telephone.  A topic guide was used to ensure consistency across the interviews.  
Interviews were audio-recorded, transcribed verbatim and analysed thematically.  
Findings  
Preliminary analysis of the data suggests that for those with long-term anxiety, and those with chronic 
co-morbid depression, GPs should discuss anxiety as a clearly distinct diagnosis, with consideration 
given to the causes, symptoms, impact on their life, and management. Anxiety was frequently felt to 
be a cause of depression, and patients highlighted the importance of early management of anxiety 
preventing later transition into depression. In addition, patients also felt that within society, and within 
primary care, anxiety is viewed as less serious than depression, yet it may be more disabling to 
patients than depression. Furthermore, receiving a diagnosis is just as important as the management 
of symptoms, particularly in terms of acceptance and readiness to engage with treatment. Non-
specific symptom codes, such as ‘anxiousness’ can be unhelpful for patients, and can contribute to a 
lack of clarity in understanding their mental health.  
Consequences  
In order to continue providing patient-centred care, consideration and discussion of anxiety as a 
distinct disorder of importance that can exist alongside depression may improve patients' 
understanding of their mental health, increasing readiness to engage with treatment. For those with 
co-morbid depression, understanding the distinction between the disorders may encourage earlier 
management of anxiety, and reduce the likelihood of subsequent depressive symptoms.  
Furthermore, facilitating the conversation regarding the differences between the conditions may 
promote improved understanding and awareness of anxiety within society. In addition, consideration 
should be given to how anxiety is diagnosed and communicated to the patient during the consultation, 
with care taken over the use of non-specific symptom codes and how these are shared with patients. 
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4D.1 Parents online exchanges about eczema treatments: qualitative analysis of online 
discussion forums 
Bethan Treadgold, University of Southampton 
Emma Teasdale, Ingrid Muller, Neil Coulson, Miriam Santer 
Problem  
Parents and carers of children with eczema often turn to social media sites and online discussion 
forums for information and peer-support. Previous research has shown that sharing and receiving 
experiences online about long-term conditions helps individuals to; address offline information gaps, 
learn self-management behaviours from others, receive validation, build community with similar 
others, navigate health services, and all within the protection of anonymity. Nevertheless, concerns 
exist regarding the quality of the advice shared on discussion forums. Recent online discussion forum 
studies of parents of children with eczema found diverse beliefs expressed about the use of topical 
corticosteroids to treat eczema. However, little is known about the beliefs that parents share on 
discussion forums about other treatments for eczema, such as emollients, antihistamines and 
bandages/wet wraps. This study aimed to explore the views and experiences exchanged by parents 
on social media sites and online parenting forums about eczema treatments.  
Approach 
We conducted an online survey to identify the most popular online resources used by parents of 
children with eczema. We then collected online discussions about eczema treatments dating back to 
February 2016 from two online parenting forums and one social media site, identified as most 
frequently accessed in our survey. Discussions were included where the initial post referred to at least 
one treatment for their child’s eczema and received at least one response. Relevant discussions were 
identified from the parenting forums through internal search functions using terms such as ‘eczema’, 
‘steroid’ and ‘emollient’, and by reading through all discussions from the social media site group. We 
have coded the data in NVivo version 12 and are carrying out an inductive thematic analysis of the 
data.  
Findings  
243 discussions (71 from Site 1; 78 from Site 2; 94 from Site 3) were collected. The nature of 
responses to requests for information about treatments varied: some parents responded by providing 
long detailed accounts of their own child’s treatment journey, often with emphatic advice that the 
same treatment that worked for them must work for others; others expressed more awareness that 
different treatments work for different people. Questions often received responses containing 
polarised views about treatments, with some posts offering ‘standard’ advice and others offering 
advice that could lead to disagreement with health professionals. Many parents expressed their 
desperation to help their children’s eczema and discuss the high cost of treatments. There were 
frequent encouragements to others to ‘fight’ for allergy testing and referral to a dermatologist.  
Consequences  
This study will provide an insight into some of the eczema treatment advice and support shared by 
parents/carers online. Findings will help academics and clinicians to better understand the 
perspectives that parents bring to their consultations and about their use of online resources for 
advice and support for eczema. 
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4D.2 How does the adoption of digital health tools in primary care impact clinician-patient 
communication? Some lessons from the DECODE study into unintended consequences 
Andrew Turner, University of Bristol 
Michelle Farr, Jon Banks, Rebecca Morris, Sarah Blake, Sue Ziebland, Emma Hyde, Fiona 
Stevenson, Lorraine McDonagh, Fiona Hamilton, John Powell, Helen Atherton, Gemma Lasseter, 
Sian Jones, Bob Golding, Gene Feder, Lucy Yardley, Jeremy Horwood 
Problem  
Digital health tools, such as online consultation systems and platforms giving patients online access 
to their medical records, are becoming commonplace. NHS England advocates their use as an 
essential part of a cost-effective health service to support patient access and care. However, their 
rapid development and adoption in primary care may lead to unintended consequences (positive and 
negative) that alter healthcare processes and outcomes. The DECODE study aims to support the 
adoption of digital health tools in primary care by understanding their unintended consequences. Here 
we focus on how online consultation systems and online access to health records provide new ways 
for clinicians and patients to interact with each other, and the consequences this has for clinician-
patient communication and relationships.  
Approach 
Semi-structured individual interviews with 21 patients, 15 general practice clinicians and 8 managerial 
and administrative staff involved in the use of three types of digital health tools (online consultations, 
patient online access to health records). Thematic analysis was used to analyse the data using NVivo 
11 software for data management.  
Findings  
Our interviews highlight how these technologies can make clinician-patient communication more 
transactional, meaning information flows one-way, or only short question-and-answer exchanges take 
place. For some, this achieved the intended consequences of improving efficiency and access to 
care. For example, through patients being able to check test results and medical information online, or 
use online consultation systems to update the practice or receive answers to simple requests. 
However, the unintended consequences of this shift included patients being uncertain how to interpret 
information in their medical record, increasing pressure on patients in relation to how they describe 
their issues, and patients being unclear who they are communicating with, leading to uncertainty and 
distress. This could be seen to challenge the valued element in traditional clinician-patient 
relationships; namely personal contact and the opportunity to explore medical concerns.  
Consequences  
Examining unintended consequences of digital tools that increase the scope and extent of 
transactional communication shows how prioritising convenience and access for some, can come at 
the expense of providing holistic, patient centered care for others. Developing an understanding of the 
unintended consequences of digital health tools is vital to aid their future successful implementation in 
primary care. 
  
87 
 
4D.3 Optimisation of Eczema Care Online (ECO) a web-based intervention to support self-
management: a qualitative think aloud interview study with parents or carers of children with 
eczema 
Mary Steele, University of Southampton 
Emma Teasdale, Katy Sivyer, Kate Greenwell, Miriam Santer, Daniela Ghio, Sylvia Wilczynska, 
Amanda Roberts, Lucy Yardley, Ingrid Muller 
Problem  
Eczema is an inflammatory skin condition that affects approximately 1 in 5 children. Inadequate 
support for self-managing eczema can lead to poor adherence to treatments and poor control of 
eczema. An intervention designed to provide this support requires an in-depth understanding of the 
needs of the user.  
Approach 
This study aimed to optimise ECO (Eczema Care Online), a web-based intervention to support 
eczema self-management for parents/carers of children with eczema (aged 0-12 years). We recruited 
24 parents/carers from primary care to take part in a qualitative think-aloud interview where they were 
asked to express their thoughts about the intervention as they used it.  Participants were purposively 
sampled, based on child’s age and eczema severity. Interviews were audio-recorded and transcribed. 
Analysis was carried out using a table of changes approach which provided a systematic method of 
assessing and addressing user feedback. Agreed modifications were tested in further think aloud 
interviews until no further significant problems occurred.  
Findings  
Early interviews identified issues with the usability and acceptability of the intervention. For example, 
information that was identified as unclear, repetitive or not relevant to many participants was either re-
written or placed on an optional ‘click-through’ page. Participants who had been managing their child’s 
eczema for longer did not think the intervention would be useful to them because they believed that 
they already knew a lot of the information. Participants also stated they wished to hear more from 
other parents/carers about their experiences of managing eczema so further quotes were added, 
adapted from previous interview data. In later interviews, after changes had been made, feedback 
was increasingly positive. Participants welcomed quotes from other parents/carers, saying this 
addressed feelings of isolation. Barriers such as a lack of time, and dislike of reading lengthy text 
were overcome with design including: allowing participants to immediately access content directly 
relevant to them; interactive pages with ‘pop-up’ boxes; short concise answers; and important 
information appearing in bold text.  Persuasive information designed to engage participants early on 
improved expectations.  
Consequences  
This approach allowed us to gain an in-depth understanding of the perspectives of the participants. It 
was therefore possible to accommodate these to maximise intervention acceptability and feasibility. 
Participant feedback enabled us to improve the structure, length and navigation of the intervention. 
Content likely to enhance motivation and engagement, such as quotes, was added or emphasised.  
Some of these findings could be generalisable for digital interventions across a range of health 
conditions. The findings also suggest that the intervention could be a useful adjunct to clinical advice.  
Participants indicated that the intervention gave them a more complete understanding of managing 
eczema than would be possible during a short GP appointment. 
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4D.4 Do Electronic Palliative Care Coordination Systems (EPaCCS) increase the chances of a 
good death? 
Lucy Pocock, University of Bristol 
Lydia French, Michelle Farr, Richard Morris, Sarah Purdy 
Problem  
Continuity of care is particularly important for patients at the end of life and a lack of information 
sharing is often cited as a barrier to the provision of good quality end of life care. Nationally, the policy 
drive to address this has been the development of electronic palliative care coordination systems 
(EPaCCS). The purpose of EPaCCS are to provide a shared local record for health and social care 
professionals, with key information about an individual approaching the end-of-life, including their 
expressed preferences for care. Quantitative studies have shown striking differences in place of death 
with EPaCCS, but are potentially biased and confounded. Poor uptake among primary care staff has 
been cited as a barrier to success. Little research has been undertaken to understand how, and by 
whom, EPaCCS are being used and whether EPaCCS support patients’ end of life wishes. Rigorous 
evaluation and research is needed to fully understand the benefits and harms of EPaCCS, with 
greater insight into patient and families’ experiences. Aims: 1. Describe the characteristics of patients 
who die with an EPaCCS record, compared to patients who die without. 2. Explore the impact of an 
EPaCCS on the experience of providing, or receiving, end-of-life care for healthcare professionals, 
patients and carers. 
Approach 
This is a mixed-methods study, carried out within a realist paradigm, to evaluate the impact of an 
EPaCCS on end of life care as provided by a Clinical Commissioning Group (CCG) in England. The 
study was conducted in five phases: 
1. Development of the initial programme theory. 
2. Focus group with CCG stakeholder board. 
3. Individual interviews with healthcare professionals, patients, current and bereaved carers. 
4. Retrospective cohort study of routinely collected data on EPaCCS usage. 
5. Data analysis and synthesis of study findings. 
Findings  
Data collection and analysis are still ongoing, but early findings are as follows: Only primary care staff 
can update the EPaCCS, which is frustrating for other healthcare professionals and results in 
additional workload for primary care. Patients think the EPaCCS concept is worthwhile, but they aren’t 
aware of whether they have an EPaCCS record. It is assumed that information sharing prevents 
repeated conversations with patients. Our results suggest that it may stop conversations completely 
and that patients would rather have repeated conversations than no conversation. 
Consequences  
Healthcare professional access remains a fundamental problem and is a barrier to EPaCCS success. 
Patient awareness and involvement requires further exploration, including access to their own 
EPaCCS record. 
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4D.5 The use of digital health interventions by people with type two diabetes and implications 
for health inequalities: A qualitative study 
Sophie Turnbull, University of Bristol 
Patricia Lucas, Alastair Hay and Christie Cabral 
Problem  
Type 2 Diabetes (T2D) is a common chronic disease that shows social patterning in incidence and 
severity. The use of digital health technologies such as apps and websites has been suggested as a 
way to increase access to low-cost support. This may be a route to tackling inequalities. However, if 
underserved groups are excluded from digital technologies due to issues with access and usability, 
digital health interventions may exacerbate existing health inequity. This study aimed to gain an 
insight into how and why people with T2D use web-based self-care technology and how experiences 
vary between individuals and social groups.  
Approach 
A purposive sample of people diagnosed with T2D and experience of using a web-based intervention 
to help them self-care for T2D were recruited through diabetes groups, including groups that served 
Black, Asian and Minority Ethnic  and lower income neighbourhoods. Semi-structured interviews were 
conducted in person and over the phone. Data were analysed thematically.  
Findings  
Twenty-seven people with T2D were eligible to enter the study, and data saturation on the key 
themes was reached after 21 interviews. The sample was diverse in terms or age (median 60 years, 
range 29-74), gender (11 men), socioeconomic situation and household income. Two thirds had a 
University degree or equivalent 17 participants identified as White British. Digital health interventions 
used included: websites, Blood Glucose Monitors (BGMs) with apps, wearable technology (e.g. 
Fitbits), access to electronic health records, diabetic specific and general health apps. Participants 
used their digital skills to learn about and navigate digital interventions. BGMs were particularly valued 
by the participants because they believed they provided greater control over their diabetes. There was 
a belief that the NHS rationed access to digital interventions (particularity BGMs) and not everyone 
who would benefit had access. Both material and social assets were used by participants to gain or 
support access to digital interventions. Participants used material assets to buy digital interventions. 
Participants used their social networks to learn about new interventions (in person and in the ‘online 
world’). They also used their networks and social status to gain access to the interventions through 
gifting, use with personal trainers, discounts, free samples and quick replacements for faulty 
technology. Participants also described how a lack of digital skills could be barrier to the use of digital-
health interventions, but could be overcome by drawing on support from ‘tech buddies’ in their social 
network.  
Consequences  
This research indicated that a person’s internal (digital skills and knowledge), and external (material 
and social assets) resources influences whether they hear about, have access to, and can benefit 
from digital self-care interventions.  If digital interventions are to decrease not exacerbate health 
inequalities, differences in internal, external, material and social resources must be considered. 
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4D.6 Access Study: Realist evaluation of patient access to electronic medical test results 
services in general practice in England. 
Gemma Lasseter, University of Bristol 
Dr Ludivine Garside, Dr Emma Johnson, Dr Cecily Palmer, Dr Christie Cabral,  Prof Alastair Hay, Prof 
Richard Huxtable, Dr Hannah Christensen 
Problem  
In April 2020 GP service contracts in England will be updated so all registered patients will receive full 
online access to their electronic health record. This change demonstrates the ongoing commitment by 
NHS England to deliver world-class healthcare in the 21st century, with an emphasis on personalised 
medicine, increased autonomy and digital enablement of primary care. With over 300 million patient 
consultations in general practices annually, introducing digital tools to provide patients with their 
medical test results electronically has the potential to support self-management and deliver cost-
effective improvements across a range of healthcare outcomes. Currently there is limited empirical 
evidence about either the positive or negative consequences associated with such services. Our 
study aims to evaluate the provision of electronic medical test result services in general practices 
across England to understand “what works, for whom, in what circumstances and why”. 
Approach 
Using a realist evaluation approach to explore the delivery of electronic medical test result services in 
general practices in England. The study has three phases: i) a questionnaire survey to assess 
electronic medical test result service provision (approx. 450 practices), ii) retrospective patient data 
collection to determine if patients who access their results electronically differ from those patients who 
do not (approx. 7 practices), and iii) qualitative work with patients and staff to ascertain experiences 
and opinions of using (or not) electronic medical test result service (approx. 7 practices). 
Findings  
A total of 439 completed questionnaires were received from general practices across England. 70% of 
practices already offered electronic test result services, though only 14% monitored patient usage of 
services. 72% of respondents felt using electronic test result services was ‘easy’ or ‘very easy’ for 
GPs at the practice, but 18% of practices said safety issues had been raised concerning adult 
patients receiving or accessing electronic test results. Evidence from the survey informed the 
subsequent retrospective patient data extraction and qualitative workstreams, which are due to be 
completed in Feb 2020. 
Consequences  
Evidence from the Access study will be directly fed back to the Department of Health and Social Care 
in order to inform future policy decisions, commissioning and provision of electronic medical test 
results service in general practice across England in the future. 
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5A.1 GPs’ views and experiences of patients with an at-risk mental state (ARMS) for psychosis 
Daniela Strelchuk, University of Bristol 
Daniela Strelchuk, Nicola Wiles, Stanley Zammit*, Katrina Turner 
Problem  
Psychotic illnesses are one of the leading causes of disability worldwide. Early intervention in people 
with an at high risk mental state (ARMS) for psychosis can decrease the rates of transition to 
psychosis. GPs play a key role in the identification of ARMS, as they are usually the first point of 
contact with health services. However, very few studies have explored GPs’ awareness of ARMS. 
This study aims to explore GPs’ views and experiences of identifying patients with ARMS, and the 
barriers and facilitators to identification in primary care.  
Approach 
In-depth interviews were held with 20 GPs working in the South West of England. A topic guide was 
used to ensure consistency across the interview.  It covered the following areas:  recognition, 
identification, management of ARMS patients, and facilitators and barriers to early identification. All 
the interviews were audio recorded, transcribed verbatim and analysed thematically.  
Findings  
Some GPs were unsure what was meant by ‘ARMS’. They asked if we were referring to people who 
had certain risk factors for psychosis (i.e. illicit drug use), people at risk of a psychotic relapse, or 
people with mild psychotic symptoms. When providing GPs with a definition, some GPs still struggled 
to recognise who might be patients with ARMS, as most of the patients they had seen were either in a 
florid state or had recurrent psychosis. Other GPs mentioned that in most cases, mild psychotic 
symptoms occurred in the context of other mental health illnesses, and these patients would not be 
placed in a separate diagnostic category. There were also GPs, however, who said that they were 
familiar with the term ARMS, but that they rarely saw these patients. The facilitators and barriers to 
ARMS identification related to patients (i.e. patients not consulting or disclosing psychotic symptoms), 
GPs’ knowledge of ARMS, and working in the NHS (i.e. a lack of continuity of care).  
Consequences  
Most GPs are unfamiliar with the term ARMS and would not identify patients as being at risk of 
developing psychosis. GPs’ ability to identify patients with ARMS was hindered by patients not 
disclosing symptoms, and GPs’ knowledge of this condition and specific patients. 
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5A.2 CARMEN: Evaluation of a Point of Care Device in improving physical health check uptake 
in two community mental health teams 
Joseph Butler, University of Oxford  
Simone de Cassan, Belinda Lennox, Phillip Turner, Margaret Glogowska, Thomas Fanshawe, Gail 
Hayward 
Problem  
Patients with Severe Mental Illness (SMI) have a life expectancy 15-20 years below that of the 
general population, mediated predominantly by the complications of poor cardiovascular health. 
Physical healthcare for this population is shared between General Practice (GP) and Community 
Mental Health Teams (CMHTs) and encompasses a NICE-recommended annual physical health 
check, to screen for cardiovascular complications. Audit findings in 2017 across the South of England 
show poor physical health check completion (38%), typically because HbA1c and Lipid Panel blood 
tests were omitted. Traditionally, patients are advised to attend their GP surgery for these tests, which 
can be a challenge for patients with SMI.  There is a growing market of POC devices able to calculate 
an HbA1c or Lipid Panel in rapidly from ‘fingerprick’ samples of blood at, or near the site of the 
patient. The Cardiovascular Monitoring in Mental Health (CARMEN) project hypothesised that test 
uptake would be improved by implementation of a ‘Point of Care’ (POC) blood testing device in two 
CMHTs.  
Approach 
We embedded the ‘Afinion’ device into an Early Intervention Team and an Adult Mental Health Team 
in Oxfordshire for six months. Training was provided to care coordinators with ongoing support to 
facilitate engagement with the device. We compared rates of blood test and full physical health check 
completion in the intervention teams to a matched early intervention team and adult mental health 
term in Buckinghamshire. We performed semi-structured interviews with patients receiving POC-
augmented care and clinicians from the intervention teams.  
Findings  
Data showed that whilst the Adult Mental Health team did not engage with the device and saw no 
change in outcomes, the Early Intervention Team did engage and increased rates of physical health 
check completion from 22.6% to 40.3% of their caseload per 6 months. Completion in the control 
CMHT was 7.8%. Similar trends were seen in rates of HbA1c and Lipid Panel completion. Qualitative 
interviews revealed universal patient support for POC and diverse attitudes to the role of the mental 
health teams in providing physical healthcare. We explored how clinicians engaged and why they 
didn’t engage with the device, and how access to POC modulated the therapeutic relationship.  
Consequences  
Our findings show that using POC for Physical Health Checks is acceptable to patients with SMI and 
mental health care clinicians, many of whom are from a non-clinical background.  In teams where it is 
well adopted, POC testing can improve physical health check completion in the SMI population, 
although our qualitative findings highlight important considerations for maximising clinician 
engagement. 
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5A.3 Improving psychosis prediction using primary care consultation data (MAPPED Study) 
Sarah Sullivan, University of Bristol 
Daphne Kounali, Richard Morris 
Problem  
Clinical and social outcomes of psychosis are often poor, and many risk factors are difficult to modify. 
Duration of untreated psychosis (DUP) has been linked to poorer prognosis and is potentially 
modifiable. Speedier referral from primary care to secondary mental health services is an important 
component of DUP. We previously found that specific prodromal characteristics were strongly 
associated with a later diagnosis of psychosis; attention deficit hyperactivity disorder-like problems, 
bizarre behaviour, blunted affect, depressive-like problems, role functioning problems, social isolation, 
mania, obsessive compulsive disorder-like problems, disordered personal hygiene, sleep disturbance 
and suicidal behaviour (including self-harm), cannabis use and cigarette smoking. The positive 
predictive value of these characteristics varied with age and gender. We also found increasing 
consultation frequency for some of the prodromal characteristics over time before diagnosis and 
heavier use of primary care services among people later diagnosed with psychosis than among those 
who did not develop psychosis. We have used these prodromal characteristics as candidate 
predictors for the development and validation of a prediction model for psychosis for primary care.  
Approach 
Study Design: Prospective cohort seeking help for mental health problems and a follow up of ≥5 
years. Data source: Clinical Practice Research Datalink linked to Hospital Episode Statistics for 
diagnosis outcomes. Sample: 300,000 patients without previous coded diagnosis of psychosis but 
who consult for any other mental health problem. Primary outcome: ICD coded diagnosis of psychotic 
disorder. Period of risk is from first recorded consultation for a non-psychotic mental health problem 
until first recorded psychosis diagnosis. Predictors: Characteristics described above, age, gender and 
consultation frequency overall and per characteristic. Statistical Analysis: Odds ratios were calculated 
for each characteristic and entered into a logistic regression model. Area under ROC curve (AUROC) 
was calculated, together with sensitivity and specificity for exceeding the upper quartile of the risk 
distribution.  
Findings  
355 people were diagnosed with a psychotic disorder during follow up with a median follow-up of 7.9 
(IQR 6.5, 8.9) years, resulting in an incidence of 1.5 per 10,000 person years (95% CI [1.4,1.7]) The 
most common diagnoses were; unspecified nonorganic psychosis (26.5%), delusional disorder 
(22.3%) and schizophrenia (16.6%). Of the cases 54% were female, mean age was 44 years, 88% 
were White and 33% were in the lowest deprivation quintile. Symptom prevalence ranged from 0.02% 
(bizarre behaviour) to 41.8% (depressive symptoms). Unadjusted odds ratios for the association 
between symptoms and outcome ranged from 36.5 (bizarre behaviour) to 1.01 (cannabis related 
problems). Prognostic scores integrating these predictors along with age and sex yielded a sensitivity 
57.8%, specificity 75.2% with AUROC=0.7.  
Consequences  
These initial results suggest that the specified predictors are promising candidates for a risk score for 
psychosis and have higher predictive power than current psychosis risk prediction tools. 
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5A.4 The relationship between antipsychotic prescribing and the proportion of those with 
psychosis with a care plan: a cross-sectional study of practice-level data in England. 
Ali Ridha, University of Warwick 
Ali Ridha, Rhian Stanbrook, Will Proto, Sarah Hillman, Dan Todkill, Saran Shantikumar 
Problem  
The NHS Mandate states that every person with a mental health condition should be offered a 
personalised care plan as soon as possible after diagnosis, including those living with schizophrenia 
and bipolar disorder. With the provision of a holistic approach to individuals living with psychotic 
disorders, it is possible that those with a care plan also have a more rationalised approach to the 
medication they are prescribed. In this study, we investigate the association between the proportion of 
people with a diagnosis of a psychotic disorder who have a care plan and the prescribing rate of 
antipsychotics and lithium in primary care practices in England.  
Approach 
Monthly primary care prescribing data for 2018, as well as practice age and sex profile, were 
downloaded from NHS Digital. Prescribing by practice was aggregated over the year and filtered for 
antipsychotics and lithium using British National Formulary (BNF) codes. Practice-level Index of 
Multiple Deprivation (IMD 2015) scores were obtained from Public Health England. Quality Outcomes 
Framework (QOF) data for 2017/18 were obtained for the proportions of each practice with a 
diagnosis of psychosis, dementia and depression. Multiple linear regression was used to examine the 
association between the proportions of those with psychosis with a care plan and antipsychotic/lithium 
prescribing, after adjusting for practice sex (% male), older age (% >65s), practice list size, practice-
level deprivation (using the Index of Multiple Deprivation [IMD] score), and the proportions of each 
practice with psychosis, dementia and depression. Practice-level prescribing was defined as items of 
antipsychotics or lithium per 1000 registered patients in 2018.  
Findings  
On univariate analysis, overall antipsychotic/lithium prescribing rates were negatively associated with 
the proportion of individuals with psychosis with a care plan, with less prescribing in practices with a 
greater proportion of individuals with a care plan (incidence rate ratio [IRR] 0.88, 95% CI 0.83-0.93, 
for quintile [Q] 5 vs. quintile 1). The proportion of individual with a care plan remained an independent 
predictor of prescribing after adjusting for all the other variables included in the model (adjusted IRR 
[aIRR] 0.80, 95% CI 0.75-0.85 for Q5 vs. Q1). Incidentally, IMD score was also an independent 
predictor of prescribing, with more prescribing in more deprived practices (aIRR 1.67, 95% CI 1.58-
1.76, Q5 vs. Q1).  
Consequences  
These results suggest that practices with greater proportions of individuals with a diagnosis of 
psychosis with a care plan tend to prescribe fewer antipsychotics/lithium. It is possible that practices 
that are more engaged with care plans are more likely to rationalise and optimise antipsychotic/lithium 
prescribing. Further work with individual-level patient datasets is required to confirm this result and to 
explore other possible underlying reasons for this association. 
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5A.5 Has the increased risk of cardiovascular mortality with Severe Mental Illness (SMI) 
compared to the general population changed over time? 
Amanda Lambert, University of Birmingham 
Prof Tom Marshall, Dr Helen Parretti 
Problem  
Previous reviews of the association between severe mental illness (SMI) and cardiovascular disease 
(CVD) have mainly focussed on single diagnoses (schizophrenia, bipolar disorder (BD)) or outcomes 
(coronary heart disease, stroke) and either mortality or morbidity. Results have been inconsistent 
although SMI appears to increase risk of CVD. Our study aimed to conduct a comprehensive up-to-
date systematic review of the relationship between SMI and CVD and explore changes in the 
relationship over time. Here we report effects on CVD mortality.  
Approach 
We searched for studies comparing CVD incidence or mortality in SMI compared to controls in a 
systematic search of MEDLINE, EMBASE, PsycINFO, and CINAHL, Web of Science and ZETOC 
conference abstracts and Cochrane CENTRAL database. We used SMI and CVD search terms, 
without language or date restriction. Bibliographies of included studies were also searched. Two 
independent reviewers screened titles and abstracts for initial selection, then reviewed full texts of 
selected studies and decided on inclusion. Data on risk of CVD for SMI versus controls from included 
studies was extracted. Effects were pooled using random effects meta-analysis and sources of 
heterogeneity between studies explored with meta-regression.  
Findings  
Reviewers screened 9591 titles and abstracts, initially selected 303 full texts and included 58 studies    
in quantitative analysis of CVD mortality. CVD mortality risk was increased for both schizophrenia 
(SMR: 1.96, 95%CI: 1.72-2.23) and bipolar disorder (SMR: 1.65, 95%CI: 1.53, 1.78). CVD mortality 
risk  for schizophrenia was higher than for BD (RR: 1.19, 95%CI: 1.04-1.36). Results were similar for 
CHD and stroke mortality when considered separately.  However, there was significant heterogeneity 
between studies, partly explained by an increased risk in studies conducted since the 1990s.More 
recent studies reported larger associations between SMI and cardiovascular mortality than earlier 
studies: 1990s vs 1950s-70s, RR: 1.44  (95% CI: 1.13-1.83); 2000s vs 1950s-70s, RR: 1.30 (95% CI: 
1.05-1.62); 2010s vs 1950s-70s, RR: 2.41 (95% CI: 1.41-4.13).  
Consequences  
SMI is associated with a significantly increased risk of CVD-related mortality which appears to be 
increasing over time.  Although improved physical health for people with mental health conditions is 
reflected in UK health policy, more needs to be done to understand the reasons for the higher risk in 
CVD, to identify people with SMI at risk of dying from CVD and to put appropriate interventions in 
place to reduce the risk. 
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5A.6 Do physicians in primary care and mental healthcare professionals in America treat 
marginalized patients holistically? A literature review. 
Angel Bierce, University of Bristol 
Problem  
Physicians in primary care need to look holistically at patients’ lives and community to efficiently treat 
transgenerational transmission of trauma (TTT), which is often not considered in diagnosis and 
treatment plans. TTT is the theory that trauma can be transferred from the first generation of trauma 
survivors to their offspring and onward to further generations. Evidence suggests that both prenatal 
and in utero stressors can influence the offspring’s ability to respond to stress and their susceptibility 
to PTSD through miRNA, hippocampus size, and cortisol levels. Also, a lineage that has generations 
compound? stressed (like many minority groups) can have these effects at a greater magnitude. One 
aspect that the literature has  addressed is that it’s not always a grand catastrophe that can cause the 
occurrence of these epigenetics. Stressors could be a result of abuse, food insecurity, lack of financial 
stability, and more ‘every day’ occurrences. Since these stressors happen more often itis important 
that mental healthcare and primary care providers find treatment for ‘common’ people, rather than 
focusing on cisgendered, heterosexual white men. The aim of this literature review was to identify 
evidence-base on how TTT and lesbian, gay, bisexual, transgender, and queer patients are being 
cared for and identify any discrepancies in primary healthcare regarding treatment of minorities 
suffering from TTT.  
Approach 
A search was conducted across multiple databases to identify relevant papers to conduct a qualitative 
study. First, papers relating to transgenerational transmission of trauma were reviewed to establish a 
working definition and understand circumstances in which it occurs. Then, papers investigating 
natural disasters and race were reviewed to compare how different races were impacted, and how 
primary care, or lack of, influenced the road to recovery. Lastly, a search for possible resources for 
marginalized communities was conducted and came up short due to there being an insufficient 
supply; One CBT manual for “therapy across cultures” and one LGBTQ+ manual related to 
conversion therapy. A chapter in one book is simply not enough to cover the differences in cultures, 
somatic symptoms, and the complexities of others’ lives.  
Findings  
Findings focused on the social differences, as well as lack of primary care received by ethnic 
minorities and members of the queer community. The literature review found that there was a lack of 
treatment and resources in primary care and cognitive behavioural therapy manuals to treat 
marginalized groups suffering from TTT.  
Consequences  
Moving forward, it is important to examine race, sexual orientation, and identity as a factor in primary 
and mental healthcare to improve treatment of marginalized people. This review contributes to a 
better understanding of what TTT is and identify potential issues in primary mental healthcare 
treatment when the individual is not viewed and treated holistically. 
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5B.1 How can primary care clinician’s optimise patient expectations about OA management? 
An exploratory study investigating patient perspectives about positive framing in the OA 
consultation. 
Emily Lyness, University of Southampton 
Felicity L Bishop, Jane Vennik, Jeremy Howick, Stephanie Hughes, Kirsten Smith, Mohana 
Ratnapalan, Christian Mallen, Leanne Morrison, Lucy Yardley, Hajira Dambha-Miller, Geraldine 
Leydon, Paul Little, Hazel Everitt. 
Problem  
Osteoarthritis (OA) is a common condition causing pain and reduced mobility that can have a 
significant impact on people’s lives. It has a growing prevalence in the UK due to rising risk factors 
and patients frequently present to primary care practitioners. Experimental studies suggest that 
enhancing clinicians’ communication of positive expectations regarding the management of OA may 
reduce patient experience of OA pain and encourage positive outcome expectations. It is unclear, 
however, how this fits into real world practice and there is limited insight into patient’s views about the 
role of expectation management. This qualitative study explores the views of patients with OA on the 
use of positive messages in the primary care consultation to shape outcome expectations. 
Approach 
This study was embedded within Empathica; a SPCR funded project developing a digital intervention 
to enhance practitioner skills in empathic communication and expectation management. Participants 
were recruited from primary care practices with the assistance of the Clinical Research Network 
(CRN) to include patients over 45 who had consulted for hip/knee OA in the last 12 months. 18 
participants were purposefully sampled to include a range of age, gender, severity of OA and 
deprivation index. Semi-structured interviews were conducted using a combination of vignettes and 
open-ended questions to elicit participants’ views. Two case vignettes were developed with input from 
a PPI representative to illustrate different clinician approaches to expectation management in a 
primary care OA consultation. One vignette depicted a neutral factual approach, the other included 
clear positive messages and phrases informed by the literature and expert opinion. The topic guide 
was developed inductively with open-ended questions to allow flexible responses and explore 
developing themes. Both vignettes were presented to each participant in a random order to avoid 
bias. Interviews were audio-recorded, transcribed and anonymised. Thematic data analysis was 
conducted using an inductive approach with techniques from grounded theory using NVIVO software. 
Findings  
Emerging themes appear to suggest that positive messages need to be combined with an empathic 
clinical approach to be effectively delivered. If this balanced approach could be achieved patients felt 
it may enhance patient optimism about management and their ability to control health behaviours, and 
therefore symptoms. There was however some scepticism whether this was achievable in the time 
and resource constrained environment of NHS primary care. 
Consequences  
We hypothesise that applying experimental theory of delivering positive messages is likely to be 
challenging within the real world context due to the complex interplay between chronic disease 
management and the current pressures on primary care service delivery. However, in the correct 
setting may enhance the patient engagement with self-management of their disease. Analysis will be 
complete and full results and conclusions will be available at the conference. 
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5B.2 Patient perspectives of empathic and positive communication for osteoarthritis in 
Primary Care: an analogue study 
Jane Vennik, University of Southampton 
Pranati Misurya, Felicity Bishop, Emily Lyness, Stephanie Hughes, Kirsten Smith, Mohana 
Ratnapalan,  Hazel Everitt, Jeremy Howick, Paul Little, Christian Mallen, Leanne Morrison, Lucy 
Yardley, Hajira Dambha-Miller. 
Problem  
Research has shown that empathic and positive communication can reduce pain, increase quality of 
life, and improve satisfaction with care for patients with osteoarthritis. However, there is limited 
understanding about patient’s views and insights into empathic and optimistic communication in a 
primary care consultation. This analogue study is part of Empathica; a SPCR-funded programme of 
work developing brief training for primary care practitioners in empathic and optimistic communication.  
Approach 
We developed and filmed two primary care consultations for osteoarthritis (OA); one enacting the 
Empathica-trained approach which incorporated examples of evidence-based verbal and non-verbal 
behaviours, and the other enacting a ‘neutral’ or normal-styled consultation. A purposively-varied 
sample of 15 OA patients watched the two filmed consultations in random order.  After each 
consultation, patients rated the GP’s clinical empathy using a modified Consultation and Relational 
Empathy (CARE) measure and took part in a semi-structured interview.   Descriptive statistics were 
used to present the questionnaire data.  Interviews were transcribed verbatim and were analysed 
using thematic analysis. NVIVO was used to manage the data.  
Findings  
Participants rated the Empathica-style consultation generally more positively than the neutral 
consultation (mean CARE measure 42.93 vs 16.67). With the Empathica-style consultation, patients 
identified key elements considered to enhance the interaction including the GP showing care and 
respect; demonstrating knowledge of the patient; active listening; being encouraging and positive; 
open body language and good eye contact. Key elements of the neutral consultation that patients 
thought impaired the consultation included the GP not showing she was listening; being dismissive of 
patient’s concerns; lack of clarity about likely outcomes. Participants reported that the patient 
appeared more satisfied with the Empathica-style consultation and considered them more likely to 
engage in the management plan. However, participants could perceive little difference in GP 
satisfaction between the two consultations.  
Consequences  
These findings highlight elements of empathic and optimistic communication that are acceptable to 
patients and could enhance the primary care consultation for OA. It is important to identify key 
elements that primary care practitioners can include without adding time to the consultation. These 
results have informed development of the Empathica intervention which aims to enhance practitioner 
empathic communication, and ultimately improve levels of OA pain and quality of life for patients. 
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5B.3 What are GPs perspectives, experiences and challenges when supporting patients with 
possible endometriosis in primary care? 
Sharon Dixon, University of Oxford 
Amelia Talbot, Abigail McNiven, Lisa Hinton 
Problem  
Endometriosis is the second most common gynaecological condition in the UK, affecting around 1.6 
million women of reproductive age, and 11% of women worldwide. In the UK, women with 
endometriosis typically experience a delay of approximately 7-10 years before receiving a diagnosis. 
Primary care is where women often first seek medical help, making this setting pivotal in women’s 
pathways to diagnosis and treatment. We are not aware of previous work exploring English GPs 
perspectives on supporting women with suspected endometriosis.  
Approach 
This qualitative study explores what GPs identify as important considerations when they are caring for 
women who present with symptoms that raise the possibility of endometriosis. We aim to undertake 
semi-structured interviews with 40 GPs working in England, based around a fictional scenario of a 
woman presenting to primary care with symptoms suggestive of possible endometriosis. We have 
interviewed 38 GPs from five LCRN regions to date.  
Findings  
Having completed 38 interviews (26 female, 12 male), we are in the initial stages of our analysis. 
Emerging themes include; balancing symptom control with the potential value (and risks) of further 
investigations, the role of primary care in supporting women with possible endometriosis, the value of 
on-going primary care therapeutic relationships, challenges in talking about endometriosis, and the 
potential advantages and risks of an endometriosis label. GPs described that shared decisions 
around women’s priorities (e.g. age, fertility, whether she was seeking a diagnostic label) were pivotal 
in navigating treatment and referral. The management of teenagers and peri-menopausal women 
raised uncertainties for many GPs. Resources, education and services that GPs would value included 
resources based on symptoms (not diagnoses), awareness raising education, clear guidance for 
primary care, and access to advice. Many GPs described utilising trials of treatment as both a 
therapeutic intervention and diagnostic tool. There may be a mismatch between how this is perceived 
by GPs and women. Continuity of care facilitated considering endometriosis as a possible diagnosis. 
If there was not continuity, strategies suggested to mitigate against delays in diagnosis included 
automated prompts in GP IT systems, coding suspected endometriosis, and clear written plans in GP 
notes.  
Consequences  
GPs reflections on pathways to diagnosis were primarily based around what they identified as 
women’s priorities. GPs described balancing the need for (and risks of) investigations and a diagnosis 
against adequate symptom control. Because endometriosis requires secondary care diagnosis, 
challenges for primary care include knowing when to consider it, when to refer, and the long-term 
support and management of women, once they have had a diagnosis. The potential added value of 
referral for a diagnosis, if symptoms were well controlled by primary care measures, was an important 
consideration, notably for younger women and teenagers. 
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5B.4 An Exploration of Compassionate Care from the Perspectives of Older People, Carers and 
Service Providers 
Molly Curtis, University of South Wales 
Dr Juping Yu, Dr Carolyn Wallace, Mr David Williams 
Problem  
Following the Francis report (2013), delivering compassionate care has been implemented as a core 
value for health and social care services. However, the literature indicates that there is a lack of 
agreement and consistency regarding the definition of compassion. This study aimed to explore how 
the concept of compassion is conceptualised in the context of health and social care services. The 
study aims included: identifying key elements of compassionate care; comparing similarities and 
differences between participants' perspectives; and developing a conceptual framework of 
compassionate care. 
Approach 
Group Concept Mapping (GCM) was used as the research method to gain consensus on a definition 
of compassionate care from the perspectives of older people, carers and service providers. Data were 
collected through face-to-face workshops or online. In-depth interviews were also conducted with frail 
older people, such that the perspectives of those who could not attend a workshop were included in 
the study. Data collection for GCM involved 3 tasks: “brainstorming”, “sorting” and “rating”. 
“Brainstorming” involved asking participants to generate ideas about compassionate care. Transcripts 
from in-depth interviews also contributed to the “brainstorming” task. For “sorting”, participants were 
asked to sort a collection of statements generated from “brainstorming” into categories, and to give 
each category a label. For “rating”, participants were asked to rate how important they believed each 
statement to be, and how frequently they experienced it in the care they had receive and/or provided. 
Findings  
The data were analysed to produce a point and cluster map. The cluster map represents participants’ 
responses in the “sorting” task. The steering group interpreted the data, and agreed that the concept 
of compassionate care is comprised of 8 clusters: “Non-judgemental”, “Excellent skills which set them 
apart”, “Above and beyond”, “Genuine care giving”, “Show the person is valued”, “Empathetic”, 
“Thoughtful” and “People-centred care”. 
Consequences  
This study contributes a definition of compassionate care from the perspectives of older people, 
carers and service providers in the context of health and social care services. This study had 
produced a conceptual framework of compassionate care, consisting of 8 elements: “Non-
judgemental”, “Excellent skills which set them apart”, “Above and beyond”, “Genuine care giving”, 
“Show the person is valued”, “Empathetic”, “Thoughtful” and “People-centred care”. This study is 
unique both in the UK and internationally. The resulting conceptual framework may be utilised further 
to develop a novel tool to measure compassionate care. 
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5B.5 Communication between patients and primary care providers after discharge from 
hospital - a scoping review 
Rachel Spencer, University of Warwick 
Harjot Singh 
Problem  
Care transitions from secondary to primary care are a potentially risky part of the patient journey, 
particularly for older patients with multi-morbidity and polypharmacy.  Our recent work shows that 
management in primary care after discharge from hospital causes harm to 8% of this vulnerable 
group of patients.  Communication problems between patients and primary care providers are at the 
heart of many errors and subsequent harms which occur. Improved communication might also be a 
strategy to reduce the 22.8% rise seen in emergency re admissions between 2012 and 2016. There 
are 3 participants in the communication triangle at care transition (patients, primary care providers 
and secondary care providers) and yet most current literature focuses on the latter two.  
Approach 
In order to address this communication deficit we plan to develop a tool which will help older patients 
and their carers communicate with their primary care provider after discharge.  In order to begin a co-
production process to create this tool a systematized review is being conducted to inform the possible 
content of this tool.  We used three search stems relating to: 1-Primary care or transitional care 
setting, 2-Discharge events and 3-faciliation of communication.  We deliberately did not limit our 
findings to the older patient population (in order not to miss any transferable literature).  The review 
uses a dual reviewer system and adheres to best principles described by Cochrane for systematic 
reviewing but due to the nature of the research questions is essentially a scoping review.  
Findings  
The review is in progress and will be reported in early 2020. We searched 5 databases which 
included (CINAHL, Cochrane, Embase, MEdline, Web of Science) on 7/10/19 with no limitations in 
terms of language or date of publication.  716 titles were considered after removal of duplicates.  
From these 227 abstracts were selected.  We anticipate that around 90 papers will meet the criteria 
for full review and these papers will be quality assessed prior to extraction of transferable content.  
Consequences  
The findings from the review will be used to inform the creation of a unique intervention to improve 
patient’s communication with their primary care provider after discharge from hospital.  Improving 
health efficacy is a key, and as yet, under-explored strategy to make care transitions safer for older 
patients.  This work represents the very beginning of a programme of work which seeks to give 
patients a stronger voice as the 3rd point of the triangle of care transition communication. 
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5B.6 Discussions regarding dental recall interval: preferences for shared decision-making in 
dentistry 
Hannah Scott, Cardiff University 
Hannah Scott, Anwen Cope, Fiona Wood, Natalie Joseph-Williams, Anup Karki, Candida Lovell-
Smith, Emyr Roberts, Ivor Chestnutt 
Problem  
In 2004, the NICE published guidelines recommending that dentists should tailor the interval between 
patients’ check-ups according to their disease risk. This would mean that those patients who were 
deemed low risk should be recalled at 12-24 months, instead of every six months, subsequently 
freeing up resources that could be used to improve access to NHS dental care. Research has shown, 
however, that few dentists implement risk-based recall guidelines. Since the publication of guidelines 
has not changed dental recall behaviours, it is important to understand how these decisions are made 
and the role patients play in them. Shared decision-making, whereby the patients and practitioners 
work in partnership to make decisions about care, is now considered an integral part of medicine and 
dentistry. It is therefore important to understand the barriers and facilitators to both risk-based recall 
intervals, from the point of view of both dentists and patients, and the implementation of shared 
decision-making techniques into consultations about dental recall.  
Approach 
Semi-structured telephone interviews were conducted with 25 dentists and 25 NHS dental patients, to 
explore current practices regarding recall interval setting, and barriers and facilitators to shared 
decision-making. This work was undertaken as part of a study to develop a patient decision aid that 
can be used by dentists and patients to support dental recall interval setting in general dental practice.  
Findings  
Dentists believed that shared decision-making was an important part of their practice, despite a lack 
of clarity of how this differed from informed consent. Reasons for involving patients in decisions about 
their care largely centred on the desire to encourage patients to take ownership of their health, as well 
as mitigating the threat of litigation faced by dentists. Dentists’ perceptions of their patients’ 
willingness and ability to engage in shared decision-making varied; dentists reported some patients 
wanting to be heavily involved in decisions about their dental care, and others wanting the dentist to 
make the decisions. Some patients were not aware that dental recall intervals could be anything but 
six months and had never previously discussed their recall interval with their dentist. Some wanted to 
be involved in a discussion with the dentist and demonstrated prior involvement in decisions about 
their restorative dental care. However, others were of the opinion that the dentist was the ‘expert’ and 
should therefore be the one making the decision, or expressed ambivalence regarding the frequency 
of their dental appointments.  
Consequences  
These findings highlighted a need to support patients and practitioners to collaboratively engage in 
shared decision-making in dental care. They will inform the development of a concise and patient-
friendly shared decision aid suitable for use in busy NHS general dental practice. 
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5C.1 The impact of NHS England prescription guidance for Clinical Commissioning Groups on 
prescribing rates of simple analgesia in primary care. 
Hannah Reichel, University of Warwick 
Hannah Reichel, Rhian Stanbrook, Will Proto, Pooja Bakhshi, Sarah Hillman, Dan Todkill, Saran 
Shantikumar 
Problem  
In the NHS in England in 2017/18, £17.4 billion was spent on pharmaceutical drugs, £8.9 billion of 
which was from GP prescriptions. In March 2018, as a measure to rationalise and optimise spending, 
NHS England published guidance for Clinical Commissioning Groups (CCGs) detailing a list of 
medications that could be bought over the counter and that should in most cases not be prescribed. 
This included simple analgesia. In this study, we investigate the impact of this guidance on the 
prescribing rates of simple analgesia in primary care. In addition, we explore whether CCGs have 
actively implemented this guidance, and whether there is any evidence that the guidance has created 
a health inequality.  
Approach 
The simple analgesics included were oral paracetamol; oral ibuprofen and topical non-steroidal anti-
inflammatory drugs (NSAIDs). Practice-level prescribing data from January 2015 to March 2019 were 
obtained from NHS Digital and filtered for simple analgesia by use of their British National Formulary 
(BNF) codes. Linking the resulting data to quarterly practice list sizes allowed a calculation of monthly 
prescribing rates across England. Taking the “intervention” time point to be March 2018, an 
interrupted time series analysis (ITSA) was conducted to assess the effect of the intervention, both 
with and without an adjustment for seasonality. To explore a potential health inequality, we examined 
the association between practice-level prescribing rates and deprivation (using the Index of Multiple 
Deprivation [IMD] score) both 12 months before and 12 months after the intervention, using 
multivariable Poisson regression, adjusting for sex, proportion of over-65s and practice list size. 
Freedom of information (FOI) requests were submitted to all CCGs to elicit to what extent each had 
implemented the NHS England guidance.  
Findings  
Data analysis is currently underway. Initial results suggest that the intervention was associated with a 
~4% reduction in prescribing rate of simple analgesia overall (adjusted incidence rate ratio [aIRR] 
0.956, p < 0.001) after accounting for an underlying time trend and seasonality. Practice-level 
prescribing rates were significantly associated with IMD score, although the strength of this 
association was similar before and after the intervention (aIRR 2.44 [95% CI 2.33-2.57] pre-
intervention and 2.42 [95% CI 2.30-2.56] post-intervention). All 195 CCGs responded to the FOI 
request. The results of these will be presented, along with ITSA analyses of individual simple 
analgesics.  
Consequences  
The results so far suggest that the NHS England guidance has resulted in a reduction in the 
prescribing of simple analgesia, without creating an additional health inequality. The value of varying 
strengths of implementation by CCGs requires exploration 
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5C.2 Amitriptyline at Low-dose and Titrated for Irritable Bowel Syndrome as Second-line 
Treatment (The ATLANTIS study): A Double-blind Placebo-controlled Trial 
Hazel Everitt, University of Southampton 
Hazel Everitt, Heather Cook, Matthew Ridd, Robbie Foy, Sarah Alderson, Felicity Bishop, Elspeth 
Guthrie, Matthew Chaddock, Delia Muir, Richard Brindle, Christopher Taylor, Daniel Howdon, Roberta 
Longo, Sonia Newman, Amy Herbert, Ruth Gibbins, Deborah Coop 
Problem  
Irritable Bowel syndrome (IBS) is common, causing abdominal pain, bloating and changes in bowel 
habit that can significantly affect quality of life. Many people suffer ongoing troublesome symptoms 
despite having been offered first line treatments. NICE IBS guidelines recommend low dose 
amitriptyline as a potential second-line treatment option but evidence for its use is limited and it is 
infrequently prescribed for IBS in primary care. The aim of this NIHR HTA funded ATLANTIS trial is to 
determine the clinical and cost-effectiveness of low-dose amitriptyline as a second-line treatment for 
IBS in primary care.  
Approach 
ATLANTIS is a randomised, multi-centre, parallel-group, two-arm, double-blind, placebo-controlled 
trial of low-dose amitriptyline as a second-line treatment for people with irritable bowel syndrome 
(IBS) in primary care. It includes an internal pilot and a nested, qualitative study. The aim is to recruit 
518 participants from approximately 75 GP surgeries in 3 geographical areas: West Yorkshire, 
Wessex and ,  West of England, with the support of local Clinical Research Networks. Participants will 
be identified by searching GP lists for people with a diagnosis of IBS and sending of invite letters or 
by opportunistic recruitment when people present to the GP surgery. Those eligible after screening 
will be randomised to receive 6 months of trial treatment, taking either 1 to 3 tablets (10-30 mg) of 
amitriptyline or placebo once-daily. Participants will be able to titrate their dose (between 1 and 3 
tablets) depending on symptoms and side effects. At 6 months participants will have the option to 
continue treatment for an additional 6 months (12 months total treatment).Outcome measures will be 
self-completed online or on paper (participant preference) at 3, 6, and 12 months following 
randomisation and a weekly question about relief of IBS symptoms. The primary outcome is IBS 
symptom severity score at 6 months. Secondary outcomes include the work and social adjustment 
scale, hospital anxiety and depression score (HADs), subjects global assessment of relief of IBS 
symptoms , quality of life using EQ5D and health care resource use to determine QALYs. A sub-
sample of participants and recruiting GPs will undertake two semi-structured telephone interviews at 6 
and 12 months to identify factors affecting the prescribing, acceptability and adherence of low-dose 
amitriptyline, and explore factors that might shape wider use of amitriptyline for IBS.  
Findings  
Trial set up and ethical approval has been completed and recruitment has begun. Reflections on the 
challenges of setting up this large RCT and initial recruitment figures will be presented at the 
conference  
Consequences  
This large RCT will provide robust evidence on the clinical and cost effectiveness of amitriptyline for 
IBS in the primary care population and enable patients and clinicians to make better informed 
treatment decisions. 
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5C.3 Understanding the gap between prescribing guidelines and behaviour: a qualitative study 
in UK general practice 
Mary Carter, University of Bath 
Sarah Chapman, Prasad Nishtala, Margaret Watson 
Problem  
Despite increasing expenditure on medicines and widespread availability of evidence-based 
guidelines to inform medicines’ rational use, considerable variation exists in guideline uptake and 
application by clinicians.  The range of health professionals prescribing in general practice may 
contribute to this variation.  Recent NHS policy supports pharmacists’ inclusion in general practice 
teams; pharmacists’ professional skills are viewed by some as suited to fostering an evidence-based 
approach to prescribing. There is a need to identify the key determinants of current prescribing 
behaviour before developing strategies which reduce variation and promote evidence-based 
prescribing.  
Approach 
To investigate influences on prescribing in general practice and specifically to explore: 1. 
Determinants of prescribing behaviour from prescribers’ perspectives, 2. Use/influence of National 
Institute of Health and Care Excellence (NICE) and other guidelines on prescribing, 3. Role/potential 
of general practice-based pharmacists (PBPs) to promote evidence-based prescribing. Semi-
structured qualitative telephone interviews and focus groups were conducted with two samples: (i) 
general practice-based prescribers: General Practitioners (GPs), nurses and PBPs (ii) key informants: 
individuals working in NHS roles, with responsibility for influencing and monitoring general practice 
prescribing.  A target sample matrix was developed to reflect a range of prescribers from various 
professional backgrounds and diverse general practice characteristics, and key informants working in 
assorted local, regional and national roles.  Recruitment was through local and regional contacts and 
snowball sampling.  Interviews and focus groups were audio-recorded and transcribed verbatim.  
Thematic data analysis identified themes about the influences on prescribing and PBPs' roles.  Data 
saturation was considered to be achieved when the sample matrix was complete and no new themes 
were identified.  
Findings  
Data collection took place between November 2018 and April 2019.  Interviews were completed with 
17 prescribers (GPs (n=6), pharmacists (n=6), nurses (n=5)) and six key informants.  One focus group 
was conducted with five key informants.  Both samples stated that guidelines fundamentally influence 
prescribing, but identified competing influences including the prescriber’s professional background, 
socio-economic profiles of patient populations and attitudes of individual patients.  Media portrayals of 
medicines and public opinion were also identified.  Prescribers identified practice-level influences, e.g. 
attitudes towards shared learning, and key informants emphasised the impact of NHS organisational 
policies and the availability of services.  Key informants also highlighted underlying problems (e.g. 
polypharmacy) and ‘medicines optimisation’ principles (e.g. safe prescribing) developed to address 
these issues. Both samples identified PBPs’ specific medicines expertise and highlighted variation in 
PBPs’ roles and access to support.  Prescribers’ views were mixed about the extent to which PBPs’ 
may influence prescribing in the future.  
Consequences  
Prescribing in general practice is influenced by multiple and competing factors. Development of 
successful strategies must first identify and then focus on influencing factors that are amenable to 
modification and take account of the range of professionals with prescribing responsibilities in general 
practice. 
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5C.4 Development of a model of clinical medication review for use in clinical practice 
Deborah McCahon, University of Bristol 
Dr Rachel Denholm, Dr Rupert Payne, Dr Alyson Huntley, Dr Polly Duncan, Dr Shoba Dawson 
Problem  
NICE define medication review as a “structured, critical examination of a patient’s medicines with the 
objective of reaching an agreement with the patient about treatment, optimising the impact of 
medicines, minimising the number of medication related problems and reducing waste”. Within NICE 
guidance for medicines optimisation, regular medication review is recommended as a key priority for 
implementation and a mechanism for making medicines optimisation part of routine practice. Despite 
the guidance, there is still a lack of understanding about what constitutes a clinical medication review. 
Practical and detailed descriptions for what a clinical medication review should involve and how it 
should be delivered in clinical practice are lacking. The aim of this study was to; i) identify the ‘active 
ingredients’ of a medication review described in trials aimed at improving medication safety and 
efficacy when compared with usual care; and ii) develop a model of medication review for use in 
clinical practice. 
Approach 
The starting point was a systematic review published in 2017 (Huiskes VJ. BMC Fam Pract) 
summarising the evidence for medication review as an isolated short-term intervention (as performed 
in clinical practice). An updated literature search, using the same search data sources and strategy 
was performed. Selection criteria included RCTs with adult participants (≥18 years), involving a 
medication review intervention operationalised as a single, short-term intervention, delivered by a 
healthcare professional and involving the patient, within which all medicines used by the patient were 
considered. Trials in a palliative care setting were excluded. Titles and abstracts were screened, and 
full-text articles were considered by two reviewers independently. Data related to the characteristics of 
the intervention were extracted and analysed thematically to develop a framework to classify the 
components and functions (i.e. the ingredients) of the medication review strategies used. Outcomes 
investigated in each trial were also extracted. 
Findings  
Overall, 1498 papers were identified and 31 were included. The ingredients of the medication review 
strategies of included trials have been classified. Outcomes have been organised into the six 
categories (drug efficacy, treatment safety, service use, cost, patient experience, mortality). Cross 
tabulation analysis of ingredients per trial according to each outcome is being conducted. A 
development group comprising the investigators and external advisers representing a range of 
stakeholder perspectives will be convened in January 2020 to review and synthesise the findings of 
the systematic review and develop a comprehensive and systematic approach to medication review. 
Consequences  
A medication review model for use in a routine clinical practice setting will be of use to healthcare 
professionals who have roles in medicines optimisation; help to improve the consistency, 
transparency and quality of the medication review process; and encourage routine and improved 
dialogue between patients and prescribers around the use of medicines. 
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5C.5 Factors predicting the prescribing of statins for the primary preventing of cardiovascular 
disease: an historical cohort study 
Samuel Finnikin, University of Birmingham 
B H Willis, T Marshall 
Problem  
Estimating CVD risk is central to determining potential benefits from statins and communicating this to 
patients, but statin prescribing often does not accord with estimated CVD risk. This study investigates 
how calculation of CVD risk influences statin prescribing, and what influences statin prescribing if a 
CVD risk is not calculated.  
Approach 
A historical cohort study was undertaken using data from a large database of primary care records 
(THIN). Included patients were eligible for statins for primary prevention of CVD and had a lipid test 
between 2012 and 2016. The outcome was prescription of a statin within 60 days of the lipid result 
being recorded. Recorded QRISK2 scores (coded ten-year CVD risks) were extracted, along with 
variables used in calculating QRISK2 and others that might affect statin prescribing. If QRISK2 was 
not recorded, a post-hoc QRISK2 score was calculated. The cohort was described and the recorded 
or calculated QRISK2 score was used to describe statin prescribing in relation to NICE guideline 
eligibility. A mixed effects model (with each practice included as a random intercept) was used to 
establish the predictors of statin prescribing in in patients with and without a recorded QRISK2 score.  
Non-linear predictor effects were modelled using multiple fractional polynomials.  
Findings  
There were 686,560 entries into the cohort. 146,693 (21.4%) with a recorded QRISK2 score (the 
‘recorded’ group). Statins were initiated in 6.6% of the recorded and 4.1% of the unrecorded groups 
respectively (p<0.001). Among patients in whom statins were indicated, more were prescribed statins 
if QRISK2 was recorded than unrecorded (19.2% v 6.2%, P<0.001). Among patients in whom 
QRISK2 was recorded, 85.0% of statin initiations met NICE eligibility criteria compared with 44.2% 
were QRISK2 was unrecorded (P<0.001). Among patients in whom QRISK2 was recorded, QRISK2 
score was the most important predictor of statin initiation, but when QRISK2 was not recorded, total 
cholesterol was the main predictor of statin initiation, followed by diabetes.  
Consequences  
Estimated CVD risk (QRISK2) is frequently not recorded prior to initiating statins in UK primary care. 
When QRISK2 is recorded, prescribing is more directed at patients with increased risk and hence 
those most likely to benefit. When QRISK2 is unrecorded, prescribing is mainly based on total 
cholesterol levels and therefore less associated with predicted benefit. When risk estimation is not 
used, patients will not have the required information to make treatment decision. Promoting the 
routine use of CVD risk estimation is essential to guide optimum statin prescribing and ensure 
patients have the necessary information to make shared decisions with their doctor. With increased 
focus on CVD prevention planned for early in the 2020’s, we suggest that focusing on accurate risk 
assessment is the key to effective patient-centred care. 
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5C.6 Adverse events associated with a patent Traditional Chinese Medicine (Shufeng Jiedu 
Capsule) in clinical practice: a systematic review and meta-analysis of randomized controlled 
trials 
Xiaoyang Hu, University of Southampton 
Jeanne Trill, Merlin Willcox, Yu Zhang, Ruyu Xia, Yutong Fei, Jianping Liu, Michael Moore, Xiaoyang 
Hu 
Problem  
Shufeng Jiedu capsule (SFJD) is a traditional Chinese herbal medicine made from eight Chinese 
herbs which is widely used for upper respiratory tract infections, which has been on the market in 
China since 2009. Although there is some promising evidence on effectiveness of SFJD, there is lack 
of the evidence on its safety in clinical practice. This systematic review focuses on adverse events 
(AEs) caused by using SFJD to evaluate its safety.  
Approach 
Randomized controlled trials (RCTs) reporting AEs of SFJD were included in this study. PubMed, 
Science Direct, MEDLINE, EMBASE, Web of Science, EMBASE, China National Knowledge 
Infrastructure (CNKI), Wan Fang, Sino-Med Database, and Chinese Science and Technology Journal 
Database (VIP) were searched from inception to August 2019. Two reviewers selected and screened 
studies and extracted data independently. The outcome focused on adverse events of using SFJD. 
Effect size measures were mean differences (MD), standardized mean differences (SMD), or risk 
ratios with 95% credible intervals (CIs). This study protocol was registered under PROSPERO, 
number CRD42019149389.  
Findings  
No serious safety events were identified on the SFJD formula itself. Minor AEs included nausea, 
vomiting and diarrhoea, as well as other unspecified gastrointestinal discomfort, dizziness and rash.  
However, there were no statistical differences in the AEs between SFJD and the control groups. 
There was no difference between SFJD + usual care and usual care as measured by the number of 
AEs in respiratory conditions (RR 0.85, 95% CI [0.51, 1.42]; P=0.45, I2=0%, studies=33, 
participants=5710) or in other conditions (RR 0.85, 95% CI [0.51, 1.42]; P=0.97, I2=0%, studies=14, 
participants=2360). Similarly, there was no difference between SFJD and usual care as measured by 
the number of AEs in either respiratory conditions (RR 0.66, 95% CI [0.27, 1.1]; P=0.98, I2=0%, 
studies=7, participants=1339) or in other conditions (RR 2.50, 95% CI [0.49, 12.65]; P=0.44, I2=0%, 
studies=2, participants=240). One trial which compared SFJD to placebo reported no adverse events 
in either group.  
Consequences  
No serious safety event was identified. Minor AEs included nausea and vomiting as the most common 
AEs, however, there is limited evidence showing these AEs were directly related to the SFJD 
treatment. However, the findings in this study should be interpreted with caution due to limited 
methodological quality of the included trials. Furthermore, strict trials with precise methodological 
design and rigorous reporting on safety evaluation of SFJD should be promising. 
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5D.1 Delayed Antibiotic Prescribing for Respiratory Tract Infections: an Individual Patient Data 
Meta-Analysis 
Beth Stuart, University of Southampton 
Beth Stuart, Taeko Becque, Hilda Hounkpatin, Guiqing Yao, Shihua Zhu, Dankmar Böhning, Jennifer 
Bostock, Heiner C C Bucher, Michael Moore, Paul Little 
Problem  
Antibiotics are still frequently prescribed for respiratory tract infections (RTIs), most of which are self-
limiting and for which symptomatic benefit from antibiotics is modest at best.  Delayed prescribing can 
be a useful strategy to reduce antibiotic prescribing. Whilst in some situations delayed antibiotic 
prescribing is appropriate, for other patients it may be unsuitable.  It is important to understand which 
subgroups of patients may require immediate antibiotics and which patients might benefit from a 
delayed or no prescribing strategy.  
Approach 
This study undertook a systematic review in Cochrane Central Register of Controlled Trials, Ovid 
MEDLINE, Ovid Embase, EBSCO CINAHL Plus and Web of Science to identify all randomised 
controlled trials (RCTs) and observational cohort studies of delayed prescribing. The primary outcome 
of interest was symptom severity scores.  Secondary outcomes include duration of illness and 
reconsultation.  Interaction terms for differential effects in subgroups were explored in the following 
pre-defined groups: shorter prior duration of illness, age, fever at baseline consultation, comorbid lung 
condition and severity of symptoms at baseline consultation. IPD meta-analysis was conducted using 
a one-stage approach, using generalised linear mixed modelling with a random effect for study. All 
models controlled for baseline severity of illness and diagnosis.  Propensity scores were used as 
inverse probability weights to control for confounding in observational studies.  
Findings  
We obtained data from 4 observational studies and 9 RCTs, totalling 56,301 patients.  For the primary 
outcome, there was no statistically significant difference in symptom scores between delayed and 
immediate antibiotics (mean difference 0.04;95% CI -0.05,0.13) nor between delayed and no 
antibiotics (MD 0.03;95% CI -0.13,-0.19).  The symptom duration was slightly shorter in those given 
immediate antibiotics (RR 1.07;95% CI 1.00, 1.14).  Reconsultation was significantly less likely in 
those given a delayed prescription compared to those given no prescription (OR 0.69;95% CI 
0.56,0.84).  Subgroup analyses showed a statistically significant interaction term for those under 16 
years and those with lung disease.  Compared to those aged 16-64, those aged under 16 were more 
likely to have improved symptom scores with delayed prescribing compared to none and slightly 
poorer symptom scores with delayed compared to immediate. Symptom scores in those with lung 
disease were slightly higher in those who received a delayed prescription compared to none.   
However, none of these differences were represented a clinically meaningful difference.  There were 
no statistically significant interactions in the other subgroups.  
Consequences  
Delayed prescribing appears to be a safe and effective strategy for most patients, with no clinically 
significant increase in symptom severity in any of the pre-defined subgroups.  Encouraging delayed 
prescribing as a tool in consultations may reduce reconsultation and is unlikely to be associated with 
an increase in symptoms or illness duration. 
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5D.2 Implementing a centralised nurse-led telephone-based service to manage chlamydia and 
gonorrhoea infections diagnosed in primary care: mixed methods evaluation 
Jeremy Horwood, University of Bristol 
Emer Brangan, Petra Manley, Paddy Horner, Peter Muir, Paul North, John Macleod 
Problem  
Chlamydia trachomatis and Neisseria gonorrhoeae are the two most commonly diagnosed bacterial 
sexually transmitted infections in England, with 218,095 and 56,259 diagnoses reported in 2018, a 6% 
and 26% increase since 2017. Chlamydia, which is commonly asymptomatic, causes a substantial 
burden of disease, in women particularly, including chronic pelvic pain, ectopic pregnancy and 
infertility. Gonorrhoea treatment is threatened by the emergence of antimicrobial resistance, which is 
now a global public health priority. Up to 18% of Chlamydia infections and 9% of Gonorrhoea 
infections in England are diagnosed in Primary Care. However, evidence suggests that a substantial 
proportion of these cases are not managed appropriately in line with national guidelines.  
Approach 
We investigated feasibility and acceptability of extending the National Chlamydia Screening 
Programme’s centralised, nurse-led, telephone management (NLTM) as an option for management of 
cases of chlamydia and gonorrhoea diagnosed in Primary Care. Randomised feasibility trial in 11 
practices in Bristol and North Somerset with nested qualitative study. In intervention practices patients 
and health care providers (HCPs) had the option of choosing NLTM or usual care for all patients 
tested for Chlamydia and Gonorrhoea. In control practices patients received usual care. Interviews 
were conducted with patients and HCP, purposively sampled to capture maximum variation in views 
and experiences of NLTM. Interviews were digitally recorded, transcribed verbatim and analysed 
thematically supported by NVivo11.  
Findings  
1154 Chlamydia/gonorrhoea tests took place during the 6-month study, with a chlamydia positivity 
rate of 2.6% and gonorrhoea positivity rate of 0.8%. The majority of eligible patients in intervention 
practices were managed via NLTM (n=335). Interviews were conducted with sixteen HCPs (11 GPs, 5 
nurses) and 12 patients. Patients perceived benefits of NLTM to be a faster and a more proactive 
approach to communicating test results. The convenience and greater anonymity of telephone 
consultations and being managed by a sexual health specialist was welcomed. HCPs expected the 
impact of NLTM on workload to be positive and to provide benefits for patients in relation to better and 
timely follow-up - particularly with regards to partner notification. Findings identified a need for 
improved clarity of NLTM pathway process for both patients and HCPs, and for timely HCP 
notification of actions taken by the NLTM. Without such feedback, HCPs often felt obligated to follow 
up positive test results themselves.  
Consequences  
Extension of this established NLTM intervention to a greater proportion of patients was both feasible 
and acceptable. NLTM could both provide a better service for patients whilst decreasing primacy care 
workload and contribute to better use of clinical resources and better patient outcomes. The study 
provides evidence to support the wider implementation of this NLTM approach to managing 
chlamydia and gonorrhoea diagnosed in primary care. 
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5D.3 The early use of Antibiotics for at Risk CHildren with InfluEnza (ARCHIE): a double-blind 
randomised placebo-controlled trial 
Kay Wang, University of Oxford 
Malcolm G Semple, Michael Moore, Alastair D Hay, Tricia Carver, Sharon Tonner, Ushma Galal, 
Rafael Perera, Ly-Mee Yu, Jill Mollison,  Paul Little, Andrew Farmer, Christopher Butler, Anthony 
Harnden 
Problem  
‘At risk’ children with underlying medical conditions are more likely to develop complications from 
influenza/influenza-like illness (ILI) than otherwise healthy children.  The UK government stockpiles 
co-amoxiclav to treat bacterial complications during influenza epidemics and pandemics.  However, it 
is unclear whether early antibiotics prevent influenza/ILI-related clinical deterioration.  We aimed to 
determine whether early co-amoxiclav treatment in ‘at risk’ children with influenza/ILI reduces risk of 
re-consultation due to clinical deterioration.  
Approach 
We recruited ‘at risk’ children aged 6 months-12 years who presented within five days of ILI onset. We 
opened 151 general practices, 44 hospitals and one walk-in centre for recruitment. Participants were 
randomly assigned to oral co-amoxiclav 400/57 twice daily or placebo for five days. Randomisation 
used a non-deterministic minimisation algorithm to balance age and vaccination status. Participants, 
caregivers and investigators were blinded to treatment allocation.  Our intention-to-treat analysis 
included all randomised participants with available primary outcome data. The primary outcome was 
re-consultation due to clinical deterioration within 28 days of randomisation. Proportions of children re-
consulting were compared using a log-binomial regression model with adjustment for region, age and 
seasonal influenza vaccination status. Our safety analysis included all randomised participants.  We 
conducted an exploratory subgroup analysis in participants with laboratory-confirmed influenza.  
Influenza was detected by real-time PCR analysis of nasal swabs. Trial registration: ISRCTN 
70714783. EudraCT 2013-002822-21.  
Findings  
Between February 11, 2015 and April 20, 2018, we recruited 271 children of whom 37 had laboratory-
confirmed influenza (13.7%).  Primary outcome data were available for 265 children.  No significant 
difference was observed between groups in re-consultation rates (co-amoxiclav 33/133, placebo 
28/132, unadjusted risk ratio [RR] 1.17, 95% confidence interval [CI] 0.75-1.82 risk difference[RD] 
3.6%, 95% CI -6.5%-13.7%).  This finding did not change after adjustment for baseline covariates 
(adjusted RR 1.16, 95% CI 0.75-1.80).  There was no significant difference between groups in 
proportions of children with serious adverse events, none of which were considered related to study 
medication (co-amoxiclav 8/136, 5.9%; placebo 7/135, 5.2%; RD 0.7%, 95% CI -5% to 6%).The 
proportion of children with laboratory-confirmed influenza who re-consulted was lower among those 
who received co-amoxiclav (5/21, 23.8%) versus placebo (6/16, 37.5%).  However, the difference 
between groups was not statistically significant (unadjusted RR 0.63, 95% CI 0.24-1.71; adjusted RR 
0.55, 95% CI 0.20-1.55).  We therefore did not find evidence that early co-amoxiclav treatment in ‘at 
risk’ children with influenza/ILI reduces re-consultations due to clinical deterioration.  However, there 
may be a benefit in children with laboratory-confirmed influenza.  
Consequences  
Immediate antibiotics should not be given to ‘at risk’ children presenting early with influenza/ILI 
without evidence of bacterial infection.  Antibiotics may be associated with clinical benefit during 
periods of high influenza activity.  However, further research is needed to more accurately identify 
children who may benefit from early intervention. 
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5D.4 Using evidence-based infographics to increase parents’ understanding about antibiotic 
use and antibiotic resistance: a proof-of-concept study 
Oliver Van Hecke, University of Oxford 
Joseph J Lee,  Sarah Tonkin-Crine, Michael Moore, Christopher Butler 
Problem  
Antibiotic resistance is an important societal health issue. The greatest risk factor for developing a 
resistant infection is antibiotic use. Almost 75% of all antibiotics in the UK are prescribed in primary 
care. Estimates suggests that at least one third of all antibiotics prescribed in primary care are 
unnecessary especially in preschool children with self-limiting respiratory tract infections. Public 
misconceptions about antibiotic use persist despite the efforts of antibiotic awareness campaigns. 
These campaigns have often followed a top-down approach and have not sought input from the public 
about their personal experiences of managing illness. It is crucial that communities see antibiotic 
campaign messages as relevant, accessible and important in order to have an influence on health 
seeking behaviour and antibiotic use. We therefore set to develop a series of evidenced-based 
infographics (EBIs) on antibiotic use for common infections in children and to evaluate their 
effectiveness at increasing parents’ understanding of antibiotic use and antibiotic resistance.  
Approach 
There are three phases to this research. In phase 1 we set out to identify and summarise scientific 
evidence for the use of antibiotics for three common infections in children (sore throat, acute cough 
and otitis media). Phase 2 focussed on co-design of a series of prototype EBIs for each infection in 
focus groups with parents of young children to test the face- and content validity. Phase 3 will test the 
feasibility of EBIs in increasing parents’ understanding about antibiotic use and the perceived 
relevance of antibiotic resistance in an online survey.  
Findings  
This proof-of-concept study is a work in progress. We have co-developed, reviewed and revised a 
series of EBIs with parents and professional graphic designers using the evidence from phase 1 in 
two focus groups. The process and prototype EBIs will be showcased at conference.  
Consequences  
This study will identify how parents interpret EBIs on antibiotic use and antibiotic resistance and 
inform novel approaches to improving antibiotic stewardship initiatives in the community. 
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5D.5 Clinicians views and experiences of implementing a complex intervention to reduce 
antibiotic prescribing in children with Respiratory Tract Infections in primary care 
Clare Clement, University of Bristol 
Clare Clement, Jenny Ingram, Christie Cabral, Pete Blair, Patricia Lucas, Jeremy Horwood 
Problem  
Antimicrobial resistance is recognised as one of the most pressing global public health threats of our 
time. Respiratory Tract Infections (RTIs) in children present major primary care challenge because 
they are common, costly and ongoing uncertainty regarding diagnosis and management is a major 
driver of antibiotic prescribing. Improved identification of children at low risk of future hospitalisation 
could increase confidence of when not to prescribe antibiotics for RTIs. To address this, The CHIldren 
with Cough Cluster Randomised Controlled Trial (the CHICO RCT) aims to reduce antibiotics 
prescribing amongst children presenting with acute cough or RTI without increasing hospital 
admission. The CHICO intervention incorporates a clinician focussed prognostic algorithm to predict 
hospitalisation in children with RTIs and a carer-focussed personalised advice leaflet recording 
treatment decisions, care and safety netting information. As part of the CHICO RCT pilot study, we 
conducted qualitative interviews with clinicians to investigate the actability and feasibility of the 
CHICO intervention.  
Approach 
Semi-structured interviews with clinicians to explore views and experiences of the CHICO 
intervention.  Clinicians were sampled to include those from practices with high and low patient list 
sizes and high and low prescribing rates. Normalisation process theory, which outlines the social 
processes involved in intervention implementation, informed data collection and thematic data 
analysis.  
Findings  
We interviewed 8 GPs and 2 nurses from 8 practices. Clinicians liked the intervention and used it as a 
supportive aid within consultations, describing it as a “safety net”. It was a way of reassuring 
themselves and parents of the appropriateness of some treatment decisions. They liked the patient 
advice leaflet as it helped explain treatment decisions and home care with parents. Most clinicians 
liked the algorithm template, found it easy and straightforward to use, without adding any more time to 
consultations. However, a minority of clinicians stopped using the algorithm because they were 
unclear how to complete the template, which led them to think it wasn’t working. Other issues 
encountered during the pilot included the use of a ‘hard pop-up’ which launched for all children under 
10 years. This limited use of the intervention for some because it was launched at a point too early in 
the consultation to be useful. Findings were fed back to the Trial Management Group who used the 
information to make changes to improve the intervention for the main trial. For example, a modified 
‘soft pop-up’ in relation to diagnosis read codes was implemented.  
Consequences  
Clinicians reported the CHICO intervention to be beneficial for supporting clinician’s decision making 
around antibiotic prescribing for children with cough or RTI and helped discussions with parents. The 
findings demonstrate the value of conducting qualitative interviews early in trials to identify initial 
teething problems and inform refinements to study design. 
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